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ABSTRACT 
 
Living cells accumulate compensatory solutes for protection against the harmful effects of 
extreme environmental conditions such as high salinity, temperature and desiccation. Even at 
high concentrations these solutes do not disrupt the normal cellular functions and at times 
counteract by stabilizing the cellular components. These properties of compensatory solutes 
have been exploited for stabilizing proteins and cells in vitro. Betaines are widespread natural 
compensatory solutes that have also been used in other applications such as therapeutic 
agents and polymerase chain reaction (PCR) enhancers. Some biomedical applications of 
novel synthetic analogues of natural betaines were investigated. 
 
Natural compensatory solutes are either dipolar zwitterionic compounds or polyhydroxyl 
compounds, and the physical basis of compensation may differ between these, so one focus 
was on synthetic betaines with hydroxyl substituents. The majority of the synthetic solutes 
stabilized different model proteins against stress factors such as high and low temperatures. 
The presence of hydroxyl groups improved protection against desiccation. The observed 
stabilization effect is not just on the catalytic activity of the enzyme, but also on its structural 
conformation. Synthetic compensatory solutes have a potential application as protein 
stabilizers.  
 
Dimethylthetin was evaluated as a therapeutic agent and found to be harmful in a sheep 
model. However, from the study we were able to generate a large-animal continuous 
ambulatory peritoneal dialysis (CAPD) model and showed that glycine betaine could be 
added to the dialysis fluid in chronic renal failure. 
 
Some synthetic compensatory solutes reduce the melting temperatures of DNA better than 
most natural solutes. Synthetic solutes were identified that have potential to enhance PCR 
and could replace some reagents marketed by commercial suppliers. 
 
Density, viscosity and molecular model data on the solutes showed correlations with the 
biochemical effects of the solutes, but no physical measurements were found that reliably 
predicted their potential for biotechnological applications. 
 ix   
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Chapter 1 - INTRODUCTION 
 
1.1  GENERAL INTRODUCTION 
 
Living organisms survive in a wide variety of environmental conditions, including 
extremes of salinity, temperature and humidity. These environmental stresses disrupt key 
properties of the cells such as enzymatic catalysis, binding of ligands by enzymes, protein 
subunit assembly and protein solubility (Yancey et al., 1982). Organisms have developed 
a number of adaptive strategies to cope with these environmental stresses and one of 
these is the accumulation of high concentrations of low molecular weight solutes in the 
intracellular fluid. These solutes, termed ‘osmolytes’, are used as osmotic agents to 
maintain the osmotic balance in the cell and are found both in prokaryotic and eukaryotic 
cells (Yancey et al., 1982). Commonly occurring osmolytes are classified as sugars, 
polyhydric alcohols, amino acids and their derivatives, and methylamines (Somero, 
1992). As these organic osmolytes are accumulated to extremely high concentrations 
without perturbing the cellular functions, they are also called ‘compatible solutes’ 
(Brown and Simpson, 1972). The accumulation of compatible solutes in cells is a general 
mechanism for protein stabilization in the face of high intracellular osmolarity and is 
simpler than evolution of many intracellular proteins.        
 
Urea is an organic osmolyte which is found in different animals along with other 
osmolytes. The presence of urea is difficult to explain as it is a strong perturbant of 
macromolecules and is commonly used to denature proteins. Urea is found in certain 
cartilaginous fish (Yancey and Somero, 1978) and also in the inner medulla of 
mammalian kidneys (Yancey, 1992). Wherever there are potentially harmful 
concentrations of urea, there also appears to be the co-occurrence of second type of 
organic osmolyte, typically a methylamine. Methylamines such as glycine betaine, 
trimethylamine-N-oxide (TMAO) and sarcosine are known to counteract the perturbation 
of proteins by urea (Yancey and Somero, 1978). Therefore, these osmolytes were further 
termed as ‘counteracting solutes’.  
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In a study by Bedford et al. (1995), it was shown that the medullary and papillary regions 
of the kidney of domesticated red deer were rich in betaine, sorbitol and free amino acids, 
suggesting their role as osmolytes. NMR and HPLC analyses of the organic constituents 
of tissues of elephant fish revealed that glycine betaine and a compatible osmolyte, 
taurine, are present in high concentrations. These results suggested that osmolytes are 
accumulated to counteract the external osmotic stress (Bedford et al., 1997). 
 
Apart from their counteracting effect, a few solutes are also known to stabilize the 
cellular components and are referred to as ‘compensatory solutes’ (Galinski et al., 1997; 
Gilles, 1997). Compensatory solutes can be classified into two main categories of neutral 
polar organic compounds. The first group includes polyols or polyhydric alcohols (e.g. 
trehalose and sorbitol) and the second group includes zwitterions containing a relatively 
hydrophobic cationic region (e.g. glycine betaine and ectoine). Compensatory solutes are 
known to affect the structuring of water in solutions (Galinski et al., 1997). Solutes that 
increase the structure of water are termed ‘kosmotropes’ and those which decrease the 
structure of water are termed ‘chaotropes’. 
 
As described above, these organic solutes are often referred with different terms. Other 
than simply referring to them as solvent additives, compounds which are able to stabilize 
cells against osmotic stress and help in maintaining osmotic equilibrium are termed 
‘osmolytes’. Solutes which do not disturb the cellular mechanism even when present in 
very high concentration are called ‘compatible solutes’ and the solutes that are known to 
stabilize certain cell components are termed ‘counteracting’ or ‘compensatory’ solutes. 
Hereafter in this thesis, these solutes will be referred to as ‘compensatory solutes’ 
(natural or synthetic).  
 
Compensatory solutes, due to their effective stabilization of cell components are of great 
interest to biotechnologists. Till now, biotechnologists have focused primarily on natural 
compensatory solutes such as trehalose and glycine betaine. However, solutes such as 
trehalose are expensive to produce or purchase. Little attention has been paid to finding 
inexpensive alternatives to these natural stabilizers. Only a few systematic studies have 
2 
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tried to examine the effect of analogues of natural solutes. Lloyd et al. (1992; 1994) 
studied a few simple analogues of natural kosmotropes and showed that relationships 
existed between the solute structure and its effectiveness to stabilize proteins. Synthetic 
betaines have been shown to counter the effects of high NaCl and urea concentrations 
using cultures of E. coli as a model system (Randall et al., 1996). Recently, a synthetic 
compatible solute, homoectoine, was shown to be a potent PCR enhancer (Schnoor et al., 
2004). Hence, designing new synthetic compensatory solutes may help biotechnologists 
explore novel and inexpensive ways to stabilize proteins.  
 
The native folded structure of a protein is sensitive to changes in environmental 
conditions such as temperature, pressure, moisture content, and presence of salts and 
other solutes. Significant perturbations of these conditions can cause changes in 
secondary and tertiary structure of the protein, leading to a partial or complete loss of 
their activity. Different ways of stabilizing proteins for long-term storage or for use at 
high and low temperatures have been investigated in the past. Consequently, stabilization 
of proteins and its mechanism have been an interesting area of research for the last three 
decades. Several mechanisms of protein stabilization have been proposed; the preferential 
exclusion model by Timasheff and co-workers (Gekko and Timasheff, 1981), the 
osmophobic effect proposed by Bolen and co-workers (Bolen and Baskakov, 2001) and 
protection of proteins against low temperatures (e.g. freeze-drying) by Carpenter and 
Crowe (1989). A review of these proposed mechanisms is detailed in Chapter 2 of this 
thesis. 
 
The majority of the studies carried out to explore the mechanism of protein stabilization 
have used only a few naturally occurring solutes. These proposed mechanisms have not 
been able to explain why some of the solutes are protein specific and stabilize some 
proteins, but fail to stabilize others. In many cases the use of these natural solutes is 
insufficient to stabilize proteins completely. To gain a greater understanding of these 
stabilization mechanisms it is proposed to synthesize compensatory solutes which are 
structurally slightly different, and to study their stabilization effect on different proteins. 
This approach may give new insight into the mechanism of protein stabilization and also 
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provide biotechnologists with alternate inexpensive solutes for the purpose of protein 
stabilization. 
 
Glycine betaine (GB) is possibly the most widely distributed compensatory solute in 
nature. It enables growth under conditions of cell stress in bacteria (Redulier et al., 1984; 
Chambers and Kunin, 1985; Randall et al., 1996), higher plants (Rhodes and Hanson, 
1993) and mammals (Burg, 1992). GB also stabilizes biological macromolecules against 
heat denaturation (Santoro et al., 1992), freezing (Lloyd et al., 1994) and urea (Yancey et 
al., 1982). 
 
Other than being a compensatory solute, glycine betaine plays an important role in nature 
acting as a methyl donor in homocysteine metabolism. Homocysteine (Hcy) is an 
intermediate in the metabolism of the essential amino acid methionine. In a pathway 
catalyzed by betaine-homocysteine methyltransferase (BHMT- E.C. 2.1.1.5), glycine 
betaine donates a methyl group to homocysteine forming methionine and N,N-
dimethylglycine (Figure 1.1). 
 
 
Figure 1.1:  Homocysteine metabolism 
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It has been shown that 80% of chronic renal failure (CRF) patients receiving dialysis 
treatment have elevated plasma Hcy (Bostom and Lathrop, 1997; Soria et al., 1990; 
Hultberg et al., 1993), which in turn has been linked to increased risk of vascular disease 
(cardio, cerebral and peripheral) (Boushey et al., 1995; Nygard et al., 1997; Welch and 
Loscalzo, 1998). The cause(s) of elevated levels of Hcy in renal failure patients is 
unclear. However, the kidney primarily metabolizes Hcy rather than excreting it, and thus 
it is likely that the higher levels of plasma Hcy in CRF patients is a result of disturbed 
Hcy metabolism. Oral supplementation with GB in humans has proven useful for 
lowering plasma Hcy concentrations (Wilcken et al., 1983; McGregor et al., 2002; Olthof 
et al., 2003), however, long-term compliance is problematic and diarrhoea has been 
reported during therapy (Knopman and Patterson, 2001). Consequently, it would be 
useful to explore new and effective ways of treating renal failure patients with GB to 
increase the methyl donor availability. 
 
One of the products of BHMT pathway, N,N-dimethylglycine, is a potent feedback 
inhibitor of BHMT (Mckeever et al., 1991; Millan & Garrow, 1998), and this may be one 
of the causes for disturbed Hcy metabolism leading to elevated Hcy concentrations. 
Dimethylthetin (DMT), a synthetic analogue of GB, may be a potential therapeutic agent 
for lowering plasma Hcy. Purified BHMT has been shown to utilize DMT as a substrate 
at thirty-times the rate of GB (Goeger & Ganther, 1993). Furthermore, the demethylated 
product of DMT, methylthioacetate, does not inhibit BHMT as does N,N-dimethylglycine 
(Garrow, 1997), and it has been shown that a single dose of DMT is more effective for 
lowering Hcy in rats when compared to an equivalent dose of GB (Slow et al., 2004), 
thus suggesting that DMT could be used as a therapeutic homocysteine-lowering agent. 
 
S
H3C
H3C
CH2COON
CH3
H3C
CH3
CH2COO
Glycine betaine [GB] Dimethylthetin [DMT]
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Higher concentrations of glycine betaine have also been shown to reduce the DNA 
melting temperatures by eliminating the base pair composition dependence of DNA 
(Rees et al., 1993). Glycine betaine destabilizes the double helical conformation of DNA 
and the melting temperature decreases approximately linearly with increasing GB 
concentrations. It has been shown that addition of glycine betaine in a polymerase chain 
reaction (PCR) assay enhances/improves the amplification of GC-rich DNA sequences 
(Henke et al., 1997).  
 
1.2  OBJECTIVES 
 
Based on these various applications of glycine betaine, a natural compensatory solutes, 
we decided to synthesize a range of analogues of glycine betaine and its related 
compounds, and investigate their effectiveness in various biomedical applications. The 
objectives of this thesis were: 
 
• To synthesize a range of novel compensatory solutes. 
• To explore the application of synthetic compensatory solutes as protein stabilizers. 
For this, we plan to study the protective effects of synthetic solutes on different 
model enzymes against the deleterious effects of high and low temperatures. 
• To explore the medical application of betaine analogues by studying GB and DMT 
treatment for reducing plasma Hcy levels in an animal model of acute renal failure. 
• To investigate the effects of synthetic compensatory solutes on DNA melting 
temperatures and to identify new PCR enhancers for amplification of GC-rich DNA 
sequences. 
• To gather more physical data for novel synthetic compensatory solutes and to 
attempt to provide more information towards the understanding of mechanisms of 
protein stabilization. 
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1.3  THESIS OVERVIEW 
 
Based on the objectives, this thesis has been divided into following chapters: 
 
Chapter 2: This chapter contains a review of literature on the proposed mechanisms of 
protein stabilization by co-solvents/compensatory solutes.  
 
Chapter 3: This chapter describes the methods of syntheses of the various compensatory 
solutes used in this thesis. Results of 1H NMR and elemental analyses of the synthesized 
solutes are presented. 
 
Chapter 4: Stabilization of different model enzymes by synthetic compensatory solutes 
against heat denaturation, freeze-drying and freeze-thawing is examined in this chapter. 
The ability of compensatory solutes to prevent the unfolding of chymotrypsin is also 
examined. 
 
Chapter 5: This chapter examines the effect of addition of DMT and GB to dialysis fluid 
in order to reduce the plasma Hcy levels in a sheep model of acute renal failure. 
 
Chapter 6: The effect of synthetic compensatory solutes on melting temperatures of 
three different DNA samples is examined in this chapter. This chapter also investigates 
the effectiveness of a few synthetic solutes to act as PCR enhancers. 
 
Chapter 7: Density and viscosity measurements and calculation of  apparent hydration 
numbers of various compensatory solutes are presented and discussed in this chapter. 
Results of theoretical calculations of interactions of compensatory solutes with water are 
also presented. 
 
Chapter 8: This chapter contains the discussion and conclusions of various applications 
of synthetic compensatory solutes explored in this thesis. Recommendations for future 
work are also detailed. 
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Chapter 2 - Proteins and Stabilization Mechanisms 
 
2.1 PROTEINS 
 
Proteins, meaning “of prime importance” in Greek, are fundamental constituents of all 
cells and tissues in our body. They are essential for the function and structure of all living 
cells and viruses. Proteins are large molecules which are made up of 20 different smaller 
molecules called amino acids, an organic acid that contains an amino group. Though 
amino acids are classified into different groups, the common feature is that they all have 
central carbon atom attached to a hydrogen atom, an amino group and a carboxylic group.  
 
Several amino acids are joined together by peptide bonds to form a polypeptide. A 
peptide bond is an amide linkage between the carboxyl group of one amino acid and the 
amino group of another amino acid, with the splitting out of a molecule of water. Proteins 
may be considered as complex polypeptides with one or more polypeptide chains in each 
molecule. Peptide bonds joining to form an unbranched polypeptide chain are considered 
the primary structure of a protein. In secondary structure, several polypeptide chains are 
joined together and held in definite folded shapes by hydrogen bonds, a bonding that 
usually occurs between the carbonyl and amide groups of the peptide chain. The tertiary 
structure of a protein is formed by several types of bonds between the polypeptide chains 
that hold the structure in a more complex and a rigid shape.  
 
Primarily, proteins are classified into two broad categories, globular proteins and fibrous 
proteins. Fibrous proteins are insoluble in water and are used for structural purposes in 
organisms (e.g. skeletal muscles). Globular proteins are tightly folded, soluble in water 
and have specific functions (e.g. enzymes, hormones and antibodies). Enzymes are one of 
the major groups of globular proteins and are considered as organic catalysts that 
accelerate many reactions in a living cell. 
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Figure 2.1: The peptide bonds, peptide backbone and side chains of a 
polypeptide.(http://folding.stanford.edu/education/protein.html) 
 
A more appropriate definition of an enzyme is: Enzymes are proteins, formed by a living 
cell, which catalyze a thermodynamically possible reaction by lowering the activation 
energy so the rate of reaction is compatible with the conditions in the cell (Routh et al., 
1973). Enzymes are classified based on the type of chemical reaction they catalyze. The 
six major classes of enzymes are, 
 
1. Oxidoreductases, enzymes involved in physiological oxidation processes. 
2. Transferases, enzymes catalyzing the transfer of a chemical group from one 
substrate to another. 
3. Hydrolases, enzymes which catalyze hydrolytic reactions. 
4. Lyases, enzymes catalyzing the removal of chemical groups without hydrolysis. 
5. Isomerases, enzymes which catalyze isomerization reactions. 
6. Ligases, enzymes catalyzing the linking together of two molecules with the 
breaking of a bond. 
 
To be biologically active, proteins and enzymes need to maintain their native 
conformational structure. Changes in temperature, pH and environmental conditions, lead 
to unfolding (denaturation) of protein structure, which changes their chemical properties 
and render them inactive. In vivo, living cells have developed their own strategies, like 
accumulation of certain solutes, to stabilize proteins against environmental changes. 
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Organisms maintain their biological activity in the face of severe denaturing stresses such 
as heat, dehydration and extreme solution conditions like high salt and urea (Somero, 
1986; Yancey et al., 1982). These organisms protect themselves against the denaturing 
stresses by producing tens to hundreds of millimolar intracellular concentrations of 
certain low molecular weight compounds, known as osmolytes (Yancey, 1982). 
Osmolytes have been shown to provide stability to enzymes usually without affecting 
their catalytic activity (Bowlus and Somero, 1979; Borowitzka and Brown, 1974). 
Researchers have explored different methods to stabilize proteins for their long-term 
storage and use. Proteins usually unfold and become inactive during their storage in  
solution or when subjected to low temperatures during freezing. In order to avoid 
unfolding and to stabilize proteins, co-solvents may be added to the protein solution.  
 
2.2 MECHANISMS OF PROTEIN STABILIZATION BY COSOLVENTS 
2.2.1   Preferential Exclusion, Preferential Hydration and Preferential 
Interaction 
 
It was known for many years that addition of certain substances to aqueous solution of 
proteins results in stabilization of their native conformation. Some of the most commonly 
used compounds for this purpose were sucrose, glycerol and ethylene glycol. In 1976, 
Timasheff and colleagues tried to investigate, at the molecular level, the mechanism by 
which certain solvent systems stabilize the structure of biological macromolecules. 
Timasheff et al. (1976) reported that protein structure stabilizing solvents are 
preferentially excluded from the domain of the protein. In their study of α-chymotrypsin 
in 4 M glycerol they showed such exclusion existed and proposed that this exclusion is 
thermodynamically unfavorable and the system will tend to reduce it by decreasing the 
area of solvent-protein contact through enhancement of the protein self-association.  
 
To understand this mechanism further, Gekko and Timasheff (1981) made measurements 
of preferential interactions of proteins with components in a water-glycerol solvent 
system using six different proteins. They showed that all six proteins used were 
preferentially hydrated in the water-glycerol solvent system. Preferential binding data 
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indicated that the chemical potential of a protein (or its activity coefficient) increases 
with increasing glycerol concentration. Since glycerol is known to repel non-polar 
substances quite effectively and interacts favorably with water, the presence of glycerol 
in the aqueous medium should increase the hydrophobicity of the protein. Thus, the non-
polar/hydrophobic groups would be expected to react unfavorably to contact with the 
mixed solvent and would prefer to migrate into the interior of the protein, out of contact 
with the solvent. However, such a migration is not possible due to the tight packing of the 
three-dimensional structure of the protein and also due to the fact that hydrophobic 
groups are covalently linked to the polypeptide chain of the protein. As a result, they 
proposed, the converse takes place, i.e. the water and glycerol molecules redistribute 
themselves in the vicinity of the protein molecule.  
 
When protein denatures or unfolds, there is an increase in the surface of contact between 
protein and solvent, and it also exposes additional hydrophobic residues. Hence, 
unfolding in the presence of glycerol would increase the thermodynamically unfavorable 
situation and require the use of more free energy for unfolding than in water. They 
concluded that the presence of glycerol should tend to favour the more folded or native 
state. The main drawback of this study was that all the measurements of preferential 
interactions were done on the native protein and not on the denaturated or unfolded 
protein. Furthermore, they generalized for all proteins based on the effect of glycerol then 
observed on six model proteins. 
 
Continuing the effort to understand the stabilization of globular proteins by preferential 
hydration and the mechanism of co-solvent interactions with proteins, Arakawa et al. 
(1990a), undertook a study to examine the effect of MgCl2 on protein stability at acid pH 
and at salt concentrations of 0.5-1.5 M, conditions at which MgCl2 induced preferential 
hydration of proteins. They included 2-methyl-2,4-pentanediol (MPD) in their study as it 
had been shown that the presence of MPD induced strong preferential hydration of 
ribonuclease A (Pittz and Timasheff, 1978), and also due to the prediction that MPD 
should be a protein denaturant (Pittz and Bello, 1971). Their analysis of the relations 
between preferential interactions and structural stabilization of proteins brought out the 
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reasons why preferential interactions of native proteins with solvent additives do not 
necessarily correlate with protein stability. 
 
From their results, Arakawa et al. (1990a) classified co-solvents into two categories.  In 
their first category, consisting of good stabilizers, like sucrose and MgSO4, the protein-
solvent interactions were determined mainly by the properties of the solvent. As 
illustrated in their figure (Figure 2.2A) the interaction is always that of preferential 
hydration, whether the protein is native or unfolded, and the principal mechanism of 
interaction is the strong increase in the surface free energy (surface tension) of water 
upon their addition. During unfolding, due to the increase in surface of protein-solvent 
contact and the surface free energy, the equilibrium shifts toward the native compact state 
resulting in structure stabilization. In their second category, as illustrated in Figure 2.2B, 
it is the chemical nature of the protein surface that determines the interactions (repulsive 
or attractive). In this category, the preferential interactions varied strongly with the pH of 
the system, concentration of solvent additive and the state of folding of the protein. This 
category contained MPD (repelled by charges, bound to non-polar regions), MgCl2 
(excluded by surface tension effect, attracted by Mg2+ binding to non-polar regions) and 
polyethylene glycol (excluded by steric effect, bound to non-polar regions).  
 
Arakawa et al. (1990a) concluded, as illustrated in Figure 2.2, that when the protein-
solvent interactions are independent of the chemical nature of the protein surface, the 
effect will always be that of stabilization and if the interactions are mainly due to the 
chemical nature of the protein surface, addition of co-solvent may either stabilize or 
destabilize the protein. They also concluded that the measurement of the interactions for 
just the native protein does not give direct insight into the effect of the solvent on protein 
stability.  
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Figure 2.2: Protein-Solvent interactions (A) Protein denaturation reaction in the presence 
of a stabilizing co-solvent. (B) In the denaturation reaction, shown for water-MPD 
system, MPD binding to solvent-exposed non-polar regions in the denatured state. 
(Arakawa et al., 1990a) 
 
The thermodynamic principles that govern the structure stabilization by solvent 
components were explained by Timasheff and Arakawa (1997). They considered the 
destabilization reaction, that is, protein denaturation, and expressed it as simple two-state 
equilibrium between the native ‘N’ and denatured (unfolded or destabilized) ‘D’ states. If 
by the addition of solvent additive S, the equilibrium be shifted toward the native form of 
the protein, then the reaction can be expressed by: 
 
 
N 
 K(S)
Stabilizer
D
  ,                    
[ ]
[ ]N
DK=                            (2.1) 
Thus, by definition, the equilibrium constant of the above reaction is a function of the 
concentration of the stabilizer S. 
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The Wyman linkage relation (Wyman, 1964), expresses quantitatively the effect of the 
stabilizer on the equilibrium constant. This relation states that, when the co-solvent 
concentration changes, the change in the equilibrium constant is given by the difference 
in the number of co-solvent molecules bound by the denatured and native protein 
molecules: 
 
ND
S
sad
Kd ννν −=∆=
log
log                                              (2.2) 
 
where aS is the thermodynamic activity of the additive, S, related to its free concentration 
by the activity coefficient; ∆νS is the difference between the number of moles of solution 
component S (stabilizer) bound per mole of protein between the denatured (νD) and 
native (νN) states of the protein. 
 
From equation (2.2), Timasheff and Arakawa (1997) stated that in the case of 
stabilization the reaction will be shifted to the left, so the equilibrium constant must 
decrease with an increase in concentration of the additive, thus, (d log K/d log aS) will be 
negative, so ∆νS will also be negative. In other words, there must be less binding of the 
stabilizer to the denatured form of the protein than to the native one. To measure these, 
they used a dialysis equilibrium technique to measure the binding of stabilizing solvents 
to a variety of proteins in the native state. The results of their studies showed a negative 
number of moles of additive per mole of protein. Figure 2.3 shows the interpretation of 
the results of their dialysis equilibrium experiment. In Figure 2.3 (A) we see that at the 
end of the experiment, the solution inside the bag has a higher concentration of the 
additive than the bulk solvent, and in Figure 2.3 (B), we see the opposite, that is, the 
solution inside the bag has lower concentration of the additive than the bulk solvent. 
 
From the dialysis experiment, it was found that sugars and amino acids were 
preferentially excluded from the protein surface, thus stabilizing the proteins. 
Interestingly, all the co-solvents that stabilized the protein also raised the surface tension 
of water. These observations suggested that the stabilization of proteins by co-solvents is 
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due to the increase of the surface tension in their presence. This was consistent with the 
classic results of Gibbs (1878), who showed that substances that lower the surface tension 
of water accumulate at the surface and those that raise surface tension are depleted from 
the surface. The analyses of interfacial tension at the protein surface contained 
assumptions about the protein-solvent interface. 
 
Surface tension, classically, is measured at a flat homogeneous water-air interface, which 
varies with temperature and solvent composition. However, the protein surface is not flat 
and the effect of its curvature on the interface had to be accounted for. Also, the surface 
of the protein is not chemically homogeneous and can be regarded as a mixture with 
varying polarity, hydrophobicity and electro static charge. The increase of surface tension 
of water by several molecules gave a poor correlation between the experimentally 
measured preferential interactions and the values expected from the surface tension 
measurements, like ArgHCl and LysHCl with bovine serum albumin (Kita et al., 1994) 
and for MgCl2 (Arakawa et al., 1990a). Because ArgHCl and LysHCl have the potential 
to interact directly with the proteins by hydrogen bonding to peptide groups, Kita et al. 
(1994) proposed that the measured preferential interactions are a summation of the effects 
of the increase in surface tension and weak binding. 
 
(A)     (B) 
Figure 2.3: Solvent component distribution at dialysis equilibrium (A) Preferential 
binding (B) Preferential hydration. (Timasheff and Arakawa, 1997) 
19 
Chapter 2 
Timasheff and co-workers laid the foundation for understanding the mechanism of 
protein stabilization by co-solvents. However, there were limitations in their studies. 
They considered only a few co-solvents for their studies, and their proposed mechanisms 
were mainly based on the effect of co-solvent on the native protein not on its denatured 
form. Their mechanism emphasized the interaction of co-solvents with protein side-
chains and does not mention effects on the peptide backbone, which also contributes to 
the hydrophobic effect of proteins. 
2.2.2   Steric exclusion mechanism 
 
        
 
Figure 2.4: The steric exclusion mechanism of preferential hydration. Water, protein and 
osmolyte (co-solvent) are represented by spherical geometry (Bolen, 2004). 
 
Kauzmann (1949) (quoted in Schachmann and Lauffer, 1949) first proposed the steric 
exclusion mechanism to explain the preferential hydration of co-solvents. The difference 
in the size of co-solvent and water molecules is the basis of this phenomenon and 
according to it, if the co-solvent cannot penetrate the protein structure, a shell that is 
impenetrable to co-solvent is formed around the protein molecule. The thickness of this 
shell is determined by the distance of closest approach of protein and co-solvent. 
However, water molecules, which are smaller in size, can penetrate within this shell. This 
results in a zone around the protein molecule that is enriched in water. Effectively, this is 
preferential hydration and preferential exclusion of the co-solvent. This hypothesis has 
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been studied by Bhat and Timasheff (1992) using several proteins, with varying 
molecular weight and polarity, and with both high and low molecular weight 
polyethylene glycol (PEG) molecules. They concluded that steric exclusion is the 
principal source of preferential hydration of proteins in the presence of polyethylene 
glycols. 
 
Steric exclusion does not apply to all cases. Urea and guanidine hydrochloride have radii 
larger than that of water and preferential interaction measurements on proteins using 
these solutes have shown that these strong denaturants do not preferentially hydrate 
proteins and moreover, they bind to the native protein molecules (Arakawa and 
Timasheff, 1984; Timasheff, 1992). These two denaturants show that solutes that have 
preferences of favorably interacting with the chemical groups on the protein surface can 
override the excluded volume effects that cause preferential hydration. Thus, affinity and 
steric effects both contribute to the distribution of solute and water at the protein surface 
(Bolen, 2004). 
 
2.2.3   Osmophobic Effect 
 
Bolen and co-workers have tried to explore the mechanism of protein stabilization with 
their studies on osmolytes and related compounds. They studied the effects of osmolytes 
that are chemically similar to one another, choosing glycine based osmolytes and 
studying their stabilizing effect on ribonuclease A (RNase A) and hen egg white 
lysozyme (HEW lysozyme) against thermal unfolding (Santoro et al., 1992). They 
observed that Tm, the midpoint temperature of thermal unfolding transition for a protein, 
increased for both RNase A and HEW lysozyme in the presence of osmolytes. These 
osmolytes seemed to stabilize proteins even well beyond the physiological concentration 
and moreover, the degree of stabilization was extraordinary. They also showed that 
RNase A will refold in a completely reversible manner in the presence of up to 8 M 
sarcosine, which indicated that basic rules for RNase A refolding did not change as a 
function of the concentration of the osmolytes. Some of their results also suggested that 
there is a tendency for these osmolytes to destabilize the proteins at very high 
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concentration. They concluded that osmolytes should be able to stabilize any enzyme or 
protein to which it is exposed and it does not matter whether the protein evolved in the 
presence of osmolytes or not. 
 
Baskakov and Bolen (1998) studied the effects of two osmolytes, urea (a denaturant) and 
trimethylamine-N-oxide (TMAO) (an effective stabilizer). They showed that urea is no 
better at solubilizing hydrophobic side chains than is TMAO, as the overall side chain 
interactions with urea and TMAO are favorable, which implies that both these solutes 
should denature proteins. They suggested that the magnitude of the favorable vs. 
unfavorable interactions of the protein backbone with the solute, primarily determines 
whether the solute will be a denaturing or a protecting osmolytes. Qu et al. (1998) raised 
the possibility that the backbone might play a role in protein folding in water and also 
whether solvophobicity of the backbone in water had been overlooked so far as a 
contributor to the folding of protein in aqueous solution.  
 
Bolen and Baskakov (2001) wrote a comprehensive review of their studies with 
osmolytes and proteins, and their proposed mechanism. They classified the unfavorable 
interactions between a solvent component (an osmolytes) and a protein functional group 
(peptide backbone) as solvophobic and called the unfavorable interaction the 
‘osmophobic effect’. They argued that experimental measurements made by Timasheff 
and co-workers could not distinguish a solvophobic mechanism from other mechanisms. 
By means of their measurements of transfer Gibbs energy of amino acid side-chains and 
peptide backbone from water to a variety of naturally occurring osmolytes, Bolen and co-
workers presented the evidence that the mechanism of osmolytes action is solvophobic 
and proposed that osmophobic effect is a thermodynamic force of biological importance 
in protein folding.  
 
They revealed the consequences of the preferential exclusion of osmolytes from native 
and denatured proteins species using a thermodynamic cycle (Figure 2.5). In the 
thermodynamic cycle, reactions 2 and 4 represent the transfer of denatured (D) and native 
protein (N) from water to a fixed concentration of osmolyte. They argued that, compared 
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to the native state, denatured protein exposes more protein fabric to solvent, thus 
resulting in denatured state of the protein being more solvophobic toward osmolyte than 
the native state, making ∆GD[Os] a significantly more positive quantity than ∆GN[Os].  
 
Figure 2.5: Thermodynamic cycle of protein denaturation (Bolen and Baskakov, 2001). 
 
According to them, the thermodynamic cycle requires that ∆GD[Os] - ∆GN[Os] = ∆Gden[Os] - 
∆Gden water, and this condition forces the conclusion that denaturation of protein (∆Gden 
[Os]) is less favorable (more positive quantity) in the presence of osmolyte than it is in 
water (∆Gden water). Because osmolytes raise the Gibbs energy of the denatured state far 
more than they do the native state, proteins are more stable in the presence of osmolytes 
than they are in water.  
 
They obtained transfer Gibbs energy measurements of amino acid side-chains and 
backbone, from water to various osmolyte solutions, in order to determine the 
propensities of the side-chains and backbone to interact with several of naturally 
occurring osmolytes. They estimated the transfer Gibbs energy of native and denatured 
protein, ∆GN[Os] and ∆GD[Os], using transfer Gibbs energy data and models of denatured 
protein developed by Creamer et al. (1997). 
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The results of their measurements showed that the peptide backbone is responsible for the 
unfavorable interaction with osmolyte, and that the side chains collectively favour 
interaction with osmolyte (Liu and Bolen, 1995; Wang and Bolen, 1997; Qu et al., 1998). 
As suggested by Timasheff and co-workers, the origin of the hydrophobic effect in 
proteins lies in the unfavorable interaction between apolar side-chains and water. 
Similarly, Bolen and co-workers proposed that the origin of the hydrophobic effect in 
proteins lies in the unfavorable interaction between the peptide backbone and an 
osmolyte. The concept of both these forces is similar because an unfavorable interaction 
between a structural component of the protein and a component of solution is responsible 
for the force involved in protein folding. 
 
Bolen and co-workers also suggested that the interactions of protecting osmolytes and 
urea (denaturant) with protein side-chains are of less importance during denaturation than 
their respective favorable and unfavorable interactions with the peptide backbone (Bolen 
and Baskakov, 2001). The principal difference between urea and protecting osmolytes is 
due to the fact that urea interaction with peptide backbone is favorable and dominant over 
its favorable interactions with side-chains, while the protecting osmolytes interact 
unfavorably with backbone but favorably with side-chains (Wang and Bolen, 1997). 
They concluded that osmolytes (through the osmophobic effect) focus on the peptide 
backbone, a part of protein separate from side-chains, for protein folding in dilute 
aqueous medium (Bolen and Baskakov, 2001). 
2.2.4   Protein Stabilization at Low Temperatures (Freeze-thawing and 
Freeze-drying) 
 
Freeze-thawing and freeze-drying are the two methods commonly used for long-term 
storage of proteins and during transportation of proteins. For storage, some proteins are 
frozen and then thawed before use. During freeze-thawing and freeze-drying, proteins 
have to endure stresses such as low temperatures and formation of ice, which destabilize 
them. It has been found that many proteins are not stable against these stresses (Carpenter 
et al., 1986; Carpenter et al., 1987; Carpenter and Crowe, 1988a&b). A number of 
compounds have been examined for their effects on retention of enzyme activity upon 
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freeze-thawing and freeze-drying (Carpenter and Crowe, 1988b). During freeze-thawing, 
compounds that stabilize proteins in their solution state, protect proteins against low 
temperatures, and those compounds that are known to destabilize or denature proteins in 
solution, enhance damage due to freeze-thawing. On the other hand, it has been found 
that only sugars protect proteins from damage due to desiccation (Carpenter et al., 1987; 
Carpenter and Crowe, 1988a; Carpenter and Crowe, 1989). In the sections below, the 
effect of freeze-thawing and freeze-drying on proteins has been explained further. 
 
2.2.4.1   Freeze-thawing of proteins 
 
For long-term storage, proteins are often frozen and then thawed before use. During this 
process, proteins are exposed to critical stresses such as low temperature and formation of 
ice. Cold denaturation has been accounted for the inactivation of many proteins during 
free-thawing (Becktel and Schellman, 1987; Privalov, 1990). During freezing, protein 
molecules are excluded from the ice crystals and are subjected to chemical and physical 
changes that occur in the non-ice phase. With the formation of ice, the concentration of 
all solutes increases and if the solutes present are destabilizing, then the concentrating 
effect can lead to protein denaturation (von Hippel et al., 1969). Also, if the protein 
solution is made up of a buffer such as sodium phosphate, then during freezing the 
solution can undergo a dramatic decrease in the pH, resulting in destabilization of the 
protein (Chilson et al., 1965; van den Berg and Rose, 1969). Thus, the combination of 
factors arising during freeze-thawing, low temperatures and high destabilizing salt 
concentration, can damage the protein. The duration of exposure of a protein to these 
conditions can also influence the degree of damage. This has been proved by the finding 
that the loss of enzyme activity during freezing and thawing is often inversely correlated 
with the cooling and warming rates (Chilson et al, 1965; Whittam and Rosano, 1973).  
 
The perturbations that have been shown to destabilize the protein can be protein-specific. 
However, it is widely agreed that any factor that alters protein stability in non-frozen 
aqueous solution will tend to have the same qualitative effect during freeze-thawing 
(Arakawa et al., 2001). Also, it has been shown that increasing the protein concentration 
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will increase the stability of the protein during freeze-thawing (Carpenter and Crowe, 
1988b). To prevent the damage that occurs to the protein during freeze-thawing, a 
number of cryoprotectants have been employed. The most common cryoprotectants are 
sugars, polyols, synthetic polymers and amino acids (Carpenter and Crowe, 1988b).  
 
Several mechanisms have been proposed to explain the effect of these cryoprotectants on 
proteins. The only mechanism that seems to be applicable to most of the known 
compounds is the preferential exclusion mechanism proposed by Timasheff and co-
workers described in Section 2.2.1 of this chapter. Most of these compounds have been 
shown to be preferentially excluded from the surface of protein, and the compounds like 
urea and guanidine-HCl, which are known to preferentially bind to the proteins, have 
been found to cause additional damage during freeze-thawing (Carpenter and Crowe, 
1988b; Arakawa et al., 1990b). Arakawa et al. (2001) proposed that the destabilizing 
conditions that may arise during freeze-thawing, such as concentration of solutes and 
alterations in solution pH, can be viewed simply as other types of perturbation induced in 
solution. Thus, the basic thermodynamic principles governing protein stability in the 
frozen state is not different from those observed in non-frozen aqueous systems (Arakawa 
et al., 2001).  
 
However, there is a group of compounds, whose effect on proteins in non-frozen aqueous 
system, do not correlate with their effect during free-thawing (e.g. PEG and MPD), as 
these compounds destabilize proteins at slightly higher temperatures (Section 2.2.1). In 
fact, PEG has been found to be a very effective cryoprotectant (Carpenter and Crowe, 
1988b). This kind of effect has been attributed to the temperature dependence of 
hydrophobic interactions between proteins and co-solvents. At low temperatures, these 
solutes are preferentially excluded and the hydrophobic interactions are weaker, whereas 
at relatively higher temperatures (>25°C), the hydrophobic interactions become stronger 
and it leads to preferential binding (Arakawa et al., 1990b). 
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2.2.4.2   Freeze-drying of proteins  
 
Freeze-drying or lyophilization is a method used in preparation of protein products, when 
the proteins are not sufficiently stable for long-term storage as aqueous solutions. The 
process of lyophilization consists of freezing the protein solution followed by drying in 
vacuum. It is known that the second step of lyophilization, that is drying, takes place in 
two phases: primary drying, which removes frozen water through sublimation, and 
secondary drying which removes non-frozen ‘bound’ water (Arakawa et al., 2001). 
Freeze-drying often destabilizes proteins due to the conformational instability of many 
proteins when subjected to freezing and subsequent dehydration stresses (Crowe et al., 
1990). In contrast to free-thawing, where freezing is the only stress, freeze-drying poses 
two stresses, freezing and drying. Thus, to protect proteins against freeze-drying, both 
these fundamentally different stresses have to be overcome.  
 
Several additives have been tried in order to protect proteins against freeze-drying. 
However, the solutes that provide stabilization are sugars and polyols. The mechanism by 
which these solutes provide protection is not completely understood. Clearly, co-solute 
stabilization during freeze-drying is more complex than that of cryoprotection (Crowe et 
al., 1990). Many effective cryoprotectants fail to stabilize proteins during dehydration. It 
has been suggested that the mechanism of solute-induced stabilization during dehydration 
is fundamentally different from that for proteins in aqueous or frozen systems (Carpenter 
and Crowe, 1989). They have also suggested that the thermodynamic principles that 
explain protein stabilization by preferential exclusion are not applicable for freeze-drying 
as the solvent itself is removed from the system. 
 
Carpenter and Crowe (1989), in their study of effect of carbohydrates during freeze-
drying of proteins, have suggested that these solutes protect proteins because they 
hydrogen-bond to the dried protein acting as a water substitute, when the hydration shell 
of protein is removed. They used Fourier transform infrared spectroscopy (FTIR) to study 
the interactions between dried proteins and carbohydrates. They proved that hydrogen 
bonding does occur between proteins and carbohydrates during drying, suggesting that 
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such bonding may be a requisite for labile proteins to be preserved during drying. Their 
results are illustrated in Figure 2.6.  
 
 
Figure 2.6: Infrared spectra. (Spectrum A) Trehalose freeze-dried alone. (Spectrum B) 
Freeze-dried trehalose + 0.3 g of lysosome/g of trehalose. (Spectrum C) Freeze-dried 
trehalose + 0.1 g of BSA/g of trehalose. (Spectrum D) Hydrated trehalose. (Arakawa et 
al., 2001) 
 
Figure 2.6 illustrates the results of trehalose and protein interactions in the dried state. 
From the figure it is evident that the spectra for trehalose dried in the presence of either 
lysozyme or bovine serum albumin (BSA) are remarkably similar to that for hydrated 
trehalose, but very different from the spectrum of crystalline trehalose. Thus, they 
concluded that proteins form hydrogen bonds with the polar groups in the sugar, serving 
the same role for dried trehalose as water does for hydrated trehalose.  
 
Based on the results that proteins serve as water substitutes for dried carbohydrates, 
Carpenter and Crowe (1989) stated that the converse must also be true, which is 
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carbohydrates serve as water substitutes for dried proteins. To test this hypothesis, they 
investigated the influence of trehalose on the infrared spectrum of lysozyme. The results 
are illustrated in Figure 2.7. The effectiveness of trehalose is evident by the similarity of 
peaks at 1580, 1540 and 1520 cm-1. 
 
 
Figure 2.7: Amide band region for hydrated lysozyme (dotted line), lysozyme freeze-
dried alone (dashed line), and lysozyme freeze-dried in the presence of trehalose (solid 
line) (Arakawa et al., 2001). 
 
Based on these results, it was proposed that hydrogen-bonding of the sugar to the protein 
is mandatory for the sugar to preserve dried proteins. This conclusion has been supported 
by results of Lippert and Galinski (1992), who showed that stabilization of freeze-dried 
PFK and lactate dehydrogenase (LDH) by compatible solutes, ectoines, depended on the 
presence of hydroxyl groups on the molecule. 
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Other investigators have proposed a different mechanism for protection of proteins by 
carbohydrates during freeze-drying. Franks et al. (1991) proposed that the glass 
formation in the dried state is responsible for stabilization, which means that the 
immobilization of the protein and additives in the glassy state results in the protection of 
the protein from chemical and conformational degradation. Though this is a good 
hypothesis, there is evidence which argue against it. In a study by Tanaka et al. (1991), 
they examined the ability of various saccharide monomers and oligomers to protect 
catalase during freeze-drying. It was observed that the ability of the saccharides to protect 
the protein decreased with increase in the length of the chain. However, results from 
Franks et al. (1991) show that with the increase in the length of the chain, saccharides 
become better glass-formers as they undergo glass transitions at higher temperatures. 
These results are exactly opposite to the proposed glass formation mechanism.  
 
Of the proposed mechanisms of protection of proteins against freeze-drying,  the effect of 
saccharides, serving as water substitutes for dried proteins, seems to be the most effective 
explanation. However, the mechanism by which this interaction between protein and the 
sugar occurs is not completely understood yet.   
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Chapter 3 - SYNTHESES OF COMPENSATORY SOLUTES 
 
3.1  INTRODUCTION 
 
 
Naturally occurring compensatory solutes such as glycine betaine, TMAO, trehalose and 
sorbitol (Figure 3.1), have been studied with great interest by biotechnologists due to 
their ability to stabilize proteins against different stresses and their effectiveness in 
stabilizing cell components. Moreover, to understand the mechanism of protein 
stabilization, many researchers have used these natural solutes. Some of the natural 
solutes, like trehalose, are very expensive to purchase and there are only a limited number 
of alternatives available in the present day market. 
 
 
Figure 3.1: Structures of some natural compensatory solutes. 
 
There has been less effort to synthesize inexpensive analogues of these natural solutes. A 
few researchers have tried to synthesize analogues of compensatory solutes and have 
studied their effect on macromolecules. Lloyd et al. (1992, 1994) investigated some 
simple analogues of natural kosmotropes for their effectiveness as cryoptotective 
additives. Synthetic betaines like, propio betaine (N, N, N-trimethyl-N-(2-carboxyethyl) 
ammonium, inner salt) and dimethylthetin (N,N-dimethyl-N-carboxymethyl sulfonium, 
inner salt), have been shown to counter the effects of high NaCl and urea concentrations 
in E. coli cultures (Randall et al., 1996).  
 
A class of synthetic betaines, called sulfobetaines, has been investigated for their 
properties as protein solubilizing agents. These sulfobetaines are betaines containing a 
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sulfonate functional group instead of a carboxylate. Vuillard et al. (1995c) synthesized 
zwitterionic non-detergent sulfobetaines (NDSB) and showed that NDSBs are non-
denaturing additives that can significantly enhance protein extraction yields and do not 
interfere with the binding of proteins to ion exchange chromatography columns. In a 
study by the same group (Vuillard et al., 1995a), they observed that overnight incubation 
of β-galactosidase in NDSB solutions resulted in an increase in enzymatic activity. 
NDSBs were also shown to have the capacity to stabilize halophilic proteins against 
deactivation in low salt concentrations (Vuillard et al., 1995b).   
 
Synthetic compensatory solutes have the ability to open new insights into the mechanism 
of protein stabilization, as they could help us understand the relation between the 
structure of solutes and their stabilization effect on proteins. Lloyd et al. (1992; 1994) 
showed patterns of relationship between the solute structure and their effectiveness as 
cryoprotective additives. Results obtained in a membrane-protein extraction show that 
NDSBs with C3 bridge between N and S were more efficient than NDSBs with C4 bridge 
(Vuillard et al., 1995b). Compensatory solutes with hydroxyl group in their structure 
have been observed to have increased stabilization effect against different stresses 
(Goeller and Galinski, 1999; Randall et al., 1996). 
 
One of the most widely occurring natural compensatory solutes, glycine betaine, has 
applications in biological and medical fields. Apart from acting as an osmolyte, glycine 
betaine is a good protein stabilizer. In the laboratory it has been used in polymerase chain 
reaction (PCR) as an enhancer (Frackman et al., 1998) due to its ability to reduce DNA 
melting temperatures (Rees et al., 1993). It is also used a therapeutic agent for treatment 
of hyperhomocysteinemia, a condition which causes vascular diseases in renal failure 
patients (Knopman and Patterson, 2001; Olthof et al., 2003). This application as a 
therapeutic agent does not depend on its properties as a compatible solute, but on its other 
biochemical role as a methyl group donor. 
 
These applications of compensatory solutes, and results indicating the potential 
applications of synthetic solutes inspired the syntheses of a number of inexpensive novel 
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compensatory solutes in our laboratory. A range of analogues of glycine betaine and its 
related compounds were synthesized in order to study their effectiveness in different 
biological and medical applications. Furthermore, these synthetic solutes may help to get 
a better understanding of the mechanism of protein stabilization. 
 
In this chapter, the syntheses of different compensatory solutes will be presented, along 
with their characterization by 1H NMR and elemental analysis. 
 
3.2  MATERIALS AND METHODS 
 
 
Trimethylamine (40 wt% in water), acrylic acid, dimethylaminoethanol (deanol), 
bromoacetic acid, N-methyldiethanolamine, triethanolamine, 3-dimethylamino-1-
propanol, 3-(dimethylamino)-1,2-propanediol, 25% w/v solution of vinylsulfonic acid 
sodium salt in water (VSA), 1,3-propane sultone, 1, 4-butane sultone, 1-methylpiperidine 
and 1-methylpyrrolidine were purchased from Aldrich, USA. N-Methylmorpholine and 
dimethylsulfide were purchased from Sigma, USA. 1H NMR spectra were obtained on a 
Varian Unity 300 MHz instrument. Elemental analyses were carried out at Campbell 
Microanalytical Laboratory, University of Otago, Dunedin. 
 
The majority of the compensatory solutes described in this chapter were obtained as clean 
white crystals. They were characterised by elemental analysis and their structures 
confirmed by 1H NMR. 
3.2.1  Ion-exchange chromatography 
 
Solutes that were obtained in the hydrohalide form were converted to the free base by 
passing them through a Dowex 50 column (H+ form). The length and diameter of the 
column used depended on the number of moles of the solute to be treated. The column 
was prepared by first batch washing the resin with ~ 4 M HCl and then washing it with 
large amounts of distilled water until the washings were neutral. The crude hydrohalide 
form of the solute was dissolved in a small amount of water and poured onto the column 
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and the column was then washed with large amounts of water. The betaine is retained by 
the column. Starting materials (if present) and halide ions which do not have affinity for 
the column are eluted. The positively charged betaines were eluted from the column by 
washing with ~ 5 M aqueous ammonia solution. The solution obtained was evaporated 
under reduced pressure at ~ 30 0C in a rotary evaporator. The absence of halide ions in 
the eluant and in the final product was confirmed by testing samples with AgNO3 
solution.  
3.2.2  Propio betaine [PB] 
 
 
 
 
 
 
N
CH3
CH3
H3C CH2CH2COO
N, N, N-Trimethyl-N-(2-carboxyethyl) ammonium, inner salt 
CAS # 6458-06-6 
 
Propiobetaine was prepared by mixing trimethylamine (40 wt% in water) and acrylic acid 
in a molar ratio of 1.5:1. The mixture was allowed to stand for 3 days at room 
temperature. The product, a viscous liquid, was dissolved in warm isopropanol and a 
large volume of acetone was added. The solid precipitated was then filtered and sucked 
dry. As it was deliquescent, it was recrystallised from water/acetonitrile mixtures using a 
rotary evaporator. A clean white powder was obtained with an approximate 80% yield. 
 
 1H NMR (D2O, 500 MHz) δ 2.60 (2 H, m, CH2), 3.03 (9 H, s, (CH3)3), 3.49 (2 H, t, J 7.8 
Hz, CH2). 
3.2.3  Deanol betaine [DB] 
 
 
 
 
 
 
 
 
N
CH3
HOCH2CH2 CH2COO
CH3
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N, N-Dimethyl-N-(2-hydroxyethyl)-N-carboxymethyl ammonium, inner salt 
CAS # 7002-65-5 
 
Bromoacetic acid (0.2 moles), and dimethylaminoethanol (deanol), (0.3 moles), were 
dissolved in 60 mL of dichloromethane and the mixture was left to stand for 14 days at 
room temperature. A thick white paste of crude hydrobromide was obtained. This 
hydrobromide was converted to the betaine by ion exchange on a Dowex column as 
described in section 3.2.1. The final product was isolated from the eluant by evaporation 
under reduced pressure using a rotary evaporator with an approximate yield of 85 %. 
 
 1H NMR (D2O, 500 MHz) δ 3.19 (6 H, s, (CH3)2), 3.65 (2 H, m, CH2), 3.87 (2 H, s, 
CH2), 3.92 (2 H, m, CH2). 
3.2.4  Homodeanol betaine [HDB] 
 
 
 
 
 
N
CH3
HOCH2CH2
CH3
CH2CH2COO
N, N-Dimethyl-N-(2-hydroxyethyl)-N-(2-carboxyethyl) ammonium, inner salt 
CAS # 6249-53-2 
 
Homodeanol betaine was prepared by mixing equimolar amounts of acrylic acid and 2-
N,N-dimethylaminoethanol (deanol) and allowing the mixture to stand for 48 hours. The 
product was purified by washing several times sequentially with n-propanol and iso-
propanol, to remove the starting materials. The purified product was recrystallized from 
water/isopropanol mixtures. The final product yield was 80 % (approx.). 
 
 1H NMR (D2O, 500 MHz) δ 2.60 (2 H, t, J 7.8 Hz, CH2), 3.05 (6 H, s, (CH3)2), 3.40 (2 
H, t, J 4.9 Hz, CH2), 3.55 (2 H, t, J 7.3 Hz, CH2), 3.95 (2 H, m, CH2). 
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3.2.5  Homoglycerol betaine [HGB] 
 
 
 
 
 
 
N
CH3
CH2CH2COOHOCH2CHCH2
CH3OH
N, N-Dimethyl-N-(2,3-dihydroxypropyl)-N-(2-carboxyethyl) ammonium, inner salt 
CAS # None 
 
Acrylic acid (0.1 moles), and 3-(dimethylamino)propane-1,2-diol (0.1 moles), were 
mixed in 75 mL of dichloromethane. The mixture was allowed to stand at room 
temperature for four days. During this time the mixture separated into two layers, an 
upper crystalline layer and a lower liquid layer. The crystals were separated by filtration 
and washed sequentially with dichloromethane, isopropanol and n-propanol, to remove 
any starting materials in the product. A clean white crystalline final product was obtained 
with an approximate yield of 85 %. 
 
 1H NMR (D2O, 500 MHz) δ 2.61 (2 H, m, CH2), 3.08 (6 H, d, J 5.3 Hz, (CH3)2), 3.35 (2 
H, m, CH2), 3.48 (2 H, m, CH2), 3.58 (2 H, m, CH2), 4.18 (1 H, m, CH). 
3.2.6  Diethanol homobetaine [DEHB] 
 
 
 
 
 
 
HOCH2CH2
HOCH2CH2
NH3C CH2CH2COO
N,N-Diethanol-N-methyl-N-(2-carboxyethyl)ammonium, inner salt 
CAS # 43192-67-2 
 
N-methyldiethanolamine (0.2 moles), and acrylic acid (0.2 moles), were mixed together 
in 250 mL of dichloromethane and left to stand at room temperature for 3 weeks. After 
day 10, the solution had started turning cloudy and small crystals commenced to form in 
the medium. On day 22, the reaction was worked up. The crystals were filtered off and 
washed with dichloromethane, isopropanol and acetone, to get rid of all the impurities 
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and starting materials. The final product was dried in a desiccator for 24 hours. The 
approximate yield was 30 %.  
 
1H NMR (D2O, 500 MHz) δ 2.62 (2 H, t, J 7.8 Hz, CH2), 3.10 (3 H, s, CH3), 3.50 (4 H, 
m, (CH2)2), 3.63 (2 H, t, J 7.3 Hz, CH2), 3.93 (4 H, m, (CH2)2). 
 
The yield of the product by above method was very low but other methods tried led to 
polymer formation. Addition of hydroquinone to the reaction mixture to inhibit 
polymerization gave better yields. The final product was brownish in colour and not 
suitable for spectrophotometric analysis. 
3.2.7  Triethanol homobetaine [TEHB] 
 
HOCH2CH2
HOCH2CH2
NHOCH2CH2 CH2CH2COO
 
 
 
N,N,N-Triethanol-N-(2-carboxyethyl)ammonium, inner salt 
CAS # 857163-31-6 
 
0.25 g of hydroquinone, 0.2 moles of triethanolamine and 0.2 moles acrylic acid, were 
added to 200 mL of dichloromethane. The solution went cloudy after mixing and 
separated into two phases. The mixture was left to stand at room temperature for 30 days. 
During this time small crystals had started depositing on the walls of the flask, and the 
upper layer had became quite pink. The bottom liquid layer was discarded and the upper 
sludgy layer was dissolved in 150 mL of warm isopropanol. Crystals were precipitated 
from this by adding 500 ml of cold acetone with stirring. These were filtered off and 
dried in a desiccator. The final product was brownish in colour and the approximate yield 
was 40 %.  
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1H NMR (D2O, 500 MHz) δ 2.60 (2 H, t, J 7.8 Hz, CH2), 3.38 (2 H, t, J 5.4 Hz, CH2), 
3.56 (4 H, t, J 5.4 Hz, (CH2)2), 3.66 (2 H, t, J 7.8 Hz, CH2), 3.86 (2 H, t, J 4.9 Hz, CH2), 
3.94 (4 H, m, (CH2)2). 
 
 As the final product was brownish in colour and not suitable for spectrophotometric 
analysis, attempts were made to synthesize the solute without using hydroquinone. 
However this always resulted in polymerized products.  
3.2.8  Hydroxypropyl homobetaine [HPHB] 
 
 
 
 
 
 
 
N
CH3
HOCH2CH2CH2
CH3
CH2CH2COO
N,N-Dimethyl-N-(3-hydroxypropyl)-N-(2-carboxyethyl)ammonium, inner salt 
CAS # None 
 
3-dimethylamino-1-propanol (0.2 moles), and acrylic acid (0.2 moles), were mixed with 
125 mL of dichloromethane and left to stand at room temperature. The mixture formed 
two phases after 4 days and by the end of 7 days, some solid material had started to 
appear. After 11 days the solid material was filtered off and washed several times with 
dichloromethane and isopropanol. The product was a sticky pale yellow deliquescent 
solid. This was then resuspended twice in isopropanol and filtered. The final product was 
dried in a desiccator.  The approximate yield was 20 %. 
 
 1H NMR (D2O, 500 MHz) δ 1.95 (2 H, m, CH2), 2.60 (2 H, t, J 7.8 Hz, CH2), 3.01 (6 H, 
s, (CH3)2), 3.33 (2 H, m, CH2), 3.50 (2 H, t, J 7.8 Hz, CH2) 3.62 (2 H, t, J 5.8 Hz, CH2). 
3.2.9  Dimethylthetin [DMT] 
 
 
 
 
 
S
H3C
H3C
CH2COO
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N,N-Dimethyl-N-carboxymethyl sulfonium, inner salt 
CAS # 4727-41-7 
 
Dimethylthetin was synthesized by dissolving 0.05 moles of chloroacetic acid in 0.2 
moles of dimethylsulfide. The mixture was allowed to stand for 10 days and the crystals 
that formed were collected by filtration. These were then washed with dichloromethane. 
The crude hydrochloride was converted to free base as described in section 3.2.1. The 
final product was isolated from the eluant by evaporation under reduced pressure using a 
rotary evaporator. The yield was approximately 90 %. 
 
 1H NMR (D2O, 500 MHz) δ 2.80 (6 H, s, (CH3)2), 4.03 (2 H, s, CH2). 
 
3.2.10  Cyclic Betaines 
 
3.2.10.1  CB-1 
 
 
 
 
 
 
NO
CH3
CH2CH2COO
N-Methyl-N-(2-carboxyethyl)morpholinium, inner salt 
CAS # None 
 
Acrylic acid (0.2 moles), and N-methylmorpholine (0.2 moles), were mixed in 40 mL of 
dichloromethane and allowed to stand at room temperature. There was no apparent 
change in the mixture after 7 days, so the cover was taken off to allow the 
dichloromethane to evaporate. By the end of day 9, needle-like crystals had formed. 
These were filtered off and washed several times with dichloromethane and isopropanol. 
The final product was obtained with an approximate yield of 90 %. 
 
 1H NMR (D2O, 500 MHz) δ 2.62 (2 H, t, J 7.8 Hz, CH2), 3.09 (3 H, s, CH3), 3.42 (4 H, 
m, (CH2)2), 3.632 (2 H, t, J 7.8 Hz, CH2), 3.96 (4 H, s, (CH2)2). 
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3.2.10.2  CB-2 
 
 
 
 
 
 
 
N
CH3
CH2CH2COO
N-Methyl-N-(2-carboxyethyl)piperidinium, inner salt 
CAS # 81239-43-2 
 
Acrylic acid (0.1 moles) and 1-methylpiperidine (0.1 moles), were mixed in 50 mL of 
dichloromethane. The mixture was covered and allowed to stand at room temperature. 
There was no change after 5 days, so the cover was taken off to allow the 
dichloromethane to evaporate.  By the end of 10 days, the mixture had formed a hard 
solid layer. This was broken up and the solids were suspended in isopropanol. Further 
washing with n-propanol gave the final betaine in approximately 50% yield.  
 
1H NMR (D2O, 500 MHz) δ 1.58 (2 H, m, CH2), 1.80 (4 H, t, J 5.4 Hz, (CH2)2), 2.72 (2 
H, t, J 7.8 Hz, CH2), 2.95 (3 H, s, CH3), 3.27 (4 H, m, (CH2)2), 3.53 (2 H, t, J 7.8 Hz, 
CH2). 
 
3.2.10.3  CB-3 
 
 
 
 
 
 
N
CH3
CH2CH2COO
N-Methyl-N-(2-carboxyethyl)pyrrolidinium, inner salt 
CAS # 201931-52-4 
 
Acrylic acid (0.1 moles) and 1-methylpyrrolidine (0.1 moles) were mixed in 50 mL 
dichloromethane. There was a strong exothermic reaction. The mixture was covered and 
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allowed to stand at room temperature. Crystals started appearing after 3 days and by day 
10, there were sufficient crystals in the flask for the mixture to be worked up. The 
crystals obtained were yellowish in colour, so they were suspended several times in 
isopropanol and filtered. Finally the product was washed in n-propanol. Approximate 
yield was 75 %. Elemental analysis and 1H NMR were performed to confirm the structure 
and composition of the product. 
 
 1H NMR (D2O, 500 MHz) δ 2.13 (4 H, s, (CH2)2), 2.75 (2 H, t, J 7.3 Hz, CH2), 2.95 (3 
H, s, CH3), 3.44 (4 H, m, (CH2)2), 3.54 (2 H, t, J 7.3 Hz, CH2). 
 
3.2.11  Sulfobetaines 
 
3.2.11.1  SB-1 
 
 
 
 
 
 
N
CH3
CH2CH2SO3
CH3
HOCH2CH2
N,N-Dimethyl-N-(2-hydroxyethyl)-N-(2-sulfoethyl)ammonium, inner salt 
CAS # 91673-91-5 
 
SB-1 was prepared using the method described by Barnhurst (1961). Concentrated 
hydrochloric acid was added to 0.05 moles of a 25% w/v solution of vinylsulfonic acid 
sodium salt in water. To this 0.1 moles of dimethylaminoethanol was added and the 
mixture was mixed well. The clear straw-coloured solution was boiled for 30 minutes, 
during which time the volume decreased to 60 % of that of the original solution. The 
mixture was allowed to cool down and evaporate further. After 3 days, 50 mL of cold 
conc. hydrochloric acid was added. Betaines are soluble in this medium, while the 
inorganic salts, which are slightly soluble, were not and were filtered off. The filtrate was 
concentrated to a thick syrupy consistency in a rotary evaporator at 50°C. Addition of 
ethanol caused the betaine to precipitate. The product obtained was further purified by 
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washing with dichloromethane, isopropanol and n-propanol. The final approximate yield 
was 65 %.  
 
1H NMR (D2O, 500 MHz) δ 3.13 (6 H, s, (CH3)2), 3.37 (2 H, m, CH2), 3.46 (2 H, m, 
CH2), 3.71 (2 H, m, CH2), 3.98 (2 H, m, CH2). 
3.2.11.2  SB-2 
 
 
 
 
 
 
N
CH3
HOCH2CH2
CH3
CH2CH2CH2SO3
N,N-Dimethyl-N-(2-hydroxyethyl)-N-(3-sulfopropyl)ammonium, inner salt 
CAS # 38880-58-9 
 
Dimethylaminoethanol (0.1 moles), was dissolved in 125 mL of dichloromethane and 
1,3-propane sultone (0.1 moles), was added and mixed well. Crystals started appearing 
within 15 minutes of mixing. The solution was covered and was allowed to stand for 2 
days at room temperature and gave a paste. More dichloromethane was added and the 
solid was filtered off. The solids were resuspended in isopropanol a couple of times and 
finally filtered and sucked dry. The final product after drying in a desiccator was a white 
powder. The approximate yield was 85 %. 
 
 1H NMR (D2O, 500 MHz) δ 2.16 (2 H, m, CH2) 2.89 (2 H, t, J 7.3 Hz, CH2), 3.09 (6 H, 
s, (CH3)2), 3.44 (2 H, t, J 4.4 Hz, CH2), 3.65 (2 H, m, CH2), 3.96 (2 H, m, CH2). 
3.2.11.3  SB-3 
 
 
 
 
 
 
N
CH3
HOCH2CH2 CH2CH2CH2CH2SO3
CH3
N,N-Dimethyl-N-(2-hydroxyethyl)-N-(4-sulfobutyl)ammonium, inner salt 
CAS # 40820-99-3 
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Dimethylaminoethanol (0.1 moles) was dissolved in 20 mL of dichloromethane and to 
this 0.1 moles of 1,4-butane sultone was added and mixed well. The solution was covered 
and was allowed to stand for 3 days at room temperature. A paste formed. More 
dichloromethane was added and the solids isolated by filtration. The solids were washed 
in dichloromethane two times, resuspended in isopropanol once and finally filtered and 
sucked dry. Drying in a desiccator gave the final product in the form of a white powder in 
approximately 80 % yield.  
 
1H NMR (D2O, 500 MHz) δ 1.72 (2 H, m, CH2), 1.88 (2 H, m, CH2), 2.89 (2 H, t, J 7.8 
Hz, CH2) 3.07 (6 H, s, (CH3)2), 3.35 (2 H, m, CH2), 3.42 (2 H, m, CH2), 3.96 (2 H, m, 
CH2). 
3.2.11.4  SB-4 
 
 
 
 
 
 
 
HOCH2CH2
HOCH2CH2
NH3C CH2CH2CH2SO3
N,N-Dihydroxyethyl-N-methyl-N-(3-sulfopropyl)ammonium, inner salt 
CAS # 94159-69-0 
 
N-methyldiethanolamine (0.15 moles) and 1,3-propane sultone (0.15 moles) were mixed 
together in 200 mL of dichloromethane. Small crystals started forming within two hours. 
The mixture was allowed to stand for 3 days, after which time the crystals were filtered 
off and sucked dry. These were washed several times with dichloromethane and n-
propanol, resuspended in isopropanol, and filtered. The final product was dried in a 
desiccator and the approximate yield was 75 %. 
 
 1H NMR (D2O, 500 MHz) δ 2.168 (2 H, m, CH2), 2.93 (2 H, m, CH2), 3.13 (3 H, s, 
CH3), 3.51 (4 H, m, (CH2)2), 3.56 (2 H, m, CH2), 3.97 (4 H, m, (CH2)2). 
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3.2.12  Cyclic-Sulfo betaines 
 
3.2.12.1  CSB-1 
 
 
 
 
NO
CH3
CH2CH2CH2SO3
N-Methyl-N-(3-sulfopropyl)morpholinium, inner salt 
CAS # 111282-24-7 
 
1-Methylmorpholine (0.2 moles) and 1,3-propane sultone (0.2 moles), were mixed in 125 
mL of dichloromethane. The mixture was covered and allowed to stand at room 
temperature. Crystals started appearing within 2 days. After 5 days, more 
dichloromethane was added and the solids were filtered out. These were resuspended in 
isopropanol and filtered. Finally the product was washed with isopropanol and n-
propanol, filtered and sucked dry. The final approximate yield was 80 %. 
 
 1H NMR (D2O, 500 MHz) δ 2.18 (2 H, m, CH2), 2.92 (2 H, t, J 8.3 Hz, CH2), 3.15 (3 H, 
s, CH3), 3.46 (4 H, m, (CH2)2), 3.55 (2 H, m, CH2), 3.975 (4 H, s, (CH2)2). 
 
3.2.12.2  CSB-2 
 
 
 
 
 
 
N
CH3
CH2CH2CH2SO3
N-Methyl-N-(3-sulfopropyl)piperidium, inner salt 
CAS # 160788-56-7 
 
1-Methylpiperidine (0.2 moles) and 1,3-propane sultone (0.2 moles), were mixed in 125 
mL of dichloromethane. The mixture started depositing solids within 30 minutes of 
mixing. The mixture was covered and allowed to stand at room temperature for 4 days. 
More dichloromethane was added and the solids were filtered off. They were 
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resuspended in isopropanol and filtered. Finally the product was washed with isopropanol 
and n-propanol, filtered and sucked dry. The final product was slight pinkish in colour 
and the approximate yield was 85 %. 
 
 1H NMR (D2O, 500 MHz) δ 1.59 (2 H, m, CH2), 1.81 (4 H, t, J 5.4 Hz, (CH2)2), 2.13 (2 
H, m, CH2), 2.90 (2 H, t, J 6.8 Hz, CH2), 2.99 (3 H, s, CH3), 3.29 (4 H, m, (CH2)2), 3.42 
(2 H, m, CH2). 
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Table 3.1: Results of elemental analysis of synthetic compensatory solutes, Campbell Microanalytical Laboratory, University of 
Otago, Dunedin, New Zealand. 
 
Solute   Mol. Formula* Mol.Wt. Carbon % Hydrogen % Nitrogen % Sulfur % 
Found     46.92 9.92 8.96 ------Propio betaine [PB] C6H13NO2.H2O 149.19 
Calculated     48.30 10.13 9.39 ------
Found     47.75 8.59 9.21 ------Deanol betaine [DB] C6H13NO3 147.17 
Calculated     48.97 8.90 9.52 ------
Found     50.04 8.81 8.25 ------Homodeanol betaine 
[HDB] 
C7H15NO3
 
161.20 
Calculated     52.16 9.38 8.69 ------
Found     47.43 8.26 6.87 -----Homoglycerol 
betaine [HGB] 
C8H17NO4.H2O 209.24 
Calculated     45.92 9.15 6.69 ------
Found     48.72 8.68 7.04 ------Diethanol 
homobetaine [DEHB] 
C8H17NO4 191.23 
Calculated     50.25 8.96 7.32 ------
Found     45.64 8.56 6.66 ------Triethanol 
homobetaine[TEHB] 
C9H19NO5.H2O 239.27 
Calculated     45.18 8.85 5.85 ------
Found     48.37 8.40 6.86 ------CB-1 C8H15NO3.H2O 191.23 
Calculated     50.25 8.96 7.32 ------
Found     52.61 9.17 6.68 ------CB-2 C9H17NO2.2H2O 207.27 
Calculated     52.15 10.21 6.76 ------
Found     52.73 9.51 7.61 ------CB-3 C8H15NO2.H2O 175.23 
Calculated     54.84 9.78 7.99 ------
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Solute 
 
 
Mol. Formula* Mol.Wt.  Carbon %  Hydrogen % Nitrogen % Sulfur % 
Found     34.89 7.29 ------ 23.91Dimethylthetin 
[DMT] 
C4H8O2S.H2O 138.18 
 Calculated     34.77 7.29 ------ 23.20
Found     35.41 7.77 6.88 16.24SB-1 C6H15NO4S 197.25 
Calculated     36.54 7.66 7.10 16.25
Found     39.82 8.04 6.69 15.09SB-2 C7H17NO4S 211.28 
Calculated     39.79 8.11 6.63 15.27
Found     42.23 8.30 6.19 13.84SB-3 C8H19NO4S 225.30 
Calculated     42.65 8.50 6.22 14.23
Found     39.58 7.81 5.78 13.49SB-4 C8H19NO5S 241.30 
Calculated     39.82 7.94 5.80 13.29
Found     41.56 8.02 6.25 13.81CSB-1 C8H17NO4S.H2O 241.30 
Calculated     39.82 7.94 5.80 13.29
Found     48.73 8.71 6.58 14.21CSB-2 C9H19NO3S 221.31 
Calculated     48.84 8.65 6.33 14.49
 
*hydration of all solutes based on the results of elemental analysis 
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3.3  RESULTS AND DISCUSSION 
 
The majority of the synthetic compensatory solutes were easy to synthesize and the yield 
was usually more than 75%. Applying the principles of a few existing methods, new 
solutes were synthesized. The general method of synthesis of these solutes is, the starting 
materials were mixed and the mixture left in the fume cupboard for a few days till the 
solids precipitated. To remove any starting materials or impurities in the product, all the 
solutes were washed several times with n-propanol, isopropanol and dichloromethane, 
and sucked dry, till a clear white crystalline powder was obtained. The structure and the 
composition of the products were confirmed by 1H NMR and elemental analysis. Results 
of elemental analysis from Campbell Microanalytical Laboratory are as shown in Table 
3.1. The laboratory claims that ± 0.3 % is the standard error of their results. Hydration 
state of each solute was estimated from the results of their elemental analysis.  
 
Only two solutes, dimethylthetin and deanol betaine, were obtained as hydrohalides and 
rest of the solutes were obtained in a free base form. Solutes obtained as a hydrohalide 
were converted to free base by applying to a Dowex 50 column (H+ form) as described in 
section 3.2.1. The product was eluted from the column using 5.1 M ammonia solution. 
The final product was isolated from the eluant by evaporation under reduced pressure 
using a rotary evaporator. 
 
Though the yield of most of the syntheses was good, low yields were observed for a few 
solutes such as DEHB, TEHB and HPHB. Different methods of synthesis were tried to 
increase the yield of the product. To prevent polymerization products being formed 
during syntheses of DEHB and TEHB, we tried adding hydroquinone in order to inhibit 
the polymerization reaction. Though adding hydroquinone resulted in better yields, the 
final product was brownish in colour and several attempts to remove this colour from the 
solutes were unsuccessful. It was later realised that these brownish solutes were not 
suitable for spectrophotometric methods of measuring enzyme activity, which involved 
following the change in absorbance at wavelengths in the near UV. Thus, hydroquinone 
was not added for further syntheses. 
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All the three cyclic betaines, CB-1, 2 & 3, were not difficult to synthesize and the 
products were obtained easily by just mixing the starting materials. However, impurities 
in the product being the main problem, all the three cyclic betaines had to be washed 
several times with solvents to remove the starting materials. Furthermore, to recover the 
final product, solids were suspended in isopropanol overnight and filtered. For unknown 
reasons, aqueous solutions of CB-2 and CB-3 were acidic and were destabilizing the 
enzymes during analytical measurements. As CB-2 and CB-3 were synthesized during 
the finishing stages of this project and due to the time constraints, attempts were not 
made to remove those acidic impurities. To prevent this problem in future syntheses, we 
suggest that the solutions of CB-2 and CB-3 should be passed through an anion 
exchanger and then recrystallized using a rotary evaporator, to get the final product. 
 
SB-1 was synthesized using a method described by Barnhurst (1961) and the synthesis 
was complicated compared to other sulfobetaines. One of the starting materials, 
vinylsulfonic acid is available only in the form of 25% w/v vinylsulfonic acid sodium salt 
in water and to covert it into a free acid, concentrated HCl had to be added along with the 
starting materials. Concentrated HCl was again added during the later stages of the SB-1 
synthesis to separate inorganic salts from the product. Due to these additions, the product 
contained a lot of acidic impurities and had to be resuspended in isopropanol several 
times to get the pure product. Even though SB-1 went through several cleaning steps, we 
still suspect that the final product contained a small percentage of impurities and this was 
evident by the inconsistent results obtained during different experiments using SB-1 
(discussed in later chapters).  
 
CSB-1 and CSB-2 were also synthesized during the later stages of the project, so were 
only used for DNA melting studies and not in enzyme stability experiments. Due to the 
difficulties faced during synthesis and very low yields, HPHB and TEHB have not been 
used in any of the experiments in this thesis. Also, CB-2 and CB-3, due to their strong 
acidic impurities, were not used in any of the experiments. 
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Table 3.2 lists the estimated costs of synthetic solutes described in this chapter. For 
comparison purposes, the cost estimation has been based on the raw materials required 
for the synthesis, using the prices of raw materials in the Sigma and Aldrich catalogues. 
The listed costs are an estimation based on a laboratory scale synthesis and do not take 
into account the cost of solvents required for the synthesis, which would be recovered in 
an industrial process. If an industrial process is designed for the syntheses of these 
solutes, the cost of the solutes would reduce as the raw materials would be purchased in 
bulk and syntheses would be in a large scale.  
 
Table 3.2: Estimated cost of 500 g of synthetic compensatory solutes compared with 
price of 500 g of natural solutes based on the prices in the Sigma catalogue. 
 
Synthetic Solutes                                             Natural Solutes – Sigma, MO, USA 
 
Solute Estimated cost of 
500g (A $) 
 Solute Price of 500 g 
(A $) 
Propio betaine 66.40  Sorbitol 27.20 
DB 678.40  Glycine betaine 164.00 
HDB 45.90  Trehalose 959.00 
HGB 1173.20    
DEHB 56.90    
TEHB 32.80    
HPHB 88.80    
DMT 88.10    
CB-1 385.20    
CB-2 123.40    
CB-3 165.70    
Sulfobetaines     
SB-1 189.10    
SB-2 1565.40    
SB-3 709.10    
SB-4 1381.70    
CSB-1 1642.10    
CSB-2 1575.10    
 
(Note: Costs of synthetic solutes are based only on the price of raw materials) 
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Comparing the estimated cost of synthetic solutes with the price of natural solutes (Table 
3.2), we observe that a few solutes such as propio betaine, HDB, DEHB and DMT are 
inexpensive and are a fraction of the price of natural solutes. Solutes DB and HGB are 
slightly expensive compared to other carboxylic acid solutes. 
 
The sulfonic acid analogues or sulfobetaines are expensive as well due to the high cost of 
their raw materials. However, the costs listed in Table 3.2 are based only on a laboratory 
scale synthesis, and designing a proper large scale process for the syntheses of these 
expensive solutes could reduce their cost substantially. 
 
3.4  CONCLUSIONS 
 
We conclude that synthetic compensatory solutes described in this chapter are easy to 
synthesize and a few are inexpensive compared to the natural solutes available in the 
market. Though impurities in the final products pose a problem, design and optimization 
of a proper synthesis method could result in a better and pure product. These novel 
solutes have paved a way for synthesis of more inexpensive synthetic solutes for specific 
applications. 
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Chapter 4 Protein Stabilization Using Synthetic Compensatory 
Solutes 
Part A 
 
4.1  Stabilization of Catalytic Activity of Different Model Enzymes 
 
4.1.1  Introduction 
 
The loss of catalytic activity of enzymes limits their use in biotechnological processes. 
Most enzymes are easily unfolded by changes in conditions such as heat, changes in pH 
or in the presence of chaotropic agents. As discussed in previous chapters, in nature, 
many living cells protect their enzymes by accumulating compounds such as 
methylamines, amino acids, polyols and sugars. In vitro, laboratory workers have been 
trying to stabilize enzymes against high and low temperatures by adding those 
compounds to enzyme solutions at different concentrations. However, the stabilizing 
effect of these compounds can sometimes be enzyme or stress specific, and their 
effectiveness cannot be generalized. There is a need for more compounds or a range of 
stabilizing compounds which are inexpensive and have better stabilizing properties than 
most of the known natural solutes.  
 
In a study of thermal destabilization of RNase A by urea, glycine betaine and 
glycerophophocholine were found to be very good stabilizers of the enzyme (Burg and 
Peters, 1998). Kaushik and Bhat (1998) studied the effects of a series of carboxylic acid 
salts on the thermal stability of five different proteins that vary in their physico-chemical 
properties. They found that there was a linear correlation between the increase in thermal 
stability and the number of carboxylic groups in the salt. Sugars have been shown to 
protect proteins against thermal denaturation. Among several sugars, trehalose, has been 
known to be a superior stabilizer in providing protection to biological materials and has 
been found to be very effective for stabilization of proteins on exposure to high 
temperatures in solution (Lin and Timasheff, 1996; Xie and Timasheff, 1997). Trehalose 
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and glycerol have been used to stabilize and renature yeast inorganic pyrophosphatase 
inactivated by very high temperatures (Zancan and Sola-Penna, 2005).  
 
Lipper and Galinski (1992) studied the effects of compatible solutes, including two new 
natural solutes, ectoine and hydroxyectoine, on phosphofructokinase (PFK) and lactate 
dehydrogenase (LDH) against different stresses. During thermal destabilization of the 
enzymes, they showed that hydroxyectoine, trehalose and betaine were able to increase 
the TD-50, temperature at which 50% of enzyme activity is lost, by almost 14°C. 
Differential scanning calorimetry (DSC) study on thermal unfolding of bovine RNase A 
demonstrated that hydroxyectoine increased the melting temperature of RNaseA 
significantly and proved to be a very good protein stabilizer (Knapp et al., 1999).  
 
Protection of enzymes against low temperatures, freeze-thawing and freeze-drying, has 
also been an important area of research for biotechnologists. During freeze-thawing and 
freeze-drying, proteins have to endure stresses such as low temperatures and formation of 
ice, which destabilize them. A variety of solutes, including sugars, polyols, amino acids 
and methylamines have been examined for their effects on retention of enzyme activity 
upon freeze-thawing and freeze-drying (Carpenter and Crowe, 1989). During freeze-
thawing, several compounds that stabilize proteins in their solution state protect them 
against low temperatures, but during freeze-drying sugars have been found to protect 
proteins (Carpenter et al., 1987; Carpenter and Crowe, 1989). Hydroxyectoine, with a 
free OH group, has also been shown to be an effective stabilizer against freeze-drying 
(Lippert and Galinski, 1992).  
 
Of the variety of enzyme stabilizers known, trehalose, a disaccharide, appears to be an 
effective protectant against both high and low temperatures, both in vivo and in vitro. A 
number of hypotheses have been proposed to explain the stabilizing property of trehalose. 
Carpenter and Crowe (1989) proposed that sugars like trehalose act as water substitutes 
by replacing the hydrogen bonds during freeze-drying, thus protecting the proteins. Work 
by Kaushik and Bhat (2003) has shown a decrease in the heat capacity of protein 
denaturation (∆CP) in trehalose solutions, and that there was a direct correlation of the 
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surface tension of trehalose solutions and the thermal stability of various proteins. They 
concluded that trehalose can be expected to work as a universal stabilizer of proteins. In a 
more recent study of trehalose-protein interaction in aqueous solution (Lins et al., 2004), 
it was proposed that trehalose molecules cluster and move toward the protein, but neither 
completely expel water from the protein surface nor form hydrogen bonds with the 
protein.  
 
Even though trehalose is an exceptional and possibly a universal stabilizer, it is expensive 
to purchase and this limits its application. It has always been of interest to find 
inexpensive alternatives to expensive stabilizers. In this chapter we explore the 
stabilization effect of our inexpensive synthetic compensatory solutes on three different 
model enzymes against different stress factors. The enzymes considered are, lactate 
dehydrogenase (LDH) (from rabbit muscle), α-chymotrypsin (from bovine pancreas) and 
a microbial lipase. These enzymes were subjected to different stresses such as heat 
denaturation, freeze-thawing and freeze-drying, and the protective effect of novel 
synthetic solutes was assessed.  
 
Lactate dehydrogenase (LDH) is a tetrameric enzyme belonging to the class of 
oxidoreductases and catalyzes the conversion of pyruvate to lactate. LDH can be easily 
denatured and has been previously used to study the effect of natural compensatory 
solutes on enzyme stability (Goller and Galinski, 1999). The reaction catalyzed by LDH 
can be represented as: 
++→+ NADLactateNADHPyruvate  
α-Chymotrypsin is a protease which catalyses the hydrolysis of peptide bonds and ester 
bonds. It is a trimeric enzyme usually active in the digestive system of mammals and 
other organisms. Lipase is an enzyme which catalyzes the hydrolysis or formation of 
lipids. Lipases are being increasingly employed for biotechnological processing and are 
used in many industrial applications (e.g. detergents, oils and fats, leather and paper). The 
reaction catalyzed by lipase can be represented as:  
glycerolfattyacidsOHdestriglyceri +→+ 2  
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4.1.2  Materials and Methods 
 
4.1.2.1  Materials 
 
L-Lactate dehydrogenase (LDH) (type XI: from rabbit muscle, EC 1.1.1.27), α-
chymotrypsin (type II: from bovine pancreas, EC 3.4.21.1), pyruvate, n-benzoyl-l-
tyrosine-p-nitroanilide, 1,4 – dioxane, NADH, trehalose, sorbitol and glycine betaine 
were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Lipase (type VII: from 
Candida rugosa, EC 3.1.1.3) was purchased from Sigma, Japan. KH2PO4, K2HPO4, 
Na2HPO4 and phosphate buffer tablets (pH 7.2) were obtained from BDH (Poole, 
England). Tributyrin (98%) was purchased from Aldrich Chemical Co., USA.  
4.1.2.2  Equipment 
 
LDH activity and chymotrypsin activity was measured on a UV spectrophotometer (Cary 
4000, Varian, Melbourne, Australia) equipped with a temperature controlled cuvette 
holder. Lipase activity was measured using an autotitrator (DL50, Mettler Toledo) with a 
sensor (DG113, Mettler Toledo). Freeze drying was carried out in a general purpose 
freeze dryer (Model 24DX24, Virtis). 
4.1.2.3  LDH activity assay 
 
LDH activity was measured at 32oC. All solutions were made in 50 mM potassium 
phosphate buffer, pH 7.5. The 2.0 ml reaction mixture contained 2.3 mM pyruvate and 
0.26 mM NADH. The spectrophotometer was blanked with the reaction mixture and the 
reaction was initiated by the addition of 50 µL of LDH solution (10 µg/mL) and was 
followed by measuring the decrease in absorbance at 340 nm. The reaction mixture was 
held in a temperature controlled cuvette holder for five minutes prior to the addition of 
enzyme. 
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4.1.2.4  Chymotrypsin activity assay 
 
Chymotrypsin activity was measured at room temperature (22oC). The substrate, n-
benzoyl-l-tyrosine-p-nitroanilide, was prepared in 1,4-dioxane solution. The 1 ml reaction 
mixture contained 50 mM sodium phosphate buffer, pH 8.0, 0.4 mg/mL of enzyme and 
0.15 mM substrate. The spectrophotometer was blanked before the addition of substrate. 
The reaction was initiated by the addition of substrate and was monitored by observing 
the increase in absorbance at 405 nm. 
4.1.2.5  Lipase activity assay 
 
Lipase activity was measured at room temperature (22oC). The reaction mixture 
contained 1 mL tributyrin in 25 mL phosphate buffer (5 mM, pH 7.2, prepared from 
buffer tablets, BDH, Poole, England). A pretitration run was done to attain the set pH 
before the final titration. The titrant used was 0.05 N NaOH. The reaction was initiated 
by adding 100 µL of lipase solution (0.3% w/v) and the reaction was run for 10 min. The 
lipase activity was calculated from the amount of NaOH consumed (ie the fatty acids 
produced).  
 
Stress experiments 
 
After determining the catalytic activity of the enzyme, aliquots of the enzyme solution 
were transferred to microcentrifuge tubes, supplemented with compensatory solutes (final 
concentration: 1M) and then subjected to heat denaturation or freeze drying. The total 
volume of enzyme/stabilizer solution was 250 µL for LDH and chymotrypsin assay, and 
1000 µL for lipase assay. 
 
In controls, the enzymes were incubated with compensatory solutions (final 
concentration: 1M) for 10 min at room temperature (22oC). The activities of the enzymes 
were then determined as described above. The relative activity of the enzymes was 
expressed as a percentage of the activity prior to the stress experiments. 
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4.1.2.6  Heat denaturation 
 
For heat denaturation, the enzyme/stabilizer solutions in microcentrifuge tubes were 
incubated in a temperature block for 10 min at the specified temperature. The holes of the 
temperature block were partially filled with water to ensure good conductivity of 
temperature to the tubes. 
4.1.2.7  Freeze-drying 
 
For freeze drying, the enzyme/stabilizer solutions were frozen at approximately -50°C for 
two minutes using dry-ice in acetone followed by lyophilization for 24 hours at a 
temperature of -20oC using the freeze dryer. The enzymes were rehydrated using the 
same volume of distilled water as the mixture was before freeze-drying. 
4.1.2.8  Freeze-thawing 
 
For freeze-thawing, the enzyme/stabilizer solutions were frozen at approximately -50°C 
for two minutes using dry-ice in acetone and then thawed in a water bath at a constant 
temperature of 32°C. The same procedure was repeated for each freeze-thaw cycle. 
4.1.2.9  Data analysis 
 
The non-linear regression function of SigmaStat for Windows (v3, SPSS) was used to fit 
the relationship between the enzyme activity (% initial) and temperature to several 
empirical equations, using the Marquart-Levenberg algorithm. These equations were 
mainly used for interpolation to get TD-50 values, the temperature at which the enzyme 
loses 50% of its activity.  
 
Empirical equations that gave excellent fits were a double exponential equation: 
 
)(
2*100
txmey
−−=       (4.1) 
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a logistic equation: 
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and a sigmoid equation: 
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where ‘y’ is the relative activity of the enzyme (% initial),‘t’ is the temperature (°C) at 
which the enzyme lost 50% activity and ‘x’ is the temperature. The parameter ‘m’ is a 
measure of the steepness of the curve. All data were fitted to all three equations. Equation 
4.1 gave the best fit for heat denaturation of LDH and chymotrypsin, and equation 4.2 for 
heat denaturation of lipase. 
 
Replicate trials (three) were conducted to observe the decrease in the activity of the 
enzymes with the increase in temperature and in the presence of different compensatory 
solutes. Parameters for each set of data were estimated by curve fitting, carried out with 
weights 1/(1+s2) where s is the standard error of the mean of the activities at each 
temperature. 
4.1.3  Results 
4.1.3.1  Control experiments 
 
The activity of the enzymes was not affected by pre-incubation with 1M solute solutions 
at room temperature. With all the solutes tested (Table 4.1), activity after incubation was 
>96% of controls without solute, for lactate dehydrogenase, chymotrypsin and lipase. 
Based on triplicate experiments, these results were not significantly different from 100%. 
4.1.3.2  Heat Protection 
 
All the compensatory solutes considered were able to protect the enzymes against heat 
when compared to the absence of compensatory solutes. The data were fitted to a few 
empirical equations (section 4.1.2.9) to estimate the values of TD-50 for each enzyme in 
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the presence and absence of compensatory solutes during heat denaturation. The double 
exponential equation gave the best fit for LDH and chymotrypsin, and logistic equation 
gave the best fit for lipase. The results of estimates of TD-50 are shown in Table 4.1. 
 
In case of LDH, though all the compensatory solutes were able to protect the enzyme 
against heat, synthetic solutes HDB and HGB gave the best protection with the TD-50 
value of LDH being very high in their presence. In the absence of any solute solution, 
50% of LDH activity is lost at 50.9 ± 0.4°C, whereas in the presence of 1M HGB it 
increased to 59.5 ± 1.0°C, an approximate increase of 9°C. Similar heat protection of 
LDH were observed in the presence of propio betaine, HDB, DEHB and CB-1, which 
increased the TD-50 by more than 7°C. 
 
Of the three natural compensatory solutes considered, trehalose gave the best protection 
to LDH by increasing the TD-50 by almost 5°C. Sorbitol and GB gave a moderate heat 
protection to LDH with an increase in TD-50 by just 2.1°C and 4.4°C respectively. All the 
sulfobetaines considered were able to protect LDH against heat, but their protection was 
not similar to that of HGB or HDB. Of the sulfobetaines, SB-3 was the best stabilizer 
with an approximate 4.6 °C increase in TD-50 (Table 4.1). 
 
During heat denaturation of chymotrypsin, in the absence of any compensatory solute the 
enzyme lost 50% of its activity at 41.5 ± 0.5°C (Table 4.1). The best heat protection was 
observed in the presence of 1M HGB which increased the TD-50 of chymotrypsin to 50.9 
± 0.6°C, an approximate increase of 9.5°C. Trehalose with its 5.2°C increase in TD-50 
gave the best protection of all the three natural solutes. None of the other synthetic 
solutes were able to protect chymotrypsin against heat as effectively as HGB. Though 
HDB increased the TD-50 by almost 6°C, it was still 3.5°C less than HGB. There was no 
apparent change in the TD-50 of chymotrypsin in the presence of DEHB. Of the 
sulfobetaines considered, SB-3 was again the best stabilizer with a 5.5°C increase in TD-
50. SB-1 did not seem to protect chymotrypsin against heat as it increased the TD-50 by 
just 1°C. 
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Table 4.1: Estimates of TD-50 ± SEM (from three trials), temperature at which enzymes lost 50% activity in the presence of different 
compensatory solutes (1M). Approx. changes in TD-50 are obtained by comparing individual TD-50 values with that of no addition. 
 Lactate dehydrogenase Chymotrypsin Lipase 
Solute  
TD–50, °C 
Change in    
TD–50, °C 
 
TD–50, °C 
Change in   
TD–50, °C 
 
TD–50, °C 
Change in    
TD–50, °C 
 
No addition 
 
50.9 ± 0.4 
 
0.0 
 
41.5 ± 0.5 
 
0.0 
 
54.9 ± 0.9 
 
0.0 
Trehalose 55.8 ± 0.0 + 4.9 46.7 ± 0.5 + 5.2 67.5 ± 0.4 + 12.6 
Sorbitol 53.0 ± 0.6 + 2.1 45.1 ± 0.2 + 3.6 58.9 ± 0.8 + 4.0 
Glycine betaine 55.3 ± 0.2 + 4.4 45.9 ± 0.3 + 4.4 55.2 ± 0.8 + 0.3 
Propio betaine 58.7 ±  0.4 + 7.8 44.5 ± 0.2 + 3.0 ----- ----- 
DMT 54.3 ± 0.1 + 3.4 45.4 ± 0.6 + 3.9  55.5 ± 0.8 + 0.6 
CB-1 58.7 ± 0.3 + 7.8 45.0 ± 0.6 + 3.5 ----- ----- 
DB 54.6 ± 0.3 + 3.7 46.0 ± 0.5 + 4.5 ----- ----- 
HDB 59.2 ± 0.5 + 8.3 47.4 ± 0.4 + 5.9 66.4 ± 0.4 + 11.5 
HGB 59.5 ± 1.0 + 8.6 50.9 ± 0.6 + 9.4 ----- ----- 
DEHB 57.9 ± 0.4 + 7.0 41.3 ± 0.8 - 0.2 ----- ----- 
SB-1 54.3 ± 0.9 + 3.4 42.6 ± 0.8 + 1.1 ----- ----- 
SB-2 55.2 ± 0.6 + 4.3 46.9 ± 0.3 + 5.4 ----- ----- 
SB-3 56.2 ± 0.4 + 4.6 47.0 ± 0.7 + 5.5 ----- ----- 
SB-4 54.2 ± 0.5 + 3.3 46.0 ± 0.2 + 4.5 ----- ----- 
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Heat Denaturation of LDH
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Figure 4.1: Effect of heat (10-minute pre-incubation at each temperature) on activity of lactate dehydrogenase (LDH) in the presence 
of natural and synthetic compensatory solutes. 
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Heat Denaturation of Chymotrypsin
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Figure 4.2: Effect of heat (10-minute pre-incubation at each temperature) on activity of α-chymotrypsin in the presence of natural and 
synthetic compensatory solutes. 
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Experiments on heat denaturation of lipase were conducted during the early stages of the 
project and only two synthetic compensatory solutes, HDB and DMT, were considered for 
the study. With the application of heat, lipase lost 50% of its activity at 54.9 ± 0.9°C in the 
absence of compensatory solutions. Increases in TD-50 were not significant with glycine 
betaine and dimethylthetin, though sorbitol and especially trehalose and HDB significantly 
enhanced stability (Table 4.1 and Figure 4.3). The maximum increases were between 9 and 
13 degrees, and were in the presence of either the natural stabilizer trehalose or with 
synthetic solute HDB. 
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Figure 4.3: Heat Denaturation of Lipase: effect of heat (10-minute pre-incubation at each 
temperature) on activity of lipase in the presence of HDB and trehalose. 
68 
Chapter 4 
The rates at which the activity of the enzymes is lost in the presence of different 
compensatory solutions are shown in Figure 4.1, 4.2 and 4.3. During heat denaturation of 
LDH (Figure 4.1) at 60°C, the relative activity (%) in the presence of most of the 
compensatory solutes is less than 10%. However, at 60°C, in the presence of synthetic 
solutes HDB and HGB, the relative activity is more than 50%, and between 25% and 50 % 
in the presence of DEHB, CB-1 and propio betaine. Even in the presence of the most 
effective natural stabilizer, trehalose, only 6% of the initial activity LDH is retained at 
60°C. The results show that in the presence of synthetic stabilizers such as HDB and HGB, 
LDH activity was lost slowly with the increase in temperature and at extreme temperatures 
more activity was retained in their presence than in the presence of any of the other solutes. 
 
Similarly, during heat denaturation of chymotrypsin (Figure 4.2), HGB shows better 
protection at higher temperatures compared to other solutes. At 55°C, relative activity in 
the presence of HGB is more than 30%, whereas it is less than 10% in the presence of most 
of the other solutes. The same trend is observed in case of lipase (Figure 4.3), where 
synthetic solute HDB seems to be a better stabilizer than trehalose at extreme temperatures.  
4.1.3.3  Protection against Freeze-drying 
 
Two enzymes, LDH and lipase, were used to study the protective effects of compensatory 
solutes against freeze-drying. In the case of LDH, the enzyme could retain 26% of its 
activity in the absence of any compensatory solute (Figure 4.4). Trehalose was able to 
effectively stabilize LDH by helping it retain almost 80% of its initial activity. In the 
presence of synthetic solutes HGB and HDB, LDH retained around 63% and 42% of its 
initial activity respectively. DB, DEHB, SB-2 and sorbitol showed some moderate 
stabilizing effect, and were able help LDH retain more than 30% of its activity. However, 
on a molar basis none of the synthetic solutes were as effective as trehalose. Propio betaine, 
GB, DMT, SB-1 and SB-3 did not confer any protection to LDH during freeze-drying. 
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Freeze-drying of LDH
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Figure 4.4: Relative activity (%) of LDH after freeze-drying and reconstituting enzyme solutions containing 1 M different solutes. 
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Of the sulfobetaines, SB-2 gave the best protection to LDH by helping it retain almost 40% 
of its initial activity. Surprisingly, SB-1 and SB-3 did not protect LDH during freeze-
drying, and seemed to destabilize the enzyme as the relative activity was less than the no 
addition. Most of the synthetic solutes containing OH groups in their structure were able to 
stabilize LDH against freeze-drying, except SB-1 and SB-3. Relative activity in the 
presence of solutes without hydroxyl group such as propio betaine, GB, DMT and CB-1, 
was less than the relative activity found in the absence of any solutes (no addition).   
 
The best synthetic solutes to protect LDH during freeze-drying, HDB and HGB, were 
mixed with trehalose in various molar proportions and their effect on LDH during freeze-
drying was assessed. Results are as shown in Figure 4.5.  
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Figure 4.5: Freeze-drying of LDH with mixtures of compensatory solutes. 
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No significant results were obtained when the solutes were mixed during freeze-drying. 
The effect of trehalose seemed to be more dominant in all the mixtures. One interesting 
results was that mixtures containing 0.75 M HDB + 0.25 M trehalose and 0.75 M HGB + 
0.25 M trehalose gave a similar stabilization effect as 1 M trehalose.  
 
As mentioned earlier, lipase experiments were conducted during the early stages of the 
project and only two synthetic solutes, HDB and DMT, were used. Lipase, an enzyme 
known for its stability at low temperatures, was able to retain almost 60 % of its activity 
even in the absence of stabilizers. Trehalose and HDB significantly increased the stability, 
enabling lipase to retain more than 80% activity (Figure 4.6). Glycine betaine, sorbitol and 
DMT did not significantly affect the stability of lipase during freeze drying. 
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Figure 4.6: Relative activity (%) of lipase after freeze-drying and reconstitution. 
 
Trehalose significantly stabilized both LDH and lipase against freeze drying. Compared to 
other synthetic solutes HGB was a very effective stabilizer of LDH during freeze-drying 
and showed better stabilizing effect than sorbitol (a polyol). In the case of lipase, synthetic 
solute HDB was as effective as trehalose, but not as effective for stabilizing LDH. 
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Furthermore, HDB and HGB have approximately half the molecular weight of trehalose 
and thus the mass of these synthetic solutes used in the experiments was less. 
4.1.3.4  Protection against Freeze-thawing 
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Figure 4.7: Relative activity (%) of lactate dehydrogenase after different number of freeze-
thaw cycles in the presence of 1M compensatory solutes. 
 
Only LDH was used to study the effect of compensatory solutes during freeze-thawing. All 
the compensatory solutes considered, both natural and synthetic, were able to confer 
protection to LDH during freeze-thawing. In the absence of stabilizers, LDH lost 50% of its 
activity after two freeze-thaw cycles and by the end of fifth cycle, only 7 % of the initial 
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activity was retained (Table 4.2). Natural solutes, GB, sorbitol and trehalose, gave better 
stabilization compared to synthetic solutes. Even after five cycles, more than 80 % of the 
initial activity was maintained in the presence of natural solutes. Relative activity was 
between 50% and 80% in the presence of synthetic solutes after five freeze-thaw cycles. 
SB-1 was the only sulfobetaines that was unable to protect LDH against freeze-thawing. In 
the presence of other three sulfobetaines, SB-2, SB-3 and SB-4, more than 70% of the 
initial activity was retained after five cycles.  
 
Table 4.2: Relative activity of LDH, after 1st and 5th freeze-thaw cycle, in the presence of 1 
M compensatory solutes. All values quoted ± SEM are from three replicate trials. 
 
 Relative activity (%) after no. of freeze-thaw cycles 
Solute 1st cycle 5th cycle 
 
No addition 
 
62.2 ± 2.9 
 
7.3 ± 0.9 
Trehalose 98.6 ± 0.7 81.6 ± 1.0 
Sorbitol 96.5 ± 2.0 85.5 ± 2.4 
Glycine betaine 97.4 ± 1.9 80.9 ± 2.2 
Propio betaine 78.1 ± 2.2 55.3 ± 1.0 
DMT 90.3 ± 2.1 66.3 ± 2.0 
CB-1 82.6 ± 2.4 51.8 ± 3.5 
DB 92.6 ± 1.5 74.6 ± 2.0  
HDB 88.3 ± 1.7 65.8 ± 1.8 
HGB 88.8 ± 4.2 70.4 ± 4.8 
DEHB 78.6 ± 5.2 57.4 ± 1.9 
SB-1 76.6 ± 4.0 51.8 ±3.0 
SB-2 84.2 ± 2.2 72.6 ± 1.4 
SB-3 92.8 ± 4.2 78.3 ± 2.4 
SB-4 86.3 ± 6.8 70.6 ± 7.8 
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4.1.4  Discusssion 
 
Natural compensatory solutes have been exploited to stabilize enzyme activities, both 
zwitterionic solutes (Lippert and Galinski, 1992; Galinski, 1993; Goller and Galinski, 
1999; Burg and Peters, 1998) and polyhydric solutes (Carpenter and Crowe, 1988a&b) 
have been used for this purpose. Carboxylic acid salt solutions (Kaushik and Bhat, 1998) 
and trehalose (Kaushik and Bhat, 2003) have been shown to increase the thermal stability 
of proteins, and trehalose has been judged as an exceptional and a universal protein 
stabilizer (Kaushik and Bhat, 2003). In this first part of the chapter we have tried to assess 
the protective effects of novel synthetic compensatory solutes on three different enzymes 
against high and low temperatures. Our results show that some of the synthetic 
compensatory solutes have better stabilizing properties than most the well known natural 
stabilizers. We chose heat denaturation, freeze-thawing and freeze-drying as the stress 
factors, and LDH, α-chymotrypsin and lipase as our model enzymes. As α-chymotrypsin is 
stable at low temperatures it was not used for freeze-thawing and freeze-drying 
experiments. Only two synthetic solutes, HDB and DMT, were used for lipase experiments, 
as the experiments were conducted during the early stages of this project. 
 
Synthetic solutes, HGB and HDB, showed superior performance as thermoprotectants for 
both LDH and chymotrypsin, and effect of HDB was in par with trehalose for 
thermostabilization of lipase. Compared to trehalose, synthetic solutes were better 
performers as they helped the enzymes to retain their catalytic activity even at extreme 
temperatures. However, the degree of thermostabilization by synthetic solutes varied 
between the two enzymes. The temperature at which enzymes lost 50 % of their activity, 
TD-50 values, helped us to compare the stabilization effect of different solutes on different 
enzymes.  
 
HDB and HGB were very good stabilizers during thermostabilization of LDH and had 
similar protective effect on the enzyme. However, in case of chymotrypsin the effect of 
HDB was comparatively lesser than HGB. A similar pattern was observed with propiono 
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betaine and CB-1, as both were better stabilizers while protecting LDH against heat, but 
had a very less effect on chymotrypsin. Interestingly, DEHB, which was a very good 
stabilizer of LDH against heat (increasing the TD-50 by almost 7°C) had absolutely no 
effect on chymotrypsin. HGB was the only solute which gave a consistent 
thermoprotection to both LDH and chymotrypsin during heat denaturation. 
 
Natural stabilizers, GB, sorbitol and trehalose, were consistent in protecting the enzymes 
against heat. Trehalose showed considerably better stabilizing effect on lipase compared to 
GB and sorbitol. The TD-50 values of LDH in the presence of trehalose and GB are 
comparable to the results obtained by Lippert and Galinski (1992). In the same study, they 
examined the protection of LDH against heat stress by two novel compatible solutes, 
ectoine and hydroxyectoine, and showed that the protecting effect was pronounced in the 
case of hydroxyectoine, a solute containing hydroxyl group in its structure. Comparing 
those results with ours, it is observed that HDB and HGB seem to be better stabilizers than 
ectoines. To confirm these results, a single trial experiment of heat denaturation of LDH in 
the presence 1 M ectoine and hydroxyectoine (gifted by Prof. Erwin Galinski) was carried 
out. Results of these experiments showed that though ectoine and hydroxyectoine were 
able to protect LDH against heat (Figure 4.8), their effect was less significant compared to 
synthetic solutes HDB and HGB. 
Temperature, oC
30 35 40 45 50 55 60 65
R
el
at
iv
e 
ac
tiv
ity
 (%
)
0
20
40
60
80
100
No addtion 
Ectoine 
Hydroxyectoine 
HGB 
HDB 
 
Figure 4.8: Effect of ectoine, hydroxyectoine, HDB and HGB against heat denaturation of 
LDH. 
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Except for SB-1, sulfobetaines were consistently able to stabilize both the enzymes against 
heat. SB-1 showed some thermoprotection to LDH, but had much less effect on 
chymotrypsin, which may be due to the impurities present in SB-1. Of the four 
sulfobetaines, SB-2 and SB-3 were good thermoprotectants of the enzymes and their effect 
was similar to that of trehalose. SB-3 seemed to be a slightly better thermostabilizer than 
SB-2. 
 
Glycine betaine is known as a simple and useful cryoprotectant that works for 
cryopreservation of a wide range of prokaryotic organisms (Cleland et al., 2004). Glycine 
betaine and a few simple modified betaines have been shown to be effective cryoprotective 
additives (Lloyd et al, 1992; Lloyd et al., 1994). Trehalose has also been shown to be a 
good cryoprotectant during freeze-thawing of LDH (Galinski, 1993). It was found that all 
compensatory solutes considered in our study, synthetic and natural, gave significant 
protection to LDH during freeze-thawing (Table 4.2 and Figure 4.7). Compensatory solutes 
helped LDH retain more than 50% of its initial activity even after five freeze-thaw cycles. 
Our results show that natural solutes are better stabilizers than synthetic solutes during 
freeze-thawing of LDH. HDB and HGB, which showed better stabilization compared to 
trehalose and GB during heat denaturation, were less effective during freeze-thawing. Even 
sulfobetaines were able to protect LDH effectively during freeze-thawing, and again SB-3 
gave the best protection amongst the four sulfobetaines. 
 
Freeze-drying often destabilizes proteins due to the conformational instability of many 
proteins when subjected to freezing and subsequent dehydration stresses (Crowe et al., 
1990). In contrast to freeze-thawing, where freezing is the only stress, freeze-drying poses 
two stresses, freezing and drying. Thus, to protect proteins against freeze-drying, both these 
fundamentally different stresses have to be overcome. Several additives have been tried in 
order to protect proteins against freeze-drying, including disaccharides (Carpenter and 
Crowe, 1989) and compatible solutes (Lippert and Galinski, 1992; Galinski, 1993). Results 
presented here have shown that synthetic compensatory solutes have the potential to be 
used as stabilizers of proteins against freeze-drying. 
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Trehalose, which is known for its protection of proteins against desiccation stress, was the 
best stabilizer for both LDH and lipase. HDB was able to stabilize lipase very well, but had 
only a modest stabilizing effect on LDH. HGB was the most effect stabilizer of all the 
synthetic solutes. Most of the synthetic solutes with hydroxyl groups, except SB-1 and SB-
3, were able to stabilize LDH during freeze-drying. It is suspected the impurities in these 
solutes may be the cause for their failure to protect LDH. Carpenter and Crowe (1989) 
proposed that hydrogen-bonding between the OH groups of the solute and polar residues of 
proteins is involved in maintaining the structure of the dried protein. This is consistent with 
the superior performance of synthetic solutes with OH groups.  As expected, HGB with 
two OH groups in its structure is a better stabilizer than HDB and DB (one OH group). 
However, we are unable to explain why DEHB (with two OH groups) does not stabilize as 
effectively as HGB (see Appendix A for structures of compensatory solutes). The 
speculation in this case would be that DEHB is not pure enough and the impurities may be 
affecting the enzyme activity.  
 
Lippert and Galinski (1992) showed that hydroxyectoine, a compatible solute containing 
OH group, was a superior stabilizer to other compatible solutes in their study of freeze-
drying of LDH. Our results show that GB, propio betaine, dimethylthetin and CB-1, which 
do not have OH group in their structure, fail to protect LDH during freeze-drying, which is 
consistent with results of other investigators (Lippert and Galinski,1992). Furthermore, 
these solutes (without OH groups) seem to destabilize the enzyme as the relative activity 
after freeze-drying in their presence is less than the no addition (Figure 4.4). Thus, our 
results further support the argument (Carpenter and Crowe, 1989) that OH groups in the 
solute structure are needed for hydrogen-bonding of the solute to the protein, which is 
necessary for the solute to preserve dried proteins. However, results with more proteins are 
needed for confident generalization. 
 
When we compare, on a molar basis, the stabilization effect of trehalose and our synthetic 
solutes during freeze-drying of enzymes, trehalose is approximately twice the molecular 
weight of some of the synthetic stabilizers (e.g. HGB, HDB and DB),  so there was only 
half the mass of synthetic solutes present (compared with trehalose) in the experiments. 
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Trehalose is expensive to purchase whereas some synthetic solutes are inexpensive to 
make, so on a gram basis synthetic solutes can be a cheaper option to stabilize proteins 
during freeze-drying.  
 
Not many conclusions could be drawn from freeze-drying experiments using mixtures of 
compensatory solutes of as the effect of trehalose seemed to be dominant in every mixture. 
However, one useful result is that mixing HDB with trehalose (0.75 M HDB + 0.25 M 
trehalose) gave a similar stabilizing effect to 1 M trehalose. This may be a cost-effective 
method for freeze-drying proteins, as synthetic solutes, especially HDB, are very cheap to 
synthesize. 
 
Results of this study indicate that compensatory solutes containing OH groups are better 
stabilizers of proteins. In a study, using E.coli as a model system, to evaluate a range of 
natural and synthetic betaines for their ability to protect against salt and urea stresses 
(Randall et al., 1998), it was observed that serine betaine and betonicine (OH group 
containing solutes) were very good urea protectors, and they speculated it was a result of 
the hydrogen bonding capacity of the hydroxyl group. Hydroxyectoine has been proved to 
be a better stabilizer of enzymes compared to other compatible solutes (Lippert and 
Galinski, 1992). Even though our results support these findings, the stabilization effect of 
solutes with OH groups cannot be generalized. Except for HGB and HDB, which are 
consistent in stabilizing enzymes during heat denaturation, freeze-thawing and freeze-
drying, there are other solutes such as DEHB and DB (also with OH group) which show a 
varying degree of protection with different enzymes and stress factors. Propio betaine, CB-
1 and SB-1, were very good stabilizers during heat denaturation of LDH, but gave 
moderate protection to chymotrypsin and they also failed to protect LDH during freeze-
drying. SB-3 (sulfobetaine containing a C4 bridge between S and N in its structure) had a 
better stabilizing effect compared to SB-2 (sulfobetaine containing a C3 bridge between S 
and N in its structure, see Appendix A) during heat denaturation of both LDH and 
chymotrypsin. However, during freeze-drying of LDH, SB-2 showed a good stabilizing 
effect and SB-3 failed to protect the enzyme. In a study of membrane-protein extraction 
(Vuillard et al., 1995), results have shown that sulfobetaines with a C3 bridge between N 
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and S are more efficient than sulfobetaines with a C4 bridge. Furthermore, they state that 
they were unable to find any application where C4 bridge sulfobetaines would perform 
better than C3 bridge sulfobetaines. Though our results of freeze-drying would support the 
above mentioned argument, our heat denaturation results show the contrary. 
 
From our results of stabilization of different enzymes using a range of solutes and under 
different stresses, we believe that the stabilization effect of any particular solute cannot be 
generalized. The observed stabilization effect of a solute may be specific to the enzyme 
under investigation and the stress factor considered.  These solutes may interact with each 
protein in a different way that would result in a different degree of stabilization. It is also 
possible that the properties of the solutes themselves may change in the face of different 
stresses, like high and low temperatures or salt stress, which would in turn affect the 
protein. Most of the proposed mechanisms of protein stabilization have considered only a 
few solutes or particular group of solutes to explain the mechanisms by which they 
stabilize the proteins. The new range of synthetic stabilizers that we have presented here 
may be helpful in providing new insights into the mechanism of protein stabilization as 
they are slightly different from each other in their structure and have varied degree of 
protection with different enzymes. Protein stabilization is a very important aim in the field 
of biotechnology and our results suggest that while deciding a stabilizer for a particular 
protein, it would be helpful to choose from a range of stabilizers instead of any one 
universal stabilizer. 
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Part B 
4.2  Assessment of Stabilizing Effect of Compensatory Solutes on the 
Unfolding of Chymotrypsin Using an HPLC system. 
 
In Part A of this chapter the stabilizing effect of synthetic compensatory solutes on 
catalytic activity of three different enzymes has been explored. These catalytic activity 
results do not explain much about the conformation of the enzyme/protein in the presence 
of compensatory solutes. Therefore, to understand more about the mechanism by which 
these solutes stabilize enzymes and their effect on protein conformation, the effect of 
compensatory solutes on unfolding of chymotrypsin using was investigated. 
4.2.1 Introduction 
 
Most of the enzyme stabilization studies have used activity measurements as the basis of 
their investigation. Only a few researchers (e.g. Goller and Galinski, 1999) have used 
fluorescence spectroscopy of endogenous tryptophan-residues as a technique for 
monitoring the structural changes of an enzyme. The fluorescence of tryptophan-residues 
depends on the conformation of the protein and usually changes with 
unfolding/denaturating of the native enzyme structure. As the enzyme unfolds, it exposes 
more tryptophan residues leading to changes in the fluorescence.  
 
Goller and Galinski (1999) used time resolved fluorescence measurements to monitor the 
structural changes of LDH caused by freezing and thawing in the presence of compatible 
solutes. Their results revealed that residual fluorescence intensity correlated well with the 
residual activity determined by activity assays. They concluded that residual intensity 
reflects the proportion of native enzyme. In most of the studies involving stabilization of 
enzymes, the stabilization effect has been monitored with the help of enzyme activity 
measurements. However, in some of the studies inconsistencies have been observed 
between the stabilization of functional activity and the structure of the enzyme (Galinski, 
1993; Burg et al., 1996; Goller and Galinski, 1999). To understand this, the effect of 
compensatory solutes/ co-solvents on the fluorescence of a number of probes has been 
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studied (Wood et al., 2000; Lever et al., 2001). 8-Anilinosulfonate (ANS) is one of the 
fluorescent probes that have been used in these studies. Randall et al. (1998) found that 
adding compensatory solutes to aqueous ANS solutions increased the fluorescence yield 
without a change in Stokes shift, and trehalose and glycine betaine increased the 
fluorescence most. However, their study had problems due to the contaminants in solutes 
which affected the fluorescence. The solutes used for these studies had to be pure, as any 
fluorescent impurities present would change the fluorescence being studied. This problem 
was overcome by Lever et al. (2001) by making their measurements using HPLC 
equipment. The HPLC degassing module and the reverse-phase column removed virtually 
all fluorescent impurities in the solutes. Results of changes in fluorescence intensity of 
ANS induced by co-solvents (Lever et al., 2001) showed that changes in fluorescence of 
these probes may throw light on the hydration of functional groups in larger molecules 
(proteins) and provide new insights into the stabilization of tertiary structure.  
 
Chymotrypsin was chosen as the enzyme for our study. The emission maximum of 
denatured chymotrypsin is higher than that of its native form as the tryptophan-residues of 
chymotrypsin are exposed more in the denatured/unfolded state. This was used as the basis 
for our experiments. The emission maximum intensity of the protein usually changes in the 
presence of compensatory solutes and this change in the fluorescence can be related to the 
conformation of the protein. To ensure that the observed stabilizing effect of compensatory 
solutes is related to the conformation of chymotrypsin, we also assessed the effect of 
compensatory solutes on tryptophan solution and native/unheated chymotrypsin. An 
experimental set-up with HPLC equipment, similar to Lever et al. (2001), was used for our 
experiments. A reverse-phased HPLC column was used to remove the fluorescent 
impurities in the compensatory solutions. Degassed water was pumped slowly through an 
auto-injector and the column, and then mixed with the degassed aqueous solution of 
tryptophan or chymotrypsin in buffer, pumped by a second pump. The mixed solutions 
were passed through a coil to ensure proper mixing. For denaturation of the enzyme, the 
coil was maintained at a constant specified temperature. The fluorescence of the mixed 
solutions was measured simultaneously at two emission wavelengths (emission maxima 
corresponding to native and denatured states) using a fluorescence detector. To ensure that 
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the detector would record tryptophan or chymotrypsin in the solute solution for several 
minutes, a sufficient volume of each sample solute was injected. 
 
4.2.2  Materials and Methods 
 
4.2.2.1  Fluorescence Spectra 
 
Fluorescence spectra of chymotrypsin (native and denatured) were obtained using a Cary 
Eclipse fluorescence spectrometer (Varian, Melbourne, Australia). Chymotrypsin solution 
(100 mg/L) prepared in 50mM sodium phosphate buffer, pH 8.0, was scanned and the 
fluorescence spectra of corresponding blank solution (buffer) subtracted. With the 
excitation wavelength being 290 nm, native chymotrypsin’s maximum emission 
wavelength of 333 nm was determined by recording fluorescence emission spectra (300-
400 nm) as the average of three measurements. To obtain the emission maxima of 
denatured chymotrypsin, the enzyme solution was incubated for 10 minutes at 50°C in a 
temperature block and scanned. The emission maximum of denatured chymotrypsin was 
found to be 358 nm. 
 
4.2.2.2  HPLC system 
 
Two HPLC pumps, Shimadzu LC-10 ADVP, were used for the experimental set-up (Figure 
4.9). The pumps were referred to as ‘A’ and ‘B’. Water passed through a Shimadzu DGU-
14A membrane degassing module to Pump A (0.05 mL/min), and then through an auto-
sampler, Shimadzu SIL10AXL fitted with a 400µL loop. The auto-sampler, controlled by a 
system controller (Shimadzu SCL-10A) contained 1 M compensatory solutions in 0.5 mL 
vials and was programmed to inject 400 µL to the sample stream. The sample stream then 
passed through a reverse phase column (Merck Superspher, RP 18 endcapped, 4µ, 250 × 
2mm), which was maintained at a constant temperature of 50°C. All connecting tubing 
used in the system was 0.0007″ i.d. PEEK HPLC tubing. Chymotrypsin (100 mg/L) in 
buffer solution (sodium phosphate, pH 8.0) or tryptophan solution (10 µM) in water, 
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passed through the degassing module to Pump B (0.05 mL/min) and through a back 
pressure regulator. The sample stream and chymotrypsin or tryptophan solution mixed at 
the “T” joint (Figure 4.9) and passed through a Teflon coil (1527 XL, Upchurch Scientific 
Inc., approx. 5 m, 0.010″ id and 0.062″ od) wound around an aluminum pipe of 1.6 cm 
outer diameter. The final concentration of the compensatory solutions was 0.5 M after 
mixing with tryptophan or chymotrypsin solution at the “T” joint. The approximate volume 
of the coil was 1 mL. 
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Figure 4.9: Experimental set-up. The arrangement used two Shimadzu pumps, a Shimadzu 
SIL10 autosmpler fitted with a 400µL loop, and an Agilent 1100 series fluorescence 
detector. 
 
The outlet from the coil was passed to a fluorescence detector, Agilent 1100 series 
connected to an Agilent 1100 hand held device. The fluorescence spectra of chymotrypsin 
showed that emission maxima of native and denatured chymotrypsin were 333 nm and 358 
nm respectively. Hence, the detector was set at an excitation wavelength of 290 nm and 
fluorescence of the solution mixture (output from the coil) was monitored at two different 
emission wavelengths, 333 nm and 358 nm, simultaneously. These two emission 
wavelength outputs from the detector were monitored in two different channels using the 
DELTA Chromatography System (Digital solutions, Brisbane, Australia). 
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The Teflon coil was maintained at room temperature while monitoring the changes in 
fluorescence of trytophan solution and unheated chymotrypsin in the presence of different 
compensatory solutes. However, during experiments to assess the stabilizing effect of 
compensatory solutes on denatured chymotrypsin, the coil was maintained at a constant 
temperature of 50°C, in order to partially denature the enzyme. Water was injected as a 
control to determine if there were any effects on the measured fluorescence due to pressure 
changes in the system during sample injection. 
 
The base-line fluorescence for each run was the fluorescence of tryptophan or 
chymotrypsin solution measured at that particular wavelength, 333 nm and 358 nm, with 
water and no solute flowing through water stream. To determine the effect of each 
compensatory solute, the auto-sampler injected the compensatory solution into the water 
stream, which mixed with the tryptophan or chymotrypsin solution resulting in a sudden 
change in base-line fluorescence lasted for several minutes. This change in fluorescence 
was expressed as a percentage change in the base-line fluorescence. The percentage change 
in fluorescence ratio (Ratio % in Figure 4.11) was calculated from the plots of ratio of 
fluorescence at 333 nm and 358 nm in the presence of different solutes. 
  
4.2.3  Results 
 
As ion-exchange resin was used during the syntheses of DB and DMT, they were not used 
in the experiment due to the suspicion that impurities, if present, would affect the 
fluorescence. Propio betaine, DEHB and SB-1 were also not used as preliminary 
experiments using these solutes resulted in column blockage which in turn increased the 
pressure of the system. The concentration of solutes was 1 M during injection. However, 
after mixing with tryptophan/chymotrypsin solution their concentration was approximately 
0.5 M at the detector. The fluorescence for each run was recorded for 60 minutes. The 
effect of injected compensatory solution on the fluorescence of tryptophan/chymotrypsin 
solution, both at 333 nm and 358 nm, appeared as a sudden change in the base-line 
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fluorescence between 16th and 18th  minute and was usually a square flat-topped peak with 
a plateau width of 16 min (Figure 4.10). Other features can also be observed in Figure 4.10. 
There are a few peaks which appear within the first 10 minutes, and these are attributed to 
impurities in the solutes that were coming off the column. 
 
Figure 4.10 A, B and C, show the detector output at the two different wavelengths acquired 
simultaneously. These figures show the changes in fluorescence observed when HGB was 
mixed with tryptophan, chymotrypsin and heated/denatured chymotrypsin solution. Figure 
4.10D shows the plot of ratio of fluorescence at 333 nm and 358 nm of heated 
chymotrypsin in the presence of HGB and water. The changes in fluorescence of 
tryptophan, chymotrypsin and heated chymotrypsin solutions were expressed as % changes 
in the baseline fluorescence at that particular wavelength (Table 4.3). Table 4.3 also lists 
the change in fluorescence ratio for heated chymotrypsin, which is calculated from the 
plots of fluorescence ratio (333/358 nm). 
 
At room temperature, the fluorescence of tryptophan solution (10 µM), 333 nm and 358 
nm, is minimally affected by any of the injected compensatory solutions. The percentage 
changes in fluorescence of tryptophan is slightly higher at 333 nm compared to 358 nm. 
SB-2, SB-3 and SB-4 increased the fluorescence of tryptophan more than the other solutes. 
In the case of unheated/native chymotrypsin (chymotrypsin at room temperature), the 
percentage changes in fluorescence were similar to that of tryptophan (Table 4.3). 
However, in plot 4.10(B) we observe that as the solute appears at the 16th minute, there is a 
sudden dip and a sudden increase in the fluorescence of chymotrypsin. We suspect this is 
due to the observed changes in the pressure of the HPLC system with the injection of the 
sample. 
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Figure 4.10: Plots showing the changes in fluorescence of tryptophan (10 µM) and chymotrypsin 
solution (100 mg/L) at two different emission wavelengths, 333 nm and 358 nm, when 1 M 
homoglycerolbetaine (HGB) is injected. (A) Tryptophan solution without heat. (B) Chymotrypsin 
solution without heat. (C) Heated chymotrypsin solution (50°C). (D) Ratio (Em 333/358) of heated 
chymotrypsin (50°C) in the presence of HGB and distilled water. A higher ratio shows more native 
enzyme, i.e less denaturation. 
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Table 4.3: Changes in fluorescence intensities of tryptophan and chymotrypsin solutions affected by presence of compensatory 
solutes 
Cosolvent Changes in fluorescence in presence of 0.5 M cosolvent (% of baseline fluorescence) 
(second solute)      Unheated Tryptophan    
(10 µM) 
    Unheated Chymotrypsin  Heated Chymotrypsin (100 mg/L) 
All 0.5 M in detector 333 nm 358 nm 333 nm 358 nm  333 nm 358 nm Ratio % 
    
Glycine betaine 2.3 0.5 1.9 2.6  15.1 5.2 9.5
Sorbitol  
 
  
  
  
  
  
  
  
  
3.2 2.7 2.7 3.7 11.0 4.3 6.3
Trehalose 3.6 3.0 3.1 3.4  12.9 5.1 8.0
Urea 0.7 0.6 1.8 1.9 -1.9 1.0 -2.3
HDB 4.2 -1.8 2.9 2.1 24.2 4.2 19.6
HGB 4.2 -1.2 4.7 3.8 31.8 6.2 24.7
CB-1 6.2 3.0 2.9 2.1 20.5 3.6 16.0
SB-2 6.3 4.7 6.8 6.3 23.1 7.0 16.0
SB-3 8.5 6.1 6.6 6.7 28.8 8.8 18.5
SB-4 4.2 1.8 4.8 4.2 19.0 5.3 13.5
 
Values quoted are percentage changes in fluorescence compared with that in pure water. The Ratio % is the percentage change in the ratio 
of the fluorescence at 333 nm to that at 358 nm at the same time point, calculated from plots of the ratio (i.e. Figure 4.11).
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The few other changes observed in the plot (Figure 4.10B) are negligible if the Ratio % of 
changes in fluorescence at 333nm and 358 nm was considered. These results show that 
none of the compensatory solutes considered for these experiments show any effect on the 
native conformation of chymotrypsin at room temperature. 
 
In the case of heated chymotrypsin (50°C), as the enzyme is denatured partially, significant 
changes in fluorescence are observed with the injection of compensatory solutes. The 
percentage change in fluorescence is more at 333 nm than at 358 nm (Table 4.3). At 333 
nm, 10 – 15% increase in baseline fluorescence was observed in the presence of natural 
solutes, GB, trehalose and sorbitol. All the synthetic solutes significantly increased, 
between 20% and 32%, the fluorescence of denatured chymotrypsin at 333 nm. Urea, a 
denaturant, decreased the fluorescence at 333 nm. We also observed that the effect of 
compensatory solutes on the fluorescence of heated chymotrypsin at 358 nm is very 
minimal. However, compared to their effect on fluorescence of tryptophan and native 
chymotrypsin at 358 nm, the effect on heated chymotrypsin at 358 nm is more. 
 
The measure of stabilizing effect of compensatory solutes on the unfolding of 
chymotrypsin was shown by the plots of ratio of fluorescence at 333 nm and 358 nm for 
heated chymotrypsin (Figure 4.11). The change in fluorescence ratio (Ratio %) calculated 
from these plots show the stabilization effect of individual solutes (Table 4.3). As these 
plots are the ratios of fluorescence at 333 nm and 358 nm, with 333 nm being the emission 
maximum of native chymotrypsin and 358 nm of denatured chymotrypsin, higher values of 
Ratio % indicate higher degree of stabilization. Figure 4.11 shows the flat-topped peaks 
with a plateau width of 16 min. The best stabilization effect is seen in the presence of HGB 
and HDB with their Ratio % values of 24.7% and 19.6%. Even sulfobetaines protected 
chymotrypsin against unfolding with their Ratio % changes between 16% and 19%. 
Natural solutes GB, trehalose and sorbitol, gave a moderate protection to chymotrypsin. 
Urea, as expected, being a denaturant seemed to unfold the denatured chymotrypsin further 
with its Ratio % change of -2.3%. The denaturation effect of urea is evident from the plot 
of ratio of fluorescence (Figure 4.11). As expected, no change in ratio of fluorescence is 
observed when pure water is injected. 
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Figure 4.11: Ratio of fluorescence at 333 nm to that at 358 nm of heated chymotrypsin 
(50°C). The change in fluorescence with respect to baseline in each plot is due to the 
injection of 1 M compensatory solution. 
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4.2.4  Discussion 
 
Fluorescence spectroscopy has been used before to monitor the structural changes of an 
enzyme during its denaturation (Goller and Galinski, 1999). The effects of compensatory 
solutes and other co-solvents on the fluorescence of a number of probes have also been 
studied (Lever et al., 2001). The experiment presented here, to our knowledge, is the first 
attempt to use fluorescence spectroscopy along with an HPLC system to assess the 
stabilizing effect of solutes on the unfolding of a protein. The fluorescence of tryptophan-
residues of a protein mainly depends on the conformation of the protein and when a protein 
unfolds, it exposes more tryptophan residues to the environment leading to changes in the 
fluorescence. This was used as the basis of our experiments and investigated the effect of 
compensatory solutes on the unfolding of chymotrypsin.  
 
As the emission maxima of native and denatured chymotrypsin are 333 nm and 358 nm 
respectively, the change in fluorescence was monitored at both these wavelength 
simultaneously. The reverse-phase HPLC column was mainly used to remove the 
fluorescent impurities from the sample stream. Alternative columns were also evaluated in 
order to check if we could improve the results. However, their ability to purify the samples 
was less. Impurities in solutes were suspected as the cause for blockage of column, 
observed during the use of propio betaine, DEHB, and SB-1. 
 
To make sure that the results obtained relate to the structural changes of the protein, we 
also checked the effect of compensatory solutes on aqueous tryptophan solution (10 µM) 
and unheated/native chymotrypsin. Results of our experiments clearly show that 
compensatory solutes do not affect the fluorescence of tryptophan or the native 
chymotrypsin. However, when the chymotrypsin is partially denatured by heating the 
solution at 50°C, a significant change in the fluorescence is observed. These results, plots 
of ratio of fluorescence (Figure 4.11) and ratio % change in fluorescence (Table 4.3), show 
the stabilizing effect of compensatory solutes. Synthetic solutes, HDB and HGB, were the 
best stabilizers and prevented the unfolding of chymotrypsin due to heat.  
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In Part A of this chapter, results of effect of compensatory solutes, natural and synthetic, on 
the activity of chymotrypsin against heat was presented. In Part B, results show the effects 
of solutes against unfolding of chymotrypsin due to heat stress. To understand if there was 
any relation between the stabilization effect observed between catalytic activity and 
conformation, TD-50 values of chymotrypsin (Table 4.1) was plotted against Ratio % 
change in fluorescence (Table 4.3) in the presence of different solutes. 
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Figure 4.12: Simple regression plot of relation between Change in TD-50 (Table 4.1) and 
Ratio % (Table 4.3) of chymotrypsin in the presence of different compensatory solutes. 
(Note: TD-50 for chymotrypsin in the presence of 1 M urea was found to be 41.0 ± 0.3°C) 
 
Figure 4.12 clearly shows that there is a correlation between the stabilization effect 
observed on the catalytic activity and the conformation of the enzyme. It is evident that the 
stabilization effect of solutes which helped the enzyme retain its catalytic activity in face of 
severe stress, is not just on the catalytic activity but also on the conformation of the whole 
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enzyme. Though we can’t generalize, these results are a good example of showing that 
good stabilizers protect the enzymes by preventing them from unfolding and helping them 
to retain their native structure.  
 
Though the results give a clear picture about the stabilization effect of compensatory 
solutes on proteins, we have to keep in mind that our experiment was done using a limited 
number of solutes and on a single enzyme. It is suggested that further experiments, with 
various enzymes and more compensatory solutes, are needed to confirm that the results 
apply to other systems. 
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Part C 
4.3  Study of Effect of Compensatory Solutes on Corticosteroid Binding 
Globulin Using an Enzyme-Linked Immunosorbent assay 
 
In this part of the chapter, the study on the effect of compensatory solutes on a different 
model protein, corticosteroid binding globulin (CBG), is reported. 
 
4.3.1  Introduction 
 
Human corticosteroid-binding globulin (CBG), a circulating glycoprotein, is reported to 
bind 90-95 % of plasma cortisol with high affinity (Westphal, 1986). The bioavailability of 
endogenous glucocorticoids is predominantly influenced by CBG, and altered levels of 
CBG results in altered free cortisol levels (Coolens et al., 1987). Bonte et al. (1999) 
suggested that the free cortisol index could be calculated from total cortisol and CBG 
levels. CBG levels have been reported to be decreased in polycystic ovary syndrome in 
women (Invitti et al., 1991) and in a rare case of cyclical Cushing’s disease (Watanobe et 
al., 1995). 
 
As there is sufficient interest in CBG, researchers have tried to develop new methods, 
especially enzyme-linked immunosorbent assay (ELISA), to determine CBG levels in 
human plasma. A new “in house” ELISA to human CBG has been established at the 
Steroid and Immunochemistry Laboratory, Canterbury Health Laboratories, New Zealand 
(Lewis et al., 2003). This ELISA is a 2-site assay where CBG is captured by an 
immobilized polyclonal antibody to CBG that is subsequently detected by a CBG 
monoclonal antibody. This method has been thoroughly validated and compared against a 
ligand binding method. 
 
Previous studies to understand the true quantitative role of CBG in binding circulating 
cortisol in human plasma (Lewis et al., 2005) used heat treatment of plasma as a method to 
inactivate CBG. Heat treatment of plasma at 60°C for 60 min led to total inactivation of 
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CBG. This inactivation was further confirmed by the undetectable CBG levels by ELISA. 
This inactivation of CBG with heat treatment was used as another model to study the 
stabilizing effects of synthetic compensatory solutes. Heat treatment of plasma was done in 
the presence of different compensatory solutes, and then CBG levels were measured by 
ELISA. 
4.3.2  Materials and Methods 
4.3.2.1  Materials 
 
Human CBG, sheep antibody to CBG (IgG fraction) and antimouse IgG Fc- peroxidase 
were obtained from Cortex Biochem, San Leandro, CA, USA. Antimouse Ig-peroxidase 
was from Silenus Labs, Boronia, Victoria, AUS. 
4.3.2.2  Heat treatment 
 
Human plasma was mixed with equal volumes of 2 M compensatory solutions (final 
concentration: 1 M) and then heated in a temperature block for 75 min at 60°C. Aliquots of 
this mixture were taken at 0, 15, 30, 45, 60 and 75 min, and diluted (1:1000) in assay buffer 
for ELISA. As a control, plasma was mixed with equal volume of assay buffer and heated.  
4.3.2.3  CBG ELISA 
 
ELISA plates (Falcon 3912 microtest III; Beckton Dickinson, Oxnard, CA, U.S.A.) were 
coated with sheep anti-CBG serum diluted in PBS (30 µL in 10 mL PBS), 100 µL per well, 
and was left for overnight incubation at 4°C. Following coating the plates were washed and 
blocked with assay buffer (150 µL per well) for 1h at 20°C.  The plates were emptied by 
inversion and either 100 µL of standard or patient plasma (1:1000 dilution in assay buffer) 
added to each well for an overnight incubation at 4°C. Standard plasma was pooled third 
trimester pregnancy plasma with a CBG level of 1280 nmol/L at 1:1000 dilution. However, 
for the standards this was diluted 1:500 in assay buffer and then serially to generate a series 
of standards from 0 to 2560 nmol/L. Following overnight incubation the plates were 
washed and supernatant 12G2 diluted (1:20 in assay buffer) 100 µL per well for 2h at 
20°C.  The plates were then washed and 100 µL of anti-mouse IgG Fc-peroxidase (1:1000 
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in assay buffer) added for 1 h at 20°C after which the plates were finally washed and 
substrate added, 100 µL/well. Substrate was prepared by the addition of 600 mL aqueous 
solution containing 8.2 g anhydrous sodium acetate and 3.6 g citric acid to 400 mL of 
methanol containing 270 mg of tetramethyl benzidine. 500 µL of 30 % H2O2 was finally 
added and the substrate stored in a dark bottle at room temperature. Colour development 
was terminated by the addition of 100 µL of 1.25 M H2SO4 per well and absorbance was 
read at 450 nm on a BMG Fluostar Galaxy (BMG, Technologies GmbH, Germany). To 
avoid evaporation losses plates were covered for all steps preceding the addition of 
substrate. 
 
CBG levels from the spectrophotometer were obtained as nmol/L. However, here we 
express CBG levels in the presence of different compensatory solutes and at different 
temperatures as relative CBG (%); relative to the CBG level found in presence of that 
particular solute at 0 min incubation (room temperature). 
 
4.3.3  Results 
 
Results of relative CBG in the presence of different compensatory solutes were plotted 
against time of incubation and are as shown in Figure 4.13. In the absence of any 
compensatory solutes (plasma heated with buffer),  approximately 80 % of total CBG was 
inactivated after 15 minutes of incubation and was fully inactivated after 60 minutes heat 
treatment. Of all the compensatory solutes considered for this study, higher levels of CBG 
were found only in the presence of a few solutes. Best protection of CBG was found in the 
presence of HDB, DEHB and propio betaine. HGB was not able to confer any protection to 
CBG against heat. Natural stabilizers GB, sorbitol and trehalose showed moderate 
protection against heat inactivation of CBG. Sulfobetaines, SB-1, 2, 3 and 4, were not able 
to confer any protection to CBG.  Error bars shown in Figure 4.13 are the standard error of 
means. The error in CBG measurement was observed in the presence of solutes that 
protected CBG against heat (e.g. HDB, DEHB, DB and propio betaine) 
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Figure 4.13: Relative CBG (%) ± SEM in human plasma with heating at 60°C for 75 min 
in the presence of 1 M (final) compensatory solutions.  
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4.3.4  Discussion 
 
CBG immunoreactivity is normally destroyed by heat treatment of plasma and a likely 
explanation for this is that the heat treatment of plasma normally masks the antigenic 
determinants due to partial denaturation of CBG (Lewis et al., 2003). Here we have 
investigated the effect of compensatory solutes against inactivation of CBG due to heat 
treatment. 
 
From the results we are able to identify a few synthetic solutes such as HDB, DEHB and 
propiono betaine, which can protect CBG from inactivation even after 60 min of incubation 
at 60°C. Interestingly, HGB, which was a very good stabilizer of catalytic activity of LDH 
and chymotrypsin, and helped protect chymotrypsin against unfolding, was not able to 
prevent the inactivation of CBG. Even sulfobetaines, which were good stabilizers of native 
conformation of chymotrypsin in the face of heat stress, were not able to confer any kind of 
protection to CBG.  
 
From the results we are able to show that relatively higher levels of CBG are found in 
plasma even after 60 minutes of incubation at 60°C in the presence of synthetic solutes 
HDB, DEHB and propio betaine. Though we are able to show some positive results from 
CBG experiments, one of the main problems faced during these experiments was the 
relatively large standard errors of the mean shown in Figure 4.13 when using test solutes 
compared to the control plasma without heat or solute. Several attempts and changes to the 
experiment were made to check if these errors could be overcome, but they did not 
improve.  
 
As the CBG ELISA has been validated and has previously shown acceptable performance 
(Lewis et al., 2003), these errors could have arisen from mixing of intact plasma with very 
high concentrations of compensatory solutes (2M) and the increased possibility of 
differential heating due to variable viscosity compared to control plasma without solute. In 
addition, non-heated plasma controls with solute are also subject to variation, indicating 
that the standard ELISA is being affected by the presence of high concentrations of solutes, 
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and for this reason each solute was compared with its non-heated control and the results 
expressed accordingly. From Figure 4.13 it can be observed that the standard error of 
means is less in the case of ‘no addition’ (control), but high in the presence of good 
stabilizers such as HDB, DEHB and propio betaine. This shows that the standard ELISA is 
being affected by the presence of high concentrations of our additives. 
 
 Plasma also plays an important role in these experiments. Our experiments were done over 
a period of several months necessitating the use of several different lots of plasma. Normal 
plasma levels of CBG (nmol/L) are significantly different for males and females; 609 ± 242 
and 743 ± 271 nmol/L respectively (Lewis et al., 2003). Decreased CBG levels have also 
been reported in humans suffering from different conditions (Bladon et al., 1996; Pugeat et 
al., 1989). These altered levels of CBG in different individuals may also be one of the 
reasons for the observed high standard errors in our results.  
 
Notwithstanding these limitations the results clearly show that a few of our synthetic 
solutes can be used to prevent the inactivation of CBG due to heat. These results support 
observed stabilization of catalytic activity and conformation of proteins by synthetic 
compensatory solutes in sections 4.1 and 4.2 of this chapter. 
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Chapter 5 - Medical Application of Betaine Analogues: 
Addition of Glycine Betaine or a Synthetic Analogue to 
Peritoneal Dialysis Fluid 
 
5.1 INTRODUCTION 
 
5.1.1   Kidney and its function 
 
Blood performs the essential function of bringing nutrients and oxygen to the cells of the 
body and carrying the waste materials away from those cells. It follows therefore, that the 
chemical composition of the blood must be carefully controlled for it to be able to 
perform its function. The kidneys, a pair of organs located just behind the lining of the 
abdominal cavity (retroperitoneal), are responsible for filtering the blood to remove the 
waste products of metabolism, such as, urea, uric acid and creatinine while also 
regulating its ionic concentration. They help in retaining the essential chemical 
constituents the body requires, while simultaneously regulating body fluid volume. 
 
The functional unit of the kidney is called the nephron, of which, there are approximately 
1 million within each healthy adult kidney localized in both the cortex and medulla. The 
nephron is responsible for separating the various components of the blood through three 
basic mechanisms: filtration; resorption; and secretion. When the kidneys do not function 
properly (renal failure), toxic waste starts building up in the blood, requiring it to be 
filtered by artificial means. Renal failure also affects various biochemical reactions of the 
kidneys and results in high or low concentrations of various components.  
 
5.1.2   Real Replacement Therapy- Artificial Dialysis 
 
For patients suffering from renal failure, dialysis is a procedure that filters and purifies 
the blood, ridding the body of harmful wastes, extra salts and fluids, while maintaining 
the proper balance of chemicals such as potassium, sodium, and chloride. There are two 
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modalities of dialysis for the treatment of renal failure: haemodialysis (HD) and 
peritoneal dialysis (PD) (Figure 5.1). 
 
Haemodialysis uses a dialyzer made up of a cellulose-membrane tube that is immersed in 
a large volume of salt solution with ionic concentrations near, or slightly lower, than the 
desired blood concentration. During treatment, blood is pumped from the patient via an 
intravenous line through the dialyzer, which filters out waste and extra fluid, before being 
returned to the patient, again through an intravenous line (Figure 5.1). The membrane 
tubing in the dialyzer has a molecular-weight cut-off that will allow most solutes in the 
blood to exchange across the tubing wall enabling the retention of larger components 
such as proteins and cells. 
 
Figure 5.1: Diagrammatic representation of haemodialysis and peritoneal dialysis. 
(Haemodialysis (www.shodor.org) and peritoneal dialysis (Gokal & Mallick, 1999)) 
 
In peritoneal dialysis, the dialysis fluid flows into the abdomen via a catheter that has 
been surgically implanted. Once the fluid is inside the abdomen the catheter is closed and 
the fluid left to dwell for a pre-determined time (duration of dwell and fluid volume 
depends on an individuals dialysis prescription), after which, the fluid is drained out via 
the catheter. During peritoneal dialysis, solutes and fluids are exchanged between the 
peritoneal capillary blood and the dialysis solution in the peritoneal cavity across the 
peritoneal membrane. Laws of diffusion and convective transport govern the solute 
movement and the fluid exchange is related to osmosis created by the addition of 
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appropriate osmotic agents in the peritoneal dialysis solutions (Gokal and Mallick, 1999). 
Unlike haemodialysis, peritoneal dialysis is a passive process with fluid entering and 
leaving the abdomen via a gravity driven process. Thus it does not require the use of 
specialized machinery and patients can perform the fluid exchanges themselves. As the 
membrane cannot be manipulated in peritoneal dialysis, to achieve maximum solute and 
fluid removal, the flow rate of dialysis solutions and also the regime is changed 
frequently 
 
5.1.3   Homocysteine (Hcy) and renal failure  
 
Homocysteine (Hcy) is an intermediate in the metabolism of the essential amino acid 
methionine (Figure 5.2). Homocysteine is of interest clinically because elevated plasma 
total homocysteine (tHcy) concentrations in humans have been linked to an increased risk 
of vascular disease (cardio, cerebral and peripheral) (Boushey et al., 1995; Nygard et al., 
1997; Welch & Loscalzo, 1998). Hyperhomocysteinemia is the condition which results 
when circulating tHcy is moderately elevated. Cardiovascular disease is a major cause of 
morbidity and mortality in patients with chronic renal failure (CRF) (Brown et al., 1994). 
Numerous studies have shown that more than 80% of chronic renal failure patients 
receiving dialysis treatment have elevated plasma tHcy (Bostom and Lathrop, 1997; Soria 
et al., 1990; Hultberg et al., 1993). The cause(s) of hyperhomosysteinemia in renal failure 
patients is unclear, however, the kidney primarily metabolizes Hcy rather than excreting 
it, and thus it is likely that hyperhomocysteinemia occurs in CRF patients as a result of 
disturbed Hcy metabolism. 
 
Homocysteine is metabolized by one of two methionine conserving pathways (Figure 
5.2), both of which involve the methylation of homocysteine to reform methionine. In a 
vitamin B12 dependent reaction, homocysteine is methylated via the enzyme methionine 
synthase (E.C. 2.1.1.13) using N5-methyl-tetrahydrofolate as the methyl donor. The 
second pathway is catalyzed by betaine-homocysteine methyltransferase (BHMT- E.C. 
2.1.1.5), where a methyl group is transferred from glycine betaine (N,N,N-
trimethylglycine) to homocysteine, forming methionine and N,N-dimethylglycine. 
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BHMT is active in kidneys and liver of humans. Finkelstein and Martin (1984) estimated 
that the BHMT pathway contributes as much as 50% of the homocysteine methylation 
capacity of the liver. However, most research has focused on the methionine synthase 
methylation pathway, with most treatment strategies for the treatment of 
hyperhomocysteinemia involving folate and vitamin B12 supplementation. Comparatively 
little attention has been placed on the BHMT remethylation pathway, or indeed on the 
regulation of glycine betaine homeostasis. 
 
 
Figure 5.2: Homocysteine metabolism. 
 
Glycine betaine (GB) is formed by the endogenous oxidation of choline (Flower et al., 
1972) and is also obtained from the diet (de Zwart et al., 2003). It has been found that 
plasma concentration of GB is lower in patients with renal disease, and in non-dialysis 
chronic renal failure, renal clearance of GB is increased (Lever et al., 1994). Thus, 
replacing GB with alternative substrates for BHMT might help in regulating the Hcy 
metabolism. 
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In addition, one of the products of BHMT pathway, N,N-dimethylglycine, is found to be a 
potent feedback inhibitor of BHMT (Mckeever et al., 1991; Millan & Garrow, 1998). 
This feedback inhibition may be one of the causes for disturbed Hcy metabolism leading 
to elevated Hcy concentrations. 
 
5.1.4   Therapies for Hyperhomocysteinemia 
 
There have been several studies investigating various therapeutic treatments for reducing 
tHcy in end-stage renal failure patients in an effort to reduce the incidence of vascular 
disease. Some of the suggested treatments include: 1) medication via an intermittent 
intravenous regime, providing drugs containing low concentrations of folinic acid and 
vitamin B12 (Buccianti et al., 2001), 2) long-term oral supplementation with either folic 
acid or folinic acid, in combination with high-dose intravenous vitamin B6 and oral 
vitamin B12 supplementation (Ducloux et al., 2002). These studies do not demonstrate the 
effect of these treatments on the patient and Ducloux et al. (2002) have suggested that the 
reduction of tHcy clearance may be due to multiple abnormalities of homocysteine 
methylation that may not be related to folate alone. 
 
An alternative treatment strategy would be to increase Hcy methylation via the BHMT-
mediated pathway by supplementing with GB. Oral GB supplementation has been shown 
to successfully reduce circulating tHcy concentrations in hyperhomocysteinemic patients 
(Wilcken et al., 1983), in non-dialysis CRF patients following a methionine load 
(McGregor et al., 2002), and in healthy volunteers (Olthof, et al., 2003). Nonetheless, the 
effect of GB, or various GB analogues, on homocysteine metabolism in vivo has not been 
studied extensively. Slow et al., (2004), showed in rats, that homeostasis of GB and Hcy 
are linked, and can be disturbed by both naturally occurring and synthetic GB analogues. 
 
Dimethylthetin (DMT), a synthetic analogue of GB may be a potential therapeutic agent 
for lowering tHcy. Purified BHMT is shown to utilize DMT as a substrate at thirty-times 
the rate of GB (Goeger & Ganther, 1993) and it also displays greater specificity 
(Vmax/Km) for BHMT reaction than betaine. Furthermore, the demethylated product of 
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DMT, methylthioacetate, does not inhibit BHMT as does N,N-dimethylglycine (Garrow, 
1997). Slow et al. (2004) showed that a single dose of DMT was more effective for 
lowering tHcy when compared to an equivalent dose of GB, thus suggesting that DMT 
could be used as a therapeutic homocysteine-lowering agent. 
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5.1.5   Objectives 
 
I was part of the team that had the objective to determine whether the addition of GB or 
DMT to dialysis fluid could relieve the chronic methyl donor shortage, increase 
homocysteine methylation via the BHMT-mediated pathway and lower circulating tHcy 
concentrations in CRF patients receiving dialysis. We chose peritoneal dialysis as the 
dialysis modality because it involves manual fluid exchanges without requiring the use of 
specialized dialyzing equipment. My role in this project was work with Dr. Sandy Slow 
in all the experimental work and to carry out the animal trials. We set out with three main 
aims: 
 
• To develop an acute renal failure continuous ambulatory peritoneal dialysis (CAPD) 
model in sheep, this would be a true dialysis model that could better mimic the 
human clinical situation.  
• To assess the effect on circulating homocysteine concentrations when DMT is 
added to dialysis fluid in a CAPD sheep model, using animals that were either in 
acute renal failure or had normal renal function.  
• To assess the effect of addition of GB to dialysis fluid on homocysteine 
concentrations using the CAPD sheep model. 
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5.2 MATERIALS AND METHODS 
 
5.2.1   The CAPD sheep model 
 
5.2.1.1   Animals 
The experimental protocol was approved by the Lincoln University Animal Ethics 
Committee in compliance with the New Zealand Animal Welfare Act 1999. Coopworth 
sheep (wether or ewe hoggets), weighing 33.5-52.2 kg, were housed indoors in individual 
metabolism cages for the duration of the experimental period. Animals were offered 
1500g of food consisting of a mixture of high quality lucerne chaff, crushed barley and 
all-purpose ruminant pellets (Western Animal Nutrition, Rangiora, New Zealand, 
containing 85 % dry matter of which 16 % was crude protein and balanced 
micronutrients) and 4 L of tap water, per day. The animals were allowed to adjust to the 
diet and indoor environment for 1-2 weeks prior to commencement of the study. 
5.2.1.2   Surgery 
Two surgical operations were performed on each of the acute renal failure animals and 
one operation was performed on each of the animals with intact renal function.  For all 
surgical procedures appropriate anesthesia (0.65 mg/kg diazepam (Pamlin®, Parnell 
Laboratories, Auckland, NZ) and 13 mg/kg ketamine hydrochloride (Phoenix®, Phoenix 
Pharmaceutical Distributors, Auckland, NZ) given intravenously and topped up if 
necessary) and analgesia (0.3 mg buprenorphine hydrochloride (Temgesic®, Reckitt 
Benckimer Healthcare Ltd., Auckland, NZ, given intramuscularly as required) was 
employed.   
 
The first operation, performed by Drs Robin McFarlane and Graham Barrell, was to 
insert a standard (47 cm universal), double-cuff Tenckhoff® peritoneal dialysis silicone 
rubber catheter (Tyco Healthcare Group, Mansfield, MA, USA), into the peritoneum to 
allow dialysis (Figure 5.3A).  For 10-14 days following surgery, the catheters were 
flushed daily using 1 L of standard peritoneal dialysis fluid (either 1.36%, 2.27% or 
3.86% glucose,Dianeal®, Baxter, IL, USA) to ensure the catheter allowed flow in both 
directions. Before capping after the flush, the catheter was filled with a concentrated 
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heparin (10,000 IU; Leo Pharmaceutical Products, Ballerup, Denmark) and corticosteroid 
(20 mg methylprednisolone; Depo-Medrol®, Pharmacia, NSW, Australia) solution to 
ensure patency.  
 
The second operation, performed by veterinary surgeon, Dr. Larry Anderson, was a full 
bilateral nephrectomy to induce acute renal failure. The nephrectomy technique was 
based on that described by Horney and Archibald, (1961) and was performed at least 10 
days after placement of the Tenckhoff® catheter. Following induction of anesthesia, a 20 
cm vertical paracostal incision was made starting approximately 5 cm below the 
transverse processes in the para lumbar fossa. The skin was retracted and the underlying 
muscle layers were blunt dissected in a grid pattern to skirt around the peritoneum 
(retroperitoneal) and expose the right kidney. Perirenal adipose and connective tissue was 
removed from around the pedicle and the renal artery, renal vein and ureter were triple-
clamped as one unit. The pedicle vessels were ligated using synthetic monofilament 
suture material before severing the vessels above the ligature to remove the kidney. The 
more mobile left kidney was located transperitoneally through the same incision site and 
removed following the same procedure as the right kidney. 
 
To reduce the risk of post-operative infection, a mixture of penicillin and streptomycin 
(Penstrep LA, Bomac Laboratories Limited, Manakau City, NZ) was administered 
intramuscularly following each surgical procedure. Animals were denied food and water 
for one day prior to each operation and following the nephrectomy water availability was 
restricted to 1L per day. 
 
5.2.1.3   Dialysis 
Sheep 167, 174, 75 & 73 were used for the development of the acute renal failure CAPD 
model. At any one time, two animals went through the procedure and dialysis 
commenced within two hours of recovery from nephrectomy surgery. A standard human 
dialysis regime consisting of 4 exchanges per 24 hours using either 1.5 L (animal 167) or 
2 L (animals 174, 75 and 73) of dialysis fluid per exchange was employed for up to 14 
days.  
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A B
 
Figure 5.3: (A) Animal model showing the Tenckhoff® catheter position (B) Picture of a 
sheep undergoing dialysis showing the nephrectomy surgical site and the catheter. 
 
In each 24-hour period, the first two animals (167 and 174) had a dialysis regime where 
the first 3 exchanges dwelled for 4 hours each and the final (4th) daily exchange dwelled 
for 12 hours (overnight). The glucose concentration of the dialysis fluid (Dianeal®) varied 
between exchanges, with concentrations of 1.36%, 2.27%, or 3.86% glucose being used, 
although 2.27% was the most common. However, as a result of fluid loading problems 
with the first animals (167 and 174) the regime was modified for the latter two animals 
(75 and 73) in which all exchanges had 3 hour dwells of 3.86% glucose (Dianeal®) 
dialysis fluid and without an overnight dwell. All dialysis fluid was warmed to body 
temperature before administration and following the last exchange each day, the catheter 
was filled with a concentrated heparin and corticosteroid solution to ensure patency.   
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5.2.2   Dialysis treatment using dimethylthetin (DMT) containing fluid 
 
DMT was synthesized as described in section 3.2.1 of Chapter 3. Sheep 162, 163, 164 
and 166, were used to study the effect of addition of DMT to dialysis fluid on plasma 
homocysteine concentration in three animals that were in acute renal failure (162, 163 & 
166) and another that had intact renal function (164). Animals were housed indoors and 
surgery was performed as described above (5.2.1.2). Two animals went through the 
whole procedure at any one time.  
 
Dialysis commenced within 2 hours of recovery from nephrectomy surgery, for animals 
162, 163 & 166 and after the two week healing period following catheter insertion for 
animal 164. Animals 166 & 163 were given standard dialysis fluid containing 10g of 
DMT at each exchange, while animal 162 was maintained on standard dialysis fluid for 5 
days, after which, 10g of DMT was added to the dialysis fluid for each exchange (Table 
5.1). Animal 164 was given standard dialysis fluid containing 5g DMT per exchange 
(Table 5.1). All animals received 2L of dialysis fluid at each exchange and the DMT was 
added after the fluid had been warmed to body temperature via the injection port. Each 
day following the administration of the dialysis fluid for the fourth exchange, a 
concentrated heparin (10,000 U) and corticosteroid (20mg) solution was administered 
through the catheter to ensure patency. 
5.2.3   Dialysis treatment using glycine betaine (GB) containing fluid 
 
Glycine betaine was purchased from Sigma Chemical Co., USA. Sheep 65, 31 and 32, 
were used for this study. All animals were housed and maintained as described in section 
5.2.1.2. Acute renal failure was induced in animals 65 and 32 following full bilateral 
nephrectomy, while animal 31 had intact renal function  
 
Peritoneal dialysis commenced within two hours of recovery from nephrectomy for 
animals 65 and 32, and simultaneously for sheep 31. All the animals were given standard 
dialysis fluid containing 5g of glycine betaine per exchange. To avoid fluid loading 
problems all exchanges had 3 hour dwells of 3.86% glucose (Dianeal®) dialysis fluid and 
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without an overnight dwell. All dialysis fluid was warmed to body temperature, after 
which, glycine betaine was added to the fluid via the injection port before administration. 
After the last exchange (4th) each day, the catheter was filled with a concentrated heparin 
and corticosteroid. 
5.2.4   Measurements and Assays 
 
Blood samples were collected from each animal daily, both pre and post dialysis, via 
jugular vein venipuncture (5mL heparin and 5mL EDTA vacutainer; Becton Dickinson, 
Plymouth, UK). An aliquot of whole blood was removed for haematocrit measurement 
and plasma was separated from the remaining blood by centrifugation at 2000 g for 10 
minutes. Plasma samples were sent to the High Volume Biochemistry Unit at Canterbury 
Health Laboratories, Christchurch, where all measurements were carried out using an 
automated analyzer (Aeroset Analyser, Abbott Laboratories, IL, USA). Routine 
biochemistry analyses (electrolytes, creatinine, urea, albumin and liver enzyme activity) 
and Hcy measurements were conducted on all samples. The heart rate, respiratory rate, 
rectal temperatures and behaviour of all animals were also monitored daily. The volume 
of the dialysate and its macroscopic appearance was recorded at each exchange for all 
animals, and if the dialysate had a cloudy appearance, an aliquot was sent for 
microbiological analysis (Microbiology Department, Canterbury Health Laboratories, 
Christchurch) to detect any infection. Animals were maintained on dialysis for up to 14 
days post nephrectomy, after which, animals were euthanased by an intravenous 
administration of sodium pentobarbitone (overdose) followed by exsanguination. Post 
mortem examinations were conducted on all animals.  
 
Plasma DMT and GB were measured by Dr. Sandy Slow using a HPLC method 
previously described by Lever et al. (1992). Martin Lee from Canterbury Health 
Laboratories assayed the dialysis fluid samples for methylthioacetate (the expected 
demethylated product of DMT) by 1H-NMR as previously described (Slow et al., 2004). 
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5.2.5   Histopathological analyses 
 
Samples of heart, brain, lung, and liver were collected at post mortem for all the animals 
and in addition, kidney samples were collected from animal 164, and sent to the 
Department of Pathology, Christchurch School of Medicine, for histopathological 
analyses. Tissue samples were fixed in 10% buffered formalin solution and embedded in 
paraffin. Tissue sections (3 µm thick) were stained with haematoxylin and eosin and lung 
tissue sections were also stained using the periodic acid-Schiff reaction. 
 
5.3 RESULTS 
 
5.3.1   CAPD sheep model 
 
One of the main problems faced while developing the sheep model was maintaining the 
catheter patency. In an earlier pilot study using sheep (Slow, S., personal communication; 
unpublished data), catheter patency was difficult to maintain. The catheters became 
blocked by proteinaceous clots and were persistently encased in omentum preventing 
fluid flow, in one or both directions. In an effort to avoid this, the catheters were flushed 
daily with 1L of dialysis fluid, after which, the catheters were filled with a concentrated 
heparin and corticosteroid solution. This regime proved to be successful for maintaining 
catheter patency and was adopted as standard practice throughout the dialysis studies 
described herein. One animal (174) had dialysis fluid leak into subcutaneous tissues post 
nephrectomy, a result of one of the catheter cuffs not adhering sufficiently to the skin. As 
a result effective dialysis could not be conducted and the animal was euthanased 24 hours 
following nephrectomy. All of the catheters in the other animals remained functional 
throughout the dialysis period. Of the three sheep that had functional catheters enabling 
adequate dialysis, animal 73 died on the 13th day post nephrectomy and animals 167 and 
75 survived for the whole 14 day experimental period. 
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Figure 5.4: Daily plasma sodium, potassium, creatinine and urea of sheep numbered 167, 
75 and 73 of CAPD sheep model.  
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Just after 24 hours post nephrectomy, the feed intake of all the animals decreased to 
approximately one third of pre-nephrectomy levels. Thereafter, the feed intake continued 
to decline and within 4-6 days post-nephrectomy all the animals had ceased eating. 
Although water was restricted to 1L per day, animals stopped drinking within the first 7 
days of nephrectomy. As time on dialysis increased the animals became increasingly 
lethargic and non-responsive. In general, their heart rate increased and respiration rate 
slowed. 
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Figure 5.5: Daily plasma Hcy concentration for the three sheep on CAPD 
 
During the first two days post-nephrectomy, plasma sodium and potassium concentration 
became elevated and reached maximum levels, but gradually decreased and returned to 
normal levels within 9 days after nephrectomy. Plasma calcium and magnesium 
concentrations fell rapidly post-nephrectomy and were normalized by addition of a 
supplement (50 mL of Glucalphos®, Bomac laboratories limited, Manakau City, NZ) to 
the dialysis fluid. Haematocrit values were lower post-nephrectomy and declined as time 
on dialysis increased. Plasma creatinine concentrations increased throughout the dialysis 
period. Plasma urea concentrations increased significantly immediately following 
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nephrectomy and continued to increase, reaching maximum levels 5 days after the start of 
dialysis treatment, then they declined, but remained above normal concentrations. 
 
Plasma Hcy concentration increased for all the three animals (167, 75 and 73), and 
remained higher than the pre-nephrectomy levels throughout the dialysis period. In 
animal 167, plasma Hcy concentration was approximately three times its pre-
nephrectomy levels at the end of 14 day dialysis period (Figure 5.5). 
 
5.3.2   Dialysis with DMT containing fluid 
 
Initially, only two nephrectomised animals (163 &166) were given dialysis fluid 
containing DMT (10g/exchange) and the other nephrectomised animal (162) was given 
standard dialysis fluid (Table 5.1). Unexpectedly, however, the animals that were being 
treated with DMT began to show adverse affects within 48 hours of beginning treatment. 
It was not known whether the symptoms that were observed were a result of the trauma 
of nephrectomy or because of possible DMT toxicity. It was decided after maintaining 
animal 162 on dialysis for 5 days with standard fluid, to start giving fluid containing 
DMT to see if the same effects were observed. In addition, we began dialysis on a non-
nephrectomised animal (164) using standard fluid containing only 5g DMT per exchange 
to determine whether renal function was required for DMT treatment and whether giving 
less DMT per exchange had a similar effect.  
 
Sub-acute exposure to DMT was found to be toxic in all animals, regardless of renal 
function or dose per exchange (10g or 5g). Although there was individual variation in the 
number of doses before adverse side affects were observed, generally the animals treated 
with DMT died within 48 hours of beginning treatment, averaging less than 7 doses 
(Table 5.1). DMT was effectively taken up from the dialysis fluid into the circulation and 
continued to increase depending on the number of doses each animal was exposed to. 
DMT was not detected in pre-dialysis plasma samples, and the final concentration at 
death ranged from 0.5-7.8 mmol/L (Table 5.1). The expected de-methylated product of 
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DMT, methylthioacetate was not detected in plasma or dialysis fluid, nor was 
methylthioacetate sulfoxide. 
 
Symptoms of DMT toxicity included an increased heart rate, laboured breathing and 
excessive salivation from the nose and mouth. Animals became progressively non-
responsive, lethargic and ceased eating and drinking. Even if DMT treatment was stopped 
after the animal exhibited initial respiratory difficulties (166, final four exchanges were 
with standard dialysis fluid only), the animal did not recover, continuing to decline until 
it was euthanased when the severity of the symptoms exceeded ethical limits.   
 
Table 5.1 
Sheep 
Number 
Nephrectomy DMT dose 
/exchange 
 (g) 
Number of 
DMT doses  
Time on dialysis with 
DMT treatment (hours) 
Plasma DMT 
concentration at death 
(mmol/L) 
162* Yes 10 8 40 8.2 
163 Yes 10 4 24 1.4 
164 No 5 7 48 0.5 
166† Yes 10 6 60 7.8 
* Animal spent 5 days on dialysis with standard fluid, after animals 163 and 166 showed signs of possible DMT 
toxicity, this animal was switched to fluid containing DMT. 
† DMT treatment ceased once animal exhibited initial respiratory difficulties, the final four dialysis exchanges 
were done using standard dialysis fluid. 
 
At post mortem, compared to other animals treated with standard dialysis fluid only, the 
lungs of the DMT treated animals were abnormal in colour (deep red/purple) and were 
consolidated and heavy. The lungs did not float when placed in water and the animals 
appeared to have died from lung failure. No other organs seemed to have been affected, 
with the liver, brain, heart and kidney having a normal appearance. Histologically, lung 
tissue from DMT treated animals (Figure 5.6 A) when compared to lung tissue from 
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animals treated with standard dialysis fluid (Figure 5.6 B) showed complete lung 
consolidation and collapse. 
 
 
 
Figure 5.6: Sheep lung tissue sections (A) Nephrectomised animal treated with dialysis 
fluid containing dimethylthetin (DMT) (B) Nephrectomised animal treated with just 
standard dialysis fluid. 
 
5.3.3   Dialysis with GB containing fluid 
 
The dialysis regime was started simultaneously for two nephrectomised animals (65 & 
32) and one non-nephrectomised animal (31). All three animals were given dialysis fluid 
containing GB (5g/exchange). No adverse or toxic effects were observed in any of the 
animals. Animal 32 developed a blockage in the catheter after eight days on dialysis 
treatment with no out-flow of the dialysis fluid. As a result, the animal had fluid build-up 
in the peritoneum and dialysis had to be discontinued and the animal euthanased. 
 
After 12 days of dialysis, the non-nephrectomised animal (31) developed a blocked 
catheter and the dialysis was stopped. However, as the kidneys of the animal were intact, 
the animal was not euthanased. Animal 65 survived the full 14-day dialysis period with 
GB treatment and was euthanased on the 15th day. 
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The plasma Hcy concentration of the nephrectomised sheep (65 & 32) appeared to 
increase following nephrectomy, even with GB treatment (5g/exchange). Animal 32 was 
euthanased after 7 days on dialysis, and as a result it is difficult to draw any significant 
conclusions from the results obtained. Animal 65 showed similar changes in Hcy 
concentration as the CAPD model animals (167, 73 and 75). However, there was a trend 
towards lower Hcy during the last few days of dialysis (Figure 5.7). Plasma Hcy 
concentration in animal 31 (kidneys intact) appeared to decrease following the start of 
dialysis with GB containing fluid and was less than half the starting concentration at the 
end of dialysis period (Figure 5.7). 
 
At post mortem, the lungs of the GB treated animals had no abnormalities in colour with 
a normal appearance. None of the other organs, liver, brain, heart and kidney, appeared to 
have been affected by GB treatment. The lung tissue samples from the GB treated 
animals were similar to animals treated with standard dialysis fluid (Figure 5.6(B)). 
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Figure 5.7: Daily plasma Hcy of sheep on GB treatment 
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5.4 DISCUSSION 
5.4.1   CAPD sheep model 
 
In this study a large-animal model of continuous ambulatory peritoneal dialysis (CAPD) 
was created. Different animal models, rabbits, rats and mice, have been used to 
investigate specific aspects of peritoneal dialysis (Schambye et al., 1992; Breborowicz et 
al., 1998; Zweers et al., 2001; Zheng et al., 2001; Hekking et al., 2003). However, 
experiments that have been performed using animal models for peritoneal dialysis, have 
lasted only a few hours with only one or two exchanges of dialysis fluid (Zweers et al., 
2001; Hekking et al., 2003). Hekking et al. (2003) injected the dialysis fluid directly into 
the abdominal cavity rather than via an implanted catheter that is typical of human 
clinical subjects. To our knowledge this was the first attempt at generating a CAPD 
model in large animal (sheep).  
 
Sheep were the animals of choice because they could be manipulated to more closely 
mimic the human clinical situation compared with other animal models (rats and rabbits); 
combining renal failure with several dialysis fluid exchanges per day, using fluid 
volumes and regimes similar to that of human dialysis patients. Animals were maintained 
on dialysis treatment for up to 14 days following the induction of acute renal failure by 
full bilateral nephrectomy. While this was achieved just in three animals, it was 
technically demanding and not without its difficulties. As in human patients, catheter 
patency, fluid loading and malnutrition were difficult to control.  
 
Catheter blockage, a result of omental encasement, is not uncommon in animal model of 
peritoneal dialysis. Heparin coated catheters have been used in a chronic rat model of PD 
to prevent omental wrapping of the catheters (Zareie et al., 2004). Similarly, catheter 
patency was maintained in this study through a regime of daily flushing and loading of 
catheters with concentrated heparin and steroid solution. However, there are concerns 
about the use of heparin and steroid as they may interfere with the peritoneal membrane 
function (De Vriese et al., 2002). 
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Animals in this study, particularly 167 and 73, suffered from fluid loading that led to 
peripheral and pulmonary oedema, which manifested itself clinically as severe dypsnoea. 
This was presumably a result of high rate of water and electrolyte transport across the 
peritoneal membrane and loss of renal ultrafiltration. Although animal 167 survived the 
14 day dialysis treatment period, it was clear from the post mortem results that the 
dialysis protocol needed to be modified for animals 75 and 73 in an effort to prevent the 
fluid retention from occurring. The modified regime reduced dwell times to 3 hours, with 
no fluid overnight. Nevertheless the new regime was only partially successful in 
preventing fluid loading and also control of plasma creatinine and urea concentrations 
was less successful than in animal 167 (Figure 5.4) suggesting inadequate dialysis. 
 
An anephric haemodialysis sheep model studied by Eschbach et al., 1980, found that the 
model was less stable and harder to maintain and study than a partially nephrectomised 
model. A partially nephrectomised model however, has its disadvantages. Firstly, the 
level of renal failure and the time between sub-total nephrectomy and the requirement for 
dialysis treatment varies between individual animals. Secondly, it would also be difficult 
to maintain CAPD catheter patency for longer periods of time.  
5.4.2   Dialysis with DMT containing fluid 
 
It has been previously shown in rats that DMT, a synthetic glycine betaine analogue, is 
more effective at lowering plasma Hcy than an equivalent dose of GB (Slow et al., 2004) 
and as such had therapeutic potential as an Hcy lowering agent. This was evaluated in a 
CAPD sheep model with the addition of DMT to the dialysis fluid. 
 
It was unexpected that sub-acute exposure to DMT would be toxic in sheep causing total 
consolidation and collapse of both lungs (Figure 5.6 (A)). There were no observed 
adverse side effects in rats following the subcutaneous administration of two doses of 
DMT (Slow et al., 2004). In a pilot study of CAPD sheep model, the effects of a single 
10g subcutaneous dose of DMT in sheep was studied and no adverse side effects were 
observed (Slow, S., personal communication; unpublished). The reasons for the observed 
toxicity in the acute renal failure CAPD sheep model are not readily apparent, but could 
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be the result of several factors. Firstly, the toxicity observed in the sheep CAPD model 
might be a species-specific effect. In adult sheep, BHMT is present in the liver, pancreas 
and kidney, but the liver and pancreas are the only tissues that have been found to have 
significant BHMT activity, with the pancreas having the higher activity of the two tissues 
(Xue and Snoswell, 1986). In rats BHMT is found predominantly in the liver (McKeever 
et al., 1991) and activity is significantly higher than that of sheep liver BHMT (Xue and 
Snoswell, 1986). The different profile of tissue BHMT activity between rats and sheep 
may therefore be a significant factor in determining the metabolic fate of DMT. 
Interestingly, the expected de-methylated product of DMT, methylthioacetate, which was 
found in the plasma and urine of the DMT treated rats, was not observed in the plasma or 
dialysis fluid of the DMT treated sheep. This suggests that the DMT was not metabolised 
via BHMT in the sheep, and that the metabolic fate of DMT is different in sheep and rats. 
The presence of a rumen may also be a contributing factor, as the rumen microbes may 
metabolise DMT, potentially producing a toxic metabolite that may result in the lung 
pathology observed. 
 
Secondly, the rats were only exposed to two doses of DMT and each dose was 
administered one-week apart (Slow et al., 2004). The rats received approximately 460 
mg/kg of DMT per dose, while the sheep received approximately 500-800mg/kg of DMT 
per day, over the four dialysis exchanges (Table 5.1). Although the average time to death 
in the sheep was less than 48 hours, the sheep were continuously exposed to large doses 
of DMT for consecutive days. This combined with the possibility that DMT metabolism 
in sheep may be reduced, a result of a much lower liver BHMT activity, suggests that the 
sheep would have been exposed to high plasma DMT concentrations for longer than the 
rats. This is supported by the finding that the plasma DMT concentration in the rats 24 
hours following administration was more than 20-fold lower (Slow et al., 2004) than that 
observed in the sheep after 48 hours (0.5-7.8 mmol/L; Table 5.1). The exposure to DMT, 
particularly high plasma concentrations, may have therefore been too short in the rats to 
detect any adverse effects. Finally, the route of administration may also be important 
(intra peritoneal in sheep; subcutaneous in rats). However, none of these factors explain 
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why sub-acute exposure to DMT via dialysis fluid affected only the lungs and not other 
organs.  
5.4.3   Dialysis using GB containing fluid 
 
Although oral supplementation with GB in humans has proven useful for lowering 
plasma Hcy concentrations (Wilcken et al., 1983; McGregor et al., 2002; Olthof et al., 
2003), long-term compliance is problematic and diarrhoea has been reported during 
therapy (Knopman and Patterson, 2001). Consequently, we tried to explore the 
effectiveness of adding betaine to dialysis fluid as a means of increasing methyl donor 
availability for the treatment of hyperhomocysteinemia in CRF patients receiving 
dialysis. 
 
Unlike DMT containing fluid, sub-acute exposure to GB via dialysis fluid had no adverse 
effects on any of the animals studied. It did not affect any of the organs, including lungs, 
contrary to that which was observed with DMT treatment. At post-mortem, the heart, 
liver, lungs and all other organs had a normal appearance and the lung tissue samples 
were similar to those treated with standard dialysis fluid (Figure 5.6 (B)). This proved 
that addition of GB to dialysis fluid does not cause any toxic effect in sheep. Even though 
there was catheter patency problems (Animal 32 and 31) and the dialysis had to be 
stopped, there were no indication that this was related to the addition of GB to the 
dialysis fluid. 
 
Plasma Hcy concentration did not decrease with GB treatment in the nephrectomised 
animals, as expected. Though we could not definitively prove that addition of GB 
lowered homocysteine concentration, we were able to show that there was an increase in 
plasma GB concentration in animals, which proves that GB is effectively taken up from 
the dialysis fluid and enters the circulation. Animal 31 with normal kidney function 
showed a decrease in the plasma Hcy concentration with the GB treatment (Figure 5.7) 
and was less than half its pre-dialysis Hcy concentration by the time the dialysis was 
stopped. 
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The nephrectomised animals (32 & 65) had absolutely no renal function (acute renal 
failure), which may be a cause for sudden increase in Hcy concentration even though 
they were being treated with GB. The decrease in Hcy concentration observed in Animal 
31, a situation similar to chronic renal failure patients who have residual renal function, 
suggests that addition of GB to dialysis fluid may be a useful option for treating 
hyperhomocysteinemia.  
 
5.5 CONCLUSIONS 
 
To our knowledge this was the first attempt at generating a large-animal CAPD model, 
and although it was only achieved in a small number of animals, it provides an important 
starting point for further development. A sheep CAPD model has several advantages over 
a small animal model as it allows researchers to study the same animal repeatedly in both 
control and uremic conditions. Although the acute renal failure CAPD sheep model 
proved difficult to maintain, the problems encountered are commonly experienced in 
human CAPD patients. Development of a chronic renal failure animal through partial 
nephrectomy or deliberate damage, rather than an acute renal failure model as described 
here could ameliorate these problems, but its feasibility also requires further 
investigation.  
 
Dimethylthetin (DMT), a synthetic betaine analogue, was found to be toxic in sheep. 
Although the study here involved a small number of animals, it is clear that caution is 
required when using DMT. The safety of DMT as a therapeutic agent must be further 
assessed, preferably in multiple animal species, utilising varying doses and employing 
numerous administration routes. 
 
Long-term oral supplementation with GB in chronic renal failure patients for lowering 
homocysteine concentration has been problematic and diarrhoea has been reported during 
therapy (Knopman and Patterson, 2001). Addition of GB in dialysis fluid for chronic 
renal failure patients can now be a viable option as we have shown that GB is not toxic to 
sheep when administered via dialysis fluid. This method may also help in lowering the 
125 
Chapter 5 
plasma Hcy concentration in CRF patients. Addition of GB to dialysis fluid for lowering 
plasma Hcy has never been tried before and our results can be a basis for further 
investigations. 
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Chapter 6 - Effect of Compensatory Solutes on DNA Melting 
Temperatures and Their Use as PCR Enhancers 
 
6.1  INTRODUCTION 
6.1.1  DNA and PCR 
 
Deoxyribonucleic acid (DNA), known as the molecule of heredity, contains the genetic 
information needed for the development of life. DNA, in its native state, exists as a 
double helix which is comprised of two single strands running antiparallel to each other 
and held together by hydrogen bonds (Figure 6.1). Each DNA strand comprises units 
called nucleotides, which in turn comprises a phosphate group, a sugar and a base. Four 
different nitrogenous bases are found in DNA, adenine (A), guanine (G), cytosine (C) and 
thymine (T), which are derivatives of two parent heterocyclic compounds, pyrimidine 
and purine. The successive nucleotides of each DNA strand are covalently linked to each 
other by a phosphodiester linkage while the two different strands are held together by 
hydrogen bonds that are formed between the complementary bases  A with T (a double 
bond) and G with C (a triple bond). 
 
Figure 6.1: Double helix structure of a DNA and structures of nitrogenous bases 
(www.en.wikipedia.org  and http://evolution.berkeley.edu) 
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Two sets of forces are responsible for holding the DNA double helix: (1) Hydrogen 
bonding between base pairs and (2) hydrophobic interactions, which shield the bases 
from water and cause them to be largely hidden within the double helix (Lehninger, 
1982). The specific sequence of the four bases A, T, G and C are used for coding the 
genetic information. During replication of DNA in vivo, the DNA double helix is melted 
or dissociated and each separate DNA strand is used as a template for synthesizing a new 
strand. In vitro, the same process is mimicked by the polymerase chain reaction (PCR) 
(Newton and Graham, 1994).  
 
PCR is a very popular biological technique which is used for detection of hereditary 
diseases, cloning of genes, forensic identification, etc. PCR allows the amplification of 
any specific DNA region. The amplification of a DNA template is achieved by using 
short, single stranded synthetic DNA molecules known as primers, which are 
complementary to the ends of the DNA fragment to be amplified.  
 
Figure 6.2: The polymerase chain reaction (PCR). (1) Denaturation of DNA double 
strands (2) Annealing of primers (3) Elongation by enzyme DNA polymerase ‘P’ (4) 
New DNA strands. (www.en.wikipedia.org). 
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During PCR, the double stranded DNA is separated into two single strands by heating, 
then temperature is lowered for the primers to anneal to the single stranded DNA 
templates and then an enzyme, DNA polymerase, extends the primers by incorporation of 
deoxynucleoside triphosphates (dNTPs) under suitable reaction conditions. Thus, new 
DNA strands are synthesized that are complementary to the template strands. This kind of 
new strand synthesis can be repeated by heat denaturing the double-stranded DNA, 
annealing the primers by cooling and primer extension by DNA polymerase at a suitable 
temperature. Each repetition is called a PCR cycle and after ‘n’ cycles this results in 2n-
fold amplification of the DNA fragment. PCR is usually carried out in a thermal cycler, a 
machine that heats and cools the reaction tubes to the set temperatures. 
6.1.2  DNA melting temperature (Tm)  
 
High temperatures disrupt the hydrogen bonds between the base pairs and the 
hydrophobic interactions resulting in the denaturation of the DNA. The temperature at 
which the DNA double helix unwinds into two separate strands is known as the DNA 
melting temperature (Tm). Each species of DNA has a characteristic melting temperature. 
The GC base pair having three hydrogen bonds between them are more stable and require 
more heat energy to dissociate than the AT base pair with a double bond. Thus, the higher 
the content of GC base pairs in a DNA, the higher is its melting temperature (Newton and 
Graham, 1994). 
 
DNA melting temperature plays a very important role in PCR amplifications. With GC-
rich templates, the temperature for the denaturation step has to be very high and this 
sometimes results in reduced activity of DNA polymerase. In the past, scientists have 
used different solutes or destabilizers to reduce the DNA melting temperature. 
Tetraalkylammonium (TAA) compounds have been used as general destabilizers of DNA 
(von Hippel and Wong, 1965). Amino acids such as glycine and β-alanine have been 
observed to reduce the thermal stability of DNA macromolecule at concentrations of 
0.0001-1.0 M (Aslanyan and Arutyunyan, 1984). Rees et al. (1993) showed that glycine 
betaine (GB) can eliminate the base pair composition dependence of DNA melting and 
thus reduce the melting temperatures. At molar concentrations, GB was shown to 
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destabilize the double helical conformation of DNA, and the melting temperature, Tm, 
decreases approximately linearly with increasing GB concentrations. A number of 
different polyols, including sorbitol, have also been shown to affect the thermal stability 
of calf thymus DNA by reducing its Tm (Vecchio et al., 1999). They showed that 
increasing the concentration of polyols decreased the denaturation enthalpy and 
denaturation temperature. Trehalose, a known compatible solute, has also been observed 
to reduce DNA melting temperatures substantially (Spiess et al., 2004). 
 
The mechanism by which these solutes destabilize the DNA double helix is not properly 
understood and different mechanisms have been proposed for different group of solutes. 
TAA salts are strong electrolytes which are present in aqueous solutions as cations and 
anions, perturb the polyelectrolyte properties of the DNA resulting in denaturation (von 
Hippel and Wong, 1965). Amino acids at concentrations of 0.001-1.0 M are said to 
interact with DNA phosphate groups and destroy the spatial structure of water around 
DNA, bringing about the destabilization of macromolecule (Aslanyan and Arutyunyan, 
1984). Osmolytes and compatible solutes such as GB and sorbitol, which are known to 
stabilize proteins under different environmental stresses, have been shown to destabilize 
DNA and reduce its melting temperature (Rees et al., 1993; Vecchio et al., 1999). To 
understand the isostabilizing effect of GB on DNA, von Hippel and co-workers (Rees et 
al., 1993) proposed that the effect was due to binding of the GB to the DNA major 
groove. This binding gives rise to weak and non-cooperative hydrophobic interactions 
with the methyl group of the thymines exposed in the major groove, which increases the 
local stability of AT base pairs and in turn reduces the stability difference between GC 
and AT base pairs. Thus, higher concentrations of GB reduce the melting temperature of 
a DNA by eliminating the base-pair composition dependence (Rees et al., 1993). 
Regarding the effect of polyols on DNA, it has been proposed that the hydroxyl groups of 
polyhydric alcohols compete with water for formation of hydrogen bonds with the side 
groups of the bases. This replacement of water by molecules of higher mass might 
amplify the thermal fluctuations of the polynucleotide resulting in destabilization of DNA 
double helix (Vecchio et al., 1999).  
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6.1.3  PCR Enhancers 
 
PCR is one of the most important methods used in biological sciences. Though it is a 
very powerful and robust procedure, there are instances where a particular region of DNA 
proves difficult to amplify. The initial and critical step of the PCR, that is the melting of 
DNA double strands, depends mainly on the base pair composition of the template 
(Marmur and Doty, 1962). During amplification of targets rich in GC content high 
melting temperatures have to be used, which can be a limitation for the PCR and attempts 
to amplify GC rich targets can often result in little or no yield of the expected product 
(Frackman et al., 1998). To counter this, optimization of PCR by changing magnesium 
concentration, buffer pH, cycle number, and denaturing and annealing times have been 
tried. However, this has not been useful in all cases. Others have tried including a variety 
of additives and enhancing agents in the PCR mix in order to amplify GC rich templates 
and increase yields.  
 
It has been shown that addition of glycine betaine in a PCR assay enhances/improves the 
amplification of GC-rich DNA sequences (Henke et al., 1997). Several other additives, 
for example DMSO (Frackman et al., 1998), low molecular weight amides (Chakrabarti 
and Schutt, 2001a) and low molecular weight sulfones (Chakrabarti and Schutt, 2001b) 
have also been used for enhancement of PCR amplification. Schnoor et al. (2004), 
investigated the effects of naturally occurring ectoine-type compatible solutes and their 
synthetic derivatives on DNA melting temperatures and PCR amplification of different 
templates. They showed that homoectoine, a synthetic derivative of L-ectoine, effectively 
enhanced PCR amplification of GC-rich DNA. 
 
Detection of Fragile X syndrome by PCR analysis is an example of analysis of a GC-rich 
DNA template. Fragile X syndrome is a common cause of inherited mental retardation in 
humans and is caused by the expansion of the CGG trinucleotide repeats in the FMR1 
(Fragile X mental retardation 1) gene. The FMR1 gene is located on the X chromosome 
and is responsible for making FMRP, a protein essential for normal brain functioning. In 
the normal population the FMR1 gene has between 6 and 50 CGG repeats. However, the 
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FMR1 mutations responsible for Fragile X syndrome result in approximately 50 to 200 
CGG repeats (premutation) and full mutations result in more than 200 repeats 
(www.acmg.net). PCR analysis allows accurate determination of CGG repeat number for 
both normal alleles and mutant alleles of FMR1 gene. However, as this is a GC–rich 
DNA analysis, commercially available PCR enhancers (e.g. Roche GC-RICH PCR 
System) have to be used to obtain proper amplification of the DNA fragment. More 
information about Fragile X syndrome and its detection methods can be obtained in web 
pages cited in the references section of this chapter.  
6.1.4  Objectives 
 
The objectives of this project were to investigate the effects of novel synthetic 
compensatory solutes on DNA melting temperatures and their application as PCR 
enhancers. For DNA melting studies, we used three different DNA samples with varying 
GC content, Clostridium Perfringens (26.5% GC), Calf thymus (42% GC) and 
Micrococcus lysodeikticus (72% GC). After identifying the solutes which were effective 
in reducing the DNA melting, we tested their effectiveness as PCR enhancers in Fragile 
X PCR analysis and to check whether they would be able to replace a commercially 
available enhancer. 
6.2  MATERIALS AND METHODS 
 
Glycine betaine, DMSO, TMAO, trehalose, Clostridium perfringens DNA with 26.5% 
GC base pairs, calf-thymus DNA with 42% GC base pairs and Micrococcus lysodeikticus 
DNA with 72% GC base pairs were purchased from Sigma Chemical Co. (St. Louis, MO, 
USA). Synthetic compensatory solutes, PB, DB, HDB, HGB, CB-1, CB-2, CB-3, SB-2, 
SB-3, SB-4, CSB-1 and CSB-2 were synthesized as described in Chapter 3 of this thesis. 
Taq DNA polymerase (From Thermus Aquaticus BM, recombinant (E. Coli)) and GC-
RICH PCR system kit were purchased from Roche Diagnostics GmbH, Germany. DNA 
marker ØX174 RF DNA/ Hae III fragments were purchased from Invitrogen. DNA 
templates for PCR analyses were gifted by Dr. Jeff Upton, Molecular Pathology, 
Canterbury Health Laboratories.  
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DNA stock solutions were prepared by dissolving the lyophilized DNA samples in 5 mM 
K2HPO4 buffer containing 0.1 mM Na2EDTA (pH 7.5) and stored at 4°C for 48 hours.  
6.2.1  DNA melting studies 
 
All spectrophotometric studies were conducted at pH 7.5 in solutions containing 5 mM 
K2HPO4 and 0.1 mM Na2EDTA. DNA melting profiles were monitored at 260 nm on a 
UV spectrophotometer (Cary 4000, Varian, Melbourne, Australia) equipped with a 
Peltier temperature controller and using the ‘Thermal’ software (Varian). Before 
monitoring the melting profiles, the equipment was blanked with buffer or the particular 
compensatory solution. For all three DNA samples, 100 µL DNA solution (final 
concentration 50 µg/mL) was mixed with 900 µL buffer/ compensatory solution (final 
concentration 2 M) and the melting profile was monitored starting from 35°C. The 
temperature was raised at 1°C/min and data was collected at every 0.1°C rise in 
temperature. The DNA melting temperatures (Tm) were determined by the ‘Thermal’ 
software using derivative calculations.  
6.2.2  Effect of compensatory solutes on Taq DNA polymerase 
 
To determine the effect of compensatory solutes on the activity of Taq DNA polymerase, 
10 µL of enzyme solutions (5x diluted) were mixed with 10 µL of different compensatory 
solutions (2M final) and incubated at room temperature for 60 minutes. Aliquots (5 µL) 
of these mixtures were then used as enzyme solution for PCR analyses. To determine 
whether compensatory solutions were able to stabilize Taq DNA polymerase against heat, 
10 µL of enzyme solutions (5x diluted) were mixed with 10 µL of different compensatory 
solutions (2M final) and incubated at 95°C for 120 minutes in a Perkin–Elmer thermo 
cycler. Aliquots (5 µL) of these mixtures were then used as enzyme solution for PCR 
analyses. For control experiments, 10 µL of enzyme solutions were mixed with 10 µL of 
Roche buffer (10x diluted). The PCR reaction mixture contained 10x diluted Roche 
buffer (10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, pH 8.3), 0.5 µM CTE2F forward 
primer, 0.5 µM HP2R reverse primer, 10 ng/µL gDNA template, 0.2 mM each dNTP and 
0.025 U/µL Taq polymerase. dNTP’s were purchased from Roche and primers from 
Invitrogen. The sequences of the primers were as follows, forward 5’-
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GGGAGCGCCACCCCTAACATGCTATT-3’ and reverse 5’-
CTCTCCCAGGCAGACTGGCC-3’. Amplification reaction was carried out on a Perkin-
Elmer thermocycler using 50 µL solutions in 200 µL thin-walled tubes. Amplifications 
were run under the following conditions: Initial denaturation at 94°C for 2 min and 
annealing at 60°C for 30 sec. This was followed by 30 cycles of denaturation at 94°C for 
30 sec and anneal/extension at 65°C for 1 min. Finally the mixture was maintained at 
65°C for 10 min and cooled down to 20°C. Amplification products were analyzed by 
agarose gel electrophoresis on 2% agarose gels in which 7 µL of reaction products were 
loaded with 3 µL of loading buffer. Gels were stained with ethidium bromide, visualized 
on a UV transilluminator (Gel Doc 2000, Bio-Rad ), and documented by photography. 
6.2.3  Fragile X PCR analysis 
 
Fragile X PCR analyses were carried out to determine the effectiveness of synthetic 
compensatory solutes for their application as PCR enhancers. Fragile X PCR analysis is a 
GC-rich system and usually a GC-rich resolution solution (abbreviated as “RS” further in 
this thesis) supplied by GC-Rich PCR System kit, Roche Diagnostics, Germany, is used 
as an enhancer to obtain proper amplification of CGG repeats in the FMR1 gene. 
 
The PCR reaction mix was as follows: GC-rich reaction buffer (5x diluted containing 1.5 
mM MgCl2 and DMSO), 1.5 M GC-rich resolution solution (RS), 0.25 µM FMR1 
forward primer, 0.25 µM FAM-FMR1 reverse primer, 0.2 mM each dNTP, 0.04 U/µL 
Platinum Taq High FidelityTM polymerase (Invitrogen) 10 ng/ µL DNA template. dNTP’s 
were purchased from Roche and primers from Invitrogen. The sequences of the primers 
were as follows, forward 5’-GCTCAGCTCCGTTTCGGTTTCACTTCCGGT-3’ and 
reverse 5’-AGCCCCGCACTTCCACCACCAGCTCCTCCA-3’. Amplification reaction 
was carried out on an Eppendorf MasterCycler thermocycler using 50 µL solutions in 200 
µL thin-walled tubes. Amplifications were run under the following conditions: Initial 
denaturation 98°C for 5 min and annealing at 60°C for 1 min, followed by 3 cycles of 
extension at 72°C for 1 min, denaturation at 98°C for 30 sec and annealing at 60°C for 30 
sec. Then the amplification was run for 33 cycles with denaturation at 96°C for 15 sec, 
annealing at 67°C for 1 min and extension at 72°C for 1 min. Finally the mixture was 
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held at 72°C for 10 min and then cooled down to 20°C. Amplification products were 
analyzed by agarose gel electrophoresis on 3% agarose gels in which 7 µL of reaction 
products were loaded with 3 µL of loading buffer. Gels were stained with ethidium 
bromide, visualized on a UV transilluminator and documented by photography. 
 
Seven different Fragile X DNA templates with varying number of CGG repeats were 
available at the Molecular Pathology Department of Canterbury Health Laboratories. 
Firstly, Fragile X PCR analysis was done using all the seven templates to determine the 
exact amplification products to be expected.  
 
Secondly, to determine whether synthetic compensatory solutions could replace GC-rich 
resolution solution (Roche), different concentrations of synthetic compensatory solutions 
(prepared in reaction buffer) were added in the Fragile X PCR reaction mixture. For 
control experiments, different concentrations of the resolution solution were added to the 
reaction mixture. 
 
Thirdly, the effect of mixing compensatory solutions with the resolution solution was 
investigated. For this, 5 M compensatory solutions were mixed with 5 M resolution 
solution (Roche) in different volume fractions and added to the reaction mix. Also, 
different concentrations of compensatory solutions were prepared in the resolution 
solution instead of buffer, and then added to the reaction mix. 
 
Lastly, as magnesium is a co-factor required for the activity of thermostable DNA 
polymerase and the concentration of magnesium is an important factor that can affect the 
success of the amplification (www.promega.com), different concentrations of MgCl2 
were added along with the compensatory solutions to determine if better Fragile X PCR 
products could be obtained. 
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6.3  RESULTS 
6.3.1  DNA melting studies 
 
Table 6.1 lists the DNA melting temperatures, Tm, of three different DNA samples (with 
varying GC content) in the presence of different 2 M compensatory solutions. Trehalose 
was used at 1 M final concentration because of solubility constraints. Also listed are the 
approximate changes in Tm (°C) compared to the Tm of a DNA sample in the absence of 
any additive. In the absence of any additive the Tm of Clostridium perfringens (CP) DNA 
was approximately 58°C, calf thymus (CT) DNA was approximately 65°C and 
Micrococcus lysodeikticus (ML) was approximately 80°C. It is evident from the results 
that as the GC% of DNA increases, its Tm increases. 
 
As expected, GB, dimethyl sulfoxide (DMSO), sorbitol and trehalose were able to 
destabilize the different DNA samples. However, their destabilization effect on the DNA 
samples was different. The destabilization effect of GB seemed to increase with the 
increasing GC content of the DNA samples. A similar effect was observed in the 
presence of DMSO. Trehalose showed an opposite effect with its effectiveness to reduce 
Tm of the DNA decreasing with increasing GC content. The effect of sorbitol did not 
change though the GC content of the DNA increased. In the presence of sorbitol, the 
change in Tm remained approximately the same (Table 6.1). Trimethyl-N-oxide (TMAO) 
had very little effect on all three DNA samples. 
 
Interesting results were obtained when the DNA samples were heated in the presence of 
synthetic compensatory solutes. Propio betaine increased the Tm of both CP and CT 
DNA, and had a negligible effect on ML DNA. The stabilizing effect of propio betaine 
seemed to decrease with the increase in GC content of the DNA samples. A similar 
stabilization effect was observed in the presence of hydroxyl group containing solutes, 
DB, HDB and HGB. HGB was the best stabilizer of the three, and it increased the Tm of 
all the DNA samples significantly, though its stabilizing effect seemed to decrease with 
increasing GC content. 
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Table 6.1: Tm ± SEM of different DNA samples in the presence of 2M compensatory solutions. Changes in Tm (°C) listed in the table 
are the approximate changes in melting temperature compared to Tm of that particular DNA in the absence of any additive (no 
addition) 
Additive Clostridium perfringens 
(26.5% GC) 
Calf thymus 
(42.0% GC) 
Micrococcus lysodeikticus 
(72.0% GC) 
(2 M) Tm, °C Change in Tm, °C  Tm, °C Change in Tm, °C Tm, °C Change in Tm, °C 
No addition 57.9 ± 1.0  0.0 64.8 ± 0.7  0.0 80.1 ± 0.1  0.0 
GB 54.6 ± 0.9 -3.3 60.2 ± 0.3 -4.5 72.4 ± 0.2 -7.7 
DMSO 54.2 ± 0.4 -3.7 59.9 ± 0.7 -4.9 74.6 ± 0.5 -5.5 
TMAO 60.1 ± 1.3 2.1 66.3 ± 0.3 1.5 79.6 ± 1.0 -0.5 
Sorbitol 52.3 ± 0.3 -5.6 58.0 ± 0.6 -6.8 73.8 ± 1.1 -6.3 
Trehalose* 53.4 ± 0.4 -4.5 59.7 ± 0.4 -5.1 77.0 ± 0.6 -3.1 
PB 64.8 ±1.5 6.9 68.2 ± 3.4 3.4 79.2 ± 1.0 -0.9 
DB 67.6 ± 0.8 9.7 72.4 ± 1.2 7.7 82.3 ± 0.7 2.2 
HDB 68.6 ± 0.4           10.7 69.8 ± 0.2 5.0 81.6 ± 0.8 1.5 
HGB 73.2 ± 1.0           15.3 77.6 ± 1.1           12.8 84.8 ± 0.2 4.7 
CB-1 56.2 ± 0.8 -1.7 59.7 ± 0.5 -5.1 70.3 ± 0.3 -9.8 
Sulfobetaines       
SB-2 51.6 ± 1.1 -6.3   56.5 ± 0.7 -8.3 67.0 ± 1.0 -13.1 
SB-3 69.3 ± 1.5           11.4 71.5 ± 0.5 6.8 81.9 ± 0.7 1.8 
SB-4 52.6 ± 3.4 -5.4 59.2 ± 2.0 -5.6 71.1 ± 1.9 -9.0 
CSB-1 54.3 ± 0.4 -3.6 59.7 ± 0.3 -5.1 70.5 ± 0.5 -9.6 
CSB-2 52.8 ± 1.8 -5.1 56.1 ± 0.9 -8.6 64.8 ± 0.7           -15.3 
* Trehalose was used at 1 M concentration 
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Sulfobetaines were generally effective in reducing the Tm of the DNA’s, except for SB-3. 
In the presence of SB-2 and CSB-2, maximum reduction in Tm of all the three DNA 
samples was observed. Their destabilization effect increased sharply with the increase in 
the GC content and they reduced the Tm of the DNA samples almost twice as much as 
GB and sorbitol (Table 6.1). SB-4 and CSB-1 were also better in reducing the Tm 
compared to the natural solutes, but they were not as effective as SB-2 and CSB-2. 
Surprisingly, SB-3 increased the Tm of the DNA samples instead of reducing their Tm, as 
expected. The stabilization effect of SB-3 was similar to that of HDB.   
 
From the melting profiles of CT DNA (Figure 6.3), we observe that in the absence of any 
additive the melting curve is broad. In the presence of GB, DMSO and sorbitol, which 
reduced the Tm, the melting curves are broad and similar to that of DNA without an 
additive. However, in the presence of synthetic solutes, both stabilizers and destabilizers, 
the melting curves seem to sharpen and are less broad. This is evident from the melting 
curves of SB-2, CSB-1 and CSB-2, which are very effective in reducing the Tm of the 
DNA samples. Similarly, melting curves in the presence of solutes that increased the Tm 
(stabilizers), such as propio betaine, DB and HDB, were narrower. 
 
The relation between change in melting temperatures (Tm) and CG content of DNA 
samples in the presence of various solutes, both destabilizers and stabilizers, is shown in 
Figure 6.4. From the figure we observe that there is a particular trend in the way in which 
these solutes affect DNA stability with the increase in GC %. The change in Tm decreases 
with the increase in GC%, irrespective of whether the solute is stabilizing or destabilizing 
the DNA. Solutes such as HDB and HGB stabilize CP DNA (26.5 % GC) effectively and 
increase its Tm by approximately 14°C. However, as the GC content increases (e.g. ML 
DNA with 72% GC), their stabilization effect becomes minimal. On the other hand, the 
destabilization effect by solutes SB-2 and CSB-2 increases with the GC content and they 
reduce the Tm further. Thus, we observe that the effect of stabilization decreases and 
effect of destabilization increases with the increase in DNA GC content. 
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Figure 6.3: Melting profiles (derivative curves) of calf thymus DNA (42% GC) in the 
presence of different 2 M compensatory solutions. Melting was monitored by UV 
absorbance at 260 nm using Cary 4000 (Varian) UV spectrophotometer.  
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Figure 6.4: Relation between change in Tm (°C) and GC% of DNA samples in the 
presence of different 2 M compensatory solutes. 
6.3.2  Effect of compensatory solutes on Taq DNA polymerase 
 
The effect of compensatory solutes on the activity of Taq DNA polymerase is shown in 
Figure 6.5. Taq polymerase was incubated at room temperature for 60 min in the 
presence of 2 M compensatory solutes and then an aliquot of this enzyme solution was 
used in the PCR analysis. Except for CB-2 and CB-3, none of the solutes inhibit the 
activity of the enzyme. Amplification products similar to that of control are obtained even 
though the enzyme was incubated in presence of 2 M solutes. Initially, no products were 
found in the presence of HGB, CB-2, CB-3 and SB-1 (Gel 1, Figure 6.5). To reconfirm 
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these results, the experiments were repeated a few times and subsequently it was 
consistently found that HGB and SB-1 do not inhibit the activity of Taq polymerase (Gel 
3, Figure 6.5). 
 
 
Figure 6.5: Effect of compensatory solutes on normal activity of Taq DNA polymerase. 
Gel 1: (1) Control/expected product (2) GB (3) Sorbitol (4) Trehalose (5) Propio betaine 
(6) DB (7) HDB (8) HGB (9) CB-1 (10) CB-2 (11) CB-3 (12) SB-1 Gel 2: (1) 
Control/expected product (2) SB-2 (3) SB-3 (4) SB-4 (5) CSB-1 (6) CSB-2 (7) DMT Gel 
3: (1) Control (2) HDB (3) HGB (4) CB-1 (5) CB-2 (6) CB-3 (7) SB-1 (8) SB-4 (9) CSB-
2.  (Ladder: ØX174) 
 
Figure 6.6 shows the ability of compensatory solutes to stabilize Taq polymerase against 
heat. Enzyme solutions were incubated with 2 M compensatory solutions at 95°C for 2 
hours and then used in PCR analysis. Though the majority of the compensatory solutes 
do not affect the normal activity of the enzyme, only a few were able to protect the 
enzyme against extreme heat. In the absence of any solutes (lane 2, Gel 4 and 5) Taq 
polymerase is completely inactivated by heat and no amplification products are found. 
However, in the presence of 2 M GB, sorbitol, trehalose, SB-1, SB-2, SB-3, CSB-1 and 
DMT, amplification products similar to that of untreated enzyme are found. These results 
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show that a few solutes are effective in protecting Taq polymerase against extreme heat. 
Solutes such as propiobetaine, HGB, HDB and CB-1, which were very good stabilizers of 
LDH and chymotrypsin against heat were unable to protect Taq polymerase from 
inactivation by prolonged exposure to heat.  
 
Figure 6.6: Stabilization effect of compensatory solutes against heat treatment of Taq 
polymerase. The enzyme was heated at 95°C for 2 hours in the presence of 2 M solutes 
and then used in the PCR. Gel 4: (1) Untreated control/expected product (2) Heat treated 
control (3) GB (4) Sorbitol (5) Trehalose (6) Propio betaine  (7) DB (8) HDB (9) HGB 
(10) CB-1 (11) CB-2 (12) CB-3 Gel 5:  (1) Untreated control/expected product (2) Heat 
treated control (3) SB-1 (4) SB-2 (5) SB-3 (6) SB-4 (7) CSB-1 (8) CSB-2 (9) DMT.  
(Ladder: ØX174) 
6.3.3  Fragile X PCR analysis: Compensatory solutes as PCR enhancers 
 
Fragile X PCR analyses of the seven different DNA samples (available at Molecular 
Pathalogy, Canterbury Health Laboratories) were done using Roche supplied GC-Rich 
Resolution Solution as the PCR enhancer, and the expected products are shown in Figure 
6.7. The sizes of PCR products show the approximate number of CGG repeats present in 
each allele of the individual being tested. The PCR products in lane 1, 2, 4, 5 and 7 on 
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Gel 6 (Figure 6.7) show premutation of the FMR1 gene and approximate number of CGG 
repeats. Full mutations (n>200) are not detected by PCR analysis and this is shown on 
lane 3 and 6, where only normal allele has been amplified. 
Mutant
allele
Normal Allele Full mutation
 
Figure 6.7: Expected amplification products of Fragile X PCR analysis using different 
DNA templates. Gel 6:  (1) DNA #1 (2) DNA #2 (3) DNA #3 (4) DNA #4 (5) DNA #5 
(6) DNA #6 (7) DNA #7 (8) No DNA (control). (Note: These analyses were carried out 
using Roche supplied GC-Rich Resolution Solution as the PCR enhancer) (Ladder: 
ØX174) 
 
In DNA samples in which premutations are detected (lane 1, 2, 4, 5 and 7), we can see 
two bands of PCR products. The lower band represents the normal allele and the upper 
band shows the results from the mutant allele. DNA # 1 has a premutation with 
approximately 55-65 CGG repeats (shown by upper band on lane 1). Similarly, DNA # 2, 
4, 5 and 7 have premutations with approximately 60-70, 80-100, 90-110, and 100-200 
CGG repeats respectively. As the amplification of these CGG repeats on mutant alleles is 
difficult in a fragile X PCR analysis, enhancers like GC-Rich Resolution Solution are 
always added in the reaction mixture. 
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We chose synthetic solutes SB-2 and CSB-1, and the natural solute GB, to study the 
effects of replacing GC-Rich Resolution Solution in a standard fragile X PCR. In the 
standard method, GC-Rich Resolution Solution is used at a final concentration of 1.5 M. 
However, as we were not sure about the exact concentration of our synthetic solutes that 
would give optimal results, we tried adding our solutions in a range of concentrations to 
determine their effect.  Figure 6.8 and 6.9 show the results of these experiments.  
 
For control experiment, GC-rich resolution solution was diluted to a range of 
concentrations starting at 1.5 M and the results are shown in Gel 7. We observe that the 
expected PCR products along with the CGG repeats are only obtained with the addition 
of 1.5 M resolution solution. 
 
Primer dimers
  
Figure 6.8: Synthetic compensatory solutes as Fragile X PCR enhancers, replacing GC-
rich resolution solution (GCRRS or RS). Gel 7- varying concentrations of RS. Gel 8 – 
varying concentrations of CSB-1. GEL 7: (1) No enhancer (2) 1.5 M RS/expected 
product (3)1.25 M RS (4) 1 M RS (5) 0.75 M RS (6) 0.5 M RS (7) 0.25 M RS GEL 8: 
(1) No enhancer (2) 1.5 M RS/expected product (3) 2 M CSB-1 (4)1.75 M CSB-1 (5) 1.5 
M CSB-1 (6) 1.25 M CSB-1 (7) 1 M CSB-1 (8) 0.75 M CSB-1 (9) 0.5 M CSB-1 (10) 
0.25 M CSB-1 (Note: DNA # 5 was used for both the gels, Ladder: ØX174) 
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As the concentration of resolution solution decreases, we observe that the PCR fails to 
amplify the expanded CGG repeats required to detect Fragile X syndrome, and at 
concentrations less than 0.5 M, amplification of normal allele also fails. 
 
Gel 8 (Figure 6.8) shows the effect of replacing resolution solution with the synthetic 
solute CSB-1. CSB-1 was used in a concentration range starting from 2 M (final). Results 
show that the addition of 2 M CSB-1 (lane 3) in the reaction mixture gives the expected 
products along with the amplification of expanded CGG repeats and the products are 
similar to those obtained with the addition of resolution solution (lane 2). However, this 
amplification is concentration dependent and as the concentration of CSB-1 decreases 
there is an abrupt termination of the ability to amplify CGG repeats in the premutation 
range. 
 
Figure 6.9: Synthetic compensatory solutes as fragile X PCR enhancers, replacing GC-
rich resolution solution (GCRRS or RS). Gel 9- varying concentrations of GB and Gel 10 
– varying concentrations of SB-2. Gel 9: (1) No enhancer (2) 1.5 M RS/expected product 
(3) 2 M GB (4) 1.75 M GB (5) 1.5 M GB (6) 1.25 M GB (7) 1 M GB (8) 0.75 M GB (9) 
0.5 M GB (10) 0.25 M GB Gel 10: (1) No enhancer (2) 1.5 M RS/expected product (3) 2 
M SB-2 (4) 1.75 M SB-2 (5) 1.5 M SB-2 (6) 1.25 M SB-2 (7) 1 M SB-2 (8) 0.75 M SB-2 
(9) 0.5 M SB-2 (10) 0.25 M SB-2 (Note: DNA # 5 was used for Gel 9 and DNA # 1 was used for Gel 
10, Ladder: ØX174) 
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Addition of GB (Gel 9, Figure 6.9) instead of resolution solution did not result in the 
amplification of the expanded CGG repeats, though the normal allele is effectively 
amplified. Due to the limited quantity of DNA samples available for the experiments, a 
different DNA sample, DNA # 1, was used for experiments with SB-2.  
 
Results of addition of SB-2 to the PCR mix are shown in Gel 10 (Figure 6.9). SB-2 fails 
to produce the expected amplification products at 2 M concentration. Good amplification 
products are observed when SB-2 is added at concentrations of 1.75 M and 1.5 M (lane 4 
and 5, Gel 10, Figure 6.9). Though there is the amplification of the normal allele, SB-2 
fails to amplify the CGG repeats needed to detect the premutation in the gene. However, 
the appearance of light coloured bands in lane 4 and 5 indicate that there may be minimal 
amplification of the CGG repeats. No amplification products are detected after a further 
decrease in the concentration of SB-2. 
 
Figure 6.10: Effect of mixing 1.5 M resolution solution and 1.5 M SB-2 and CSB-1 
solutions. GEL 13: (1) No enhancer (2) RS/expected product (3) 7.5 µL RS + 7.5 µL SB-
2 (4) 5 µL RS + 10 µL SB-2 (5) 7.5 µL RS + 7.5 µL CSB-1 (6) 5 µL RS + 10 µL CSB-1 
(7) 0.5M SB-2 (8) 1M SB-2 (9) 2M SB-2 (10) 0.5M CSB-1 (11) 1M CSB-1 (12) 2M 
CSB-1 (Note: Solutions of compensatory solutes in column 7-12 were prepared in 
resolution solution instead of buffer, Ladder: ØX174) 
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Resolution solution and compensatory solutions (equimolar) were mixed in different 
volume fractions and their effect on the fragile X PCR was studied (lane 3-6, figure 6.10). 
None of the mixtures were able to produce the expected amplification products. Mixing 
equal volumes of CSB-1 and resolution solution gave satisfactory products, but the 
products were not similar to those products with just the resolution solution (lane 2). We 
also tried adding solutions of compensatory solutes prepared in the resolution solution, 
instead of buffer. Results of these attempts are shown in lane 7-12, Gel 13, Figure 6.10. 
As we observe from the figure, even these attempts did not yield products similar to the 
resolution solution (lane 2). 
 
Figure 6.11 shows the results of adding different concentrations of MgCl2 along with 2 M 
CSB-1 and 1.5 M SB-2. No significant result could be obtained with these experiments 
when DNA # 5 was used (Gel 14, Figure 6.11). However, when DNA # 1 was used (Gel 
16, Figure 6.11), we observe that adding different concentrations of MgCl2 along with 2 
M CSB-1 gives products similar to that of resolution solution. With the addition of 1.5 
mM and 1 mM MgCl2 with 2 M CSB-1 (lane 4 and 5, Gel 16), we see that amplification 
products are better than those obtained with the addition of resolution solution (lane 2, 
Gel 16). CGG repeats that help in detection of mutation in the FMR1 gene were also very 
well amplified when 2 M CSB-1 and 1.5 mM MgCl2 were used in combination during the 
Fragile X PCR analysis.  
 
These results show that synthetic compensatory solutes CSB-1 and SB-2 have the 
potential to replace the more expensive GC-rich resolution solution (Roche) as a PCR 
enhancer, especially for analysis of DNA templates that are rich in GC content. However, 
due to time constraint of this project, the experiments were not continued further. More 
experiments and PCR optimization are required for use of these solutes effectively. 
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Figure 6.11: Effect of addition different concentrations of MgCl2 along with 2 M CSB-1 
and 1.5 M SB-2 to fragile X PCR analysis. GEL 14: (1) RS/expected product (2) CSB-1 
(3) CSB-1 + 0.5 mM MgCl2 (4) CSB-1 + 1 mM MgCl2 (5) CSB-1 + 1.5 mM MgCl2 (6) 
CSB-1 + 2 mM MgCl2 (7) RS (8) SB-2 (9) SB-2 + 0.5 mM MgCl2 (10) SB-2 + 1 mM 
MgCl2 (11) SB-2 + 1.5 mM MgCl2 (12) SB-2 + 2 mM MgCl2 GEL 16: (1) No enhancer 
(2) RS/expected product (3) CSB-1 + 2 M mMgCl2 (4) CSB-1 + 1.5 mM MgCl2 (5) CSB-
1 + 1 mM MgCl2 (6) CSB-1 + 0.5 mM MgCl2 (Note: DNA # 5 was used for Gel 14 and 
DNA # 1 for Gel 16) 
 
6.4  DISCUSSION 
 
Destabilization of DNA or reducing the Tm is very important for methods such as PCR 
where the initial step is the separation (melting) of double stranded DNA into single 
strands by heat denaturation. Researchers in the past have tried using different additives 
like tetraalkylammonium salts (von Hippel and Wong, 1965), glycine betaine (Rees et al., 
1993), proline (Rajendrakumar et al., 1997), polyols (Vecchio et al., 1999) and trehalose 
(Spiess et al., 2004). In this chapter the results of effects of different compensatory 
solutes, both natural and synthetic, on three different DNA samples with varying GC 
151 
Chapter 6 
content are presented. Some of these synthetic solutes destabilize the DNA better than 
most of the known natural solutes and some solutes stabilize the DNA very well against 
heat.  
 
There seems to be no general mechanism by which these additives destabilize the DNA 
and reduce the Tm. Different mechanisms have been proposed to explain the 
destabilization effect of different additives. Except for homoectoine (Schnoor et al., 
2004), most of the other studies have used naturally occurring osmolytes and compatible 
solutes for destabilizing the DNA. These osmolytes and compatible solutes have been 
extensively studied for their ability to stabilize proteins and biological assemblies without 
affecting their normal cellular functions. It is interesting that the same solutes are being 
used to destabilize a macromolecule like DNA. 
 
von Hippel and co-workers (1993)  proposed that GB binds to the major groove of the 
DNA which causes the destabilization of the DNA double helix. Hong et al. (2004) 
studying the preferential interactions of GB and urea with DNA, deduced that urea is a 
effective DNA denaturant because of its favorable interactions with the polar amide 
surfaces of G, C, and T bases exposed in denaturation, while GB is a specific GC 
denaturant because of its favorable interaction with the G or C surface, or both. This 
argument of interaction of GB with GC bases is supported by the observation that the 
destabilizing effect of GB on DNA increases with increasing fraction of GC base pairs 
(Rees et al., 1993). Even our results of melting of DNA in the presence of 2 M GB 
supports these results and shows that the destabilizing effect of GB increases with the 
increase in DNA GC% (Table 6.1). 
 
Results from Chapter 4 showed that propio betaine, DB, HDB and HGB are very good 
protein stabilizers, and results in this chapter show that they stabilize and protect the 
DNA as well. On the other hand, we observe that compensatory solutes GB, sorbitol and 
trehalose stabilize enzymes against heat (Chapter 4), but here we observe that they 
destabilize the DNA and reduce its melting temperature. Another interesting result is that 
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propio betaine which only differs from GB in its structure with an extra CH2 between the 
charges stabilizes DNA, where as GB destabilizes the DNA. 
 
Vecchio et al. (1999), in their study on effects of polyols on thermal stability of calf 
thymus DNA proposed that the presence of hydroxyl groups makes polyols capable of 
destabilizing the DNA. This was due to the hydroxyl groups forming hydrogen bonds 
with the DNA bases, both in the minor and major grooves, increasing the dehydration of 
DNA. They concluded that polyols which have more hydroxyl groups have a higher 
destabilizing effect. However, our results show a completely opposite trend. In our results 
we see that with the increase in the number of hydroxyl groups in the compensatory 
solutes increases its DNA stabilizing effect instead of destabilization.  HGB, which has 
two hydroxyl groups, stabilizes the DNA samples more than HDB and DB, which have 
one hydroxyl group each (Table 6.1). This stabilization effect by compensatory solutes 
with hydroxyl groups support the results of Schnoor et al. (2004) who showed that β-
hydroxyectoine, a compatible solute with hydroxyl group, increased the melting 
temperatures of double stranded DNA. Schnoor et al. (2004) also suggested that their 
results indicate that the carboxylic group or the zwitterionic structure is important for 
lowering the melting temperature. However, that is not the case with our results where 
propio betaine, DB, HDB and HGB tend to increase the melting temperature though they 
are zwitterionic and have carboxylic group in their structure. 
 
Sulfobetaines considered in our study were very effective in destabilizing the DNA 
samples, except for SB-3. Due to non-availability of the solute, SB-1 was not used for 
DNA melting studies. CSB-1 and CSB-2 (cyclic sulfobetaines) which were synthesized 
in the later stages of this project were included for DNA melting studies. Our results 
show that sulfobetaines SB-2, SB-4, CSB-1 and CSB-2 are very effective in destabilizing 
the DNA and they reduce the Tm twice as much as GB and sorbitol. The structural 
similarity between SB-2, SB-4, CSB-1 and CSB-2 is that they all have a C3 bridge 
between S and N. However, we are unable to explain why SB-3 stabilizes the DNA 
instead of destabilization. The only structural difference between SB-3 and SB-2 is an 
extra CH2 (C4 bridge) between the charges, but still they show a completely opposite 
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effect (see Appendix A for structures of solutes). Another important observation from our 
results is that sulfobetaines SB-2 and SB-4 do not seem to stabilize the DNA similar to 
HDB and HGB even though they have hydroxyl groups in their structure. SB-4 with two 
hydroxyl groups in its structure destabilizes the DNA, where as HGB, also with two 
hydroxyl groups, stabilizes the DNA. In addition, the difference between these two 
synthetic solutes is that SB-4 is a sulfonic acid analogue and HGB is a carboxylic acid 
analogue. 
 
These results show that the effect of compensatory solutes on DNA and their effect on 
proteins are completely different mechanisms. The influence of these solutes on nucleic 
acids is different compared to proteins. More systematic studies with DNA are needed to 
understand the exact mode of action of these solutes. 
 
Based on the effect of our synthetic compensatory solutes on the melting temperatures of 
different double stranded DNAs, we studied their effectiveness as PCR enhancers in 
fragile X PCR, a GC-rich PCR analysis. Glycine betaine (Henke et al., 1997) and DMSO 
(Frackman et al., 1998) have been used to improve the amplification of GC-rich DNA 
sequences. A recent study by Spiess et al. (2004) showed that the compatible solute 
trehalose greatly facilitates the PCR of GC-rich templates by reducing the DNA melting 
temperatures and thermostabilizing the Taq polymerase. All these studies have chosen 
their PCR enhancing additives based on their effectiveness to lower the DNA melting 
temperature. 
 
The results of DNA melting studies identified a number of synthetic solutes that are twice 
as effective as GB, DMSO and trehalose in reducing the melting temperatures. Before 
using them as enhancers in a GC-rich PCR, it was decided to determine their effect on the 
activity of Taq polymerase. For this reason the enzyme was incubated at room 
temperature in the presence of synthetic solutes and then used the enzyme in a standard 
PCR. Most of the solutes did not alter the activity of Taq polymerase, except for CB-2 
and CB-3. As described in Chapter 3, CB-2 and CB-3 form acidic solutions and that this 
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change in pH would have inhibited the enzyme’s activity or by changing the pH of the 
PCR reaction mixture, which is very critical for a PCR.  
 
Taq DNA polymerase is an enzyme originally isolated from the thermophilic 
eubacterium Thermus aquaticus BM. As it is derived from a thermophilic organism, Taq 
polymerase can withstand very high temperatures of a PCR. However in a GC-rich PCR, 
the denaturation temperature is very high and the enzyme has to endure high 
temperatures for short intervals during the approximate 2 hours of a PCR. There is a 
possibility that Taq polymerase can lose activity when exposed to such high 
temperatures, which in turn would affect the yield of amplification products. In Chapter 4 
of this thesis it was shown that some of our synthetic solutes are very good enzyme 
stabilizers against heat. Thus, it was decided to study the stabilizing effect of synthetic 
compensatory solutes on Taq polymerase against heat stress. Taq polymerase solution 
was incubated with 2 M compensatory solutions at 95°C for two hours and then used in a 
PCR. Results showed that only a few solutes were able to protect Taq polymerase against 
heat and helped it retain its activity. Solutes such as propio betaine, HDB, HGB and CB-
1, which were very good stabilizers of LDH and chymotrypsin against heat, failed to 
protect Taq polymerase. This failure to protect may be due to the lack of stability of the 
solutes themselves against very high temperatures (see Chapter 7 for stability of solutes). 
Compensatory solutes had to withstand 95°C for two hours during incubation and also 
further endure the high temperatures of the PCR; these high temperatures might have 
caused the synthetic solutes to decompose and form their starting materials, which would 
have inhibited the enzyme or affected the PCR reaction mixture. 
 
From the results of the above experiments we were able to identify two synthetic solutes, 
SB-2 and CSB-1, which could act as PCR enhancers and decided to use them in a Fragile 
X PCR. In a standard Fragile X PCR, Roche supplied GC-Rich Resolution Solution is 
used as a PCR enhancer to obtain the amplification of the (CGG)n repeats. The GC-rich 
resolution solution is usually supplied in a GC-Rich System kit from Roche and is quite 
expensive to purchase. So, we decided to replace the resolution solution with SB-2 and 
CSB-1 solutions in the Fragile X PCR and determine if we could get similar 
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amplification products as the resolution solution. We also included GB in this study due 
to its known application as a PCR enhancer. 
 
Our results have shown that 2 M CSB-1 gives the same kind of amplification products as 
that of 1.5 M Roche resolution solution. SB-1 and GB solutions did not produce similar 
products as they failed to amplify the CGG repeats of the mutant allele. However, SB-1 
seems have the potential to be a PCR enhancer as there were indications in the results that 
CGG repeats were being amplified. 
 
The GC-rich resolution solution is supplied by Roche, and the company does not reveal 
the ingredients of the solution. To investigate the identity of this commercial additive, we 
did a NMR analysis of the resolution solution (5 M) and compared it with the NMR of 
glycine betaine (5 M). The positions of the peaks in both the NMR spectra (Figure 6.12) 
indicate that the GB solution and resolution solution are same in their chemical 
composition. Even the sizes of the peak suggest that the two solutions are present in 
approximately the same concentration.  
 
In NMR spectra we are only able to identify the organic protons. We decided to get the 
resolution solution analyzed for other additives. We sent the a sample of Resolution 
Solution to Canterbury Health Laboratories to check if there were traces of Na, K, Cl, 
Phos, Mg, and Mn. Results came out to be negative for all the elements tested. These 
analyses demonstrated that the Roche supplied GC-rich resolution solution is GB 
solution. However, though the Resolution Solution is presumably GB, we could not 
determine why a GB solution that was prepared in our laboratory did not have a similar 
enhancing effect on the Fragile X PCR.  
 
Our attempts to get better Fragile X PCR products by mixing synthetic compensatory 
solutions, SB-2 and CSB-1, with resolution solution did not yield any promising results. 
As magnesium concentration is very important for a PCR, we also tried adding different 
concentrations of MgCl2 along with our compensatory solutions. Results showed that 
mixing 2 M CSB-1 with 1 mM MgCl2 results in exactly similar amplification products as 
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that of resolution solution. However, there was difference in results when two different 
DNA templates were used, which we are unable to explain. 
NMR spe
(CH3)3), 3
 
NMR spe
(2 H, s, C
 A 
ctra (GC-Rich Resolution solution): 1H NMR (D2O, 500 MHz) δ 3.15 (9 H, s, 
.78 (2 H, s, CH2) B 
ctra (Glycine betaine): 1H NMR (D2O, 500 MHz) δ 3.16 (9 H, s, (CH3)3), 3.79 
H2) 
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Figure 6.12: NMR spectra (A) Roche supplied 5 M GC-Rich Resolution solution (B) 5 
M Glycine betaine solution. Note: The peak at 4.7 ppm is water. 
Though PCR is a very robust procedure, it needs proper optimization. There are a number 
of variables such as magnesium concentration, buffer pH, enzyme concentration, 
template quality and quantity and thermal cycling parameters that need to be changed for 
every PCR. In our study, we chose a pre-optimized PCR, Fragile X, and tried to replace 
the commercial enhancer solution with our compensatory solutions. Our results have 
shown that SB-2 and CSB-1 reduce the DNA melting temperatures more than GB (main 
ingredient of resolution solution). However, we did not change the denaturation and 
annealing temperatures during thermal cycling, which might be the reason for not getting 
the exact amplification products as that of the resolution solution.  
 
Results of this chapter have identified three synthetic solutes, SB-2, CSB-1 and CSB-2, 
which have the potential to replace commercial enhancers like the GC-rich resolution 
solution. We have studied the PCR enhancing effect of these solutes in only one GC-rich 
PCR system. It is suggested that more PCR optimization, and also studying the effects of 
these solutes in a different GC-rich PCR analysis would help in proving them as effective 
PCR enhancers. 
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Chapter 7 - Physical Properties of Compensatory Solutes and 
Theoretical Calculations of Their Interactions with Water 
 
7.1 INTRODUCTION 
 
In the previous chapters, the effect of different compensatory solutes on proteins and 
DNA melting temperatures, and applications of compensatory solutes as PCR enhancers 
and therapeutic agents, was discussed. However, most of the synthetic solutes that have 
been detailed in this thesis are completely new and very little physical data is available 
for them. In this chapter results of density and viscosity measurements, apparent 
hydration numbers and the stability of the solutes themselves are presented. Theoretical 
calculations of interactions of water with different compensatory solutes by Dr. Robert 
Maclagan, Chemistry Department, University of Canterbury, New Zealand, are also 
included. 
 
It was observed (Chapter 4) that compensatory solutes have different effects on different 
proteins and sometimes the protective effect can be protein or stress specific. Several 
theories have been proposed to explain the mechanism by which osmolytes or compatible 
solutes stabilize proteins. One of the most widely accepted mechanisms is the preferential 
exclusion mechanism proposed by Timasheff and co-workers (2.2.1, Chapter 2). One of 
the common adaptation strategies developed by living systems against hostile 
environments is to modify the properties of the solvent, usually water, in such a way as to 
exclude undesirable solutes from solution (Galinski, 1993). Stabilizing solutes (co-
solvents) accumulated at very high concentrations are known to modify the water in the 
cell (Timasheff, 1993). Depending on solute/co-solvent’s effect on the structure of water 
they are classified as ‘Kosmotropes’ (order maker) and ‘Chaotropes’ (Order breaker).  
 
Kosmotropic co-solvents (e.g. glycine betaine) are more polar than water and they 
enhance the structure of water due to their ability to form hydrogen bonds (Galinski et al., 
1997). For this reason they interact with water molecules rather than with non-polar 
protein side-chains, which leads to an effective preferential exclusion from the solvation 
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shell of proteins (Timasheff and Arakawa, 1997). Chaotropic co-solvents (e.g. urea) are 
less polar than water and their presence in solution leads to an energetically unfavorable 
disruption of water structure. Thus chaotropic co-solvents are excluded from bulk water 
and they preferentially bind to the protein side chains (Timasheff and Arakawa, 1997; 
Timasheff, 2002). In a theory proposed by Wiggins (1997), it has been suggested that 
water, in the presence of compensatory solutes and proteins, displays different properties. 
According to this theory two types of water structure can be distinguished: dense water in 
the hydration sphere of proteins and less dense or bulk water, which is preferred by the 
compensatory solutes. 
 
It is evident from the proposed mechanisms of protein stabilization that the interaction of 
solutes/co-solvents with water plays a very important role in understanding the 
mechanism of protection. As the majority of the compensatory solutes described in this 
thesis are new, we decided to calculate the apparent hydration number, H, for different 
solutes and determine whether hydration number plays any role in the effect of solute. 
Hydration number, H, is usually used to express the amount of hydration of a solute, and 
is defined as the number of water molecules present in a hydration envelope of one 
molecule of solute (Vand, 1947). The hydration envelope can be regarded as consisting 
of water molecules held to the molecule of the solute by certain binding forces, as a result 
of which an activation energy E is to be overcome by the molecules leaving the envelope 
(Vand, 1947). The method of estimation of apparent hydration numbers for various 
aqueous solutions has been described by Edward (1957). Hydration numbers have also 
been used to study aqueous saccharide solutions (Kiyosawa, 1988).  
 
Maclagan et al. (2004) carried out several theoretical calculations to understand the 
interaction of compensatory solutes with water. These calculations illustrated the variety 
of computational chemistry methods that can be applied to understand biological systems. 
Some of the calculations that they carried out were: 
 
(1) Calculations of gas-phase structures that gave information about the charge 
distribution, dipole moments of the molecules and polarizability; and 
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(2) Calculations of the interaction energy of the solute molecules with a water molecule, 
which when compared with water-water interaction energy, showed whether the H-bonds 
in water will be broken by the solute molecule. 
 
Results of these calculations suggested that compensatory solute molecules, while 
uncharged, often have a large dipole moment, which could lead to the modification of 
water structure close to the solute molecule (Maclagan et al., 2004). As we were 
interested to know more about the interaction of water with our novel synthetic 
compensatory solutes, we asked Dr. Robert Maclagan to do similar calculations with a 
few of our synthetic solutes. 
 
It has been observed that some of the synthetic solutes that were good stabilizers of LDH 
and chymotrypsin failed to protect Taq polymerase against extreme heat stress (Chapter 
6). Due to the suspicion that some of the synthetic solutes are not stable enough to 
withstand very high temperatures, it was decided to study the stability of the solutes using 
an HPLC system, which will be described further in this chapter. Measurement of density 
and viscosity of compensatory solutes will also be described. 
 
7.2 MATERIALS AND METHODS 
7.2.1   Stability of compensatory solutes 
 
Stability of the compensatory solutes was determined using an HPLC system (Figure 
7.1). Glass test tubes with screw caps were filled with 5 mL of 100 mM compensatory 
solutions and were incubated at 90 °C for 2 hours in a temperature block. During 
incubation, 100 µL aliquots of the solutions were taken every 30 minutes and mixed with 
300 µl acetonitrile in HPLC vials and then transferred to the auto-sampler. 
 
The experimental set-up contained one HPLC pump, Shimadzu LC-10 ADVP. The 
mobile phase, acetonitrile water mixture (3:1), passed through a membrane degassing 
module to the pump (1.0 mL/min), and then to an auto sampler, Shimadzu SIL10AXL 
fitted with a 400µL loop. 
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Figure 7.1: Experimental set-up 
 
The auto-sampler, controlled by a system controller (Shimadzu SCL-10A) injected 40µL 
sample in to the stream. The sample then passed through a HPLC column (Shodex 
Asahipak NH2P-50), and the outlet from the column was measured using a RI detector 
(Jasco). The detector output was monitored using DELTA Chromatography System 
(Digital solutions, Brisbane, Australia). Area under the peak was also measured using the 
DELTA Chromatography system. Due to inconsistencies in results, RI detector was 
replaced by a UV detector (UVIS 200, Linear systems). Carboxylic acid analogues of 
betaine were then analyzed by UV detection at 249 nm using naphthacyl triflate for 
derivatization and a Merck Aluspher Alumina column, as described by Storer et al., 2006. 
7.2.2   Density measurements 
 
The density of synthetic compensatory solutions was measured using an Anton Parr 
Density meter using 23% w/w (kg solute/kg solution) compensatory solutions. The Anton 
Parr Density meter is a vibrating U-tube density meter, which works by counting the 
oscillations of a vibrating U-tube. According to Hooke’s law, the period of spring is 
directly proportional to the square root of the mass. Likewise, with a constant volume U-
tube, the mass or density is linearly related to the square of the period of oscillation. The 
density meter gives a read out of the period of oscillation for the U-tube, by which the 
value of density of the sample can be found. 
 
The water bath heater was first turned on and set at a constant temperature of 22°C. The 
cell was cleaned thoroughly and dried by connecting the plastic tube from the pump to 
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the top syringe connection. The pump was then turned off and the period for air recorded 
(τa). A syringe was filled with distilled water, connected to the bottom connection of the 
U-tube and approximately 1 mL was injected. The period for water was then recorded 
(τw). The water in the tube was removed and remaining water flushed out using the air 
pump. Sample solutions were incubated for five minutes at 22°C in the water bath and 
then injected into the U-tube using a syringe. The period for the sample was recorded (τs). 
Two readings for the each sample were recorded to minimize the error. The density of the 
sample (ρs) was obtained from: 
        
     ( )2222 ws
aw
aw
ws ττττ
ρρρρ −⎟⎟⎠
⎞
⎜⎜⎝
⎛
−
−+=                  (7.1) 
Where ρw and ρa are the densities of water and air at 22 °C. 
7.2.3   Viscosity measurements 
 
Viscosity of all the compensatory solutions was measured using a Cannon-Manning 
Semi-Micro Viscometer (Size 100, Cannon Instrument Co., USA). 23% w/w solutions 
were used for measuring the viscosity and all measurements were done at a constant 
temperature of 22°C. Kinematic viscosity in mm2/s of each sample was calculated by 
multiplying the efflux time by the viscometer constant (0.015 mm2/s2) 
7.2.4   Calculation of apparent hydration number (H) of compensatory solutes 
 
Apparent hydration number (H) of each solute was calculated using their density and 
viscosity. It is easy to express the amount of hydration of each solute in solution as an 
average number ‘H’ of water molecules present in the hydration envelope of one 
molecule of the solute. All solute particles are assumed spherical for these calculations. 
The following steps were followed to calculate the apparent hydration number, H. 
 
Step 1: 
Mass fraction (kg solute/kg solution) was calculated using: 
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Step 2: 
From mass fraction, density of solute, ρsolute, was found using: 
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Where ρs and ρw are the densities of solution and water respectively. 
Step 3: 
Molar volume of the solute from density, Vdensity (m3/mol), was calculated using: 
 
solute
density
unhydratedwtMolV ρ
).(.=     (7.4) 
 
Step 4: 
Dynamic viscosity (Pa.s) = Kinematic viscosity x ρs 
 
Step 5:                               
Relative viscosity, ηrel = ( )wo  C22at  water ofViscosity  
 viscosityDynamic
η  
 
Step 6: 
Assuming all solute particles to be spherical, we can use Einstein’s equation 
 ( )( )21
5.01
φ
φη −
+=rel       (7.5) 
Where φ is the total volume fraction (m3 solute/m3 solution). Substituting for ηrel from 
Step 5, value of φ was solved. 
 
Step 7: 
166 
Chapter 7 
Molar volume of solute from viscosity, Vviscosity (m3/mol), was calculated using: 
 ωρ
φ
×
×=
solution
unhydratedwtMol ).(.Vviscosity   (7.6) 
 
 
Step 8: 
Molar volume of water, Vwater (m3/mol), was obtained from 
 
 
01802.0Vwater
wρ=  
Where ρw is the density of water at 22°C. 
 
Step 9: 
The apparent hydration number, H, or the No. of water molecules per solute molecule, 
was calculated using: 
 
water
densityviscosity
V
V V
H
−=  
7.2.5   Theoretical Calculations 
 
HDB, HGB, CB-1 and SB-2 were chosen for determination of gas-phase structures. The 
calculations were performed using the GAUSSIAN03 program (Frisch et al., 2003). The 
structures were determined at HF/6-31G, MP2/6-31G, and B3LYP/6-31G levels of 
theory. The charge on each atom was calculated from the calculated wavefunction using a 
procedure first suggested by Mulliken (Mulliken, 1955) and the charges are termed 
Mulliken populations. Dipole moments and polarizability were calculated from the 
electronic wavefunction.  
 
7.3 RESULTS 
7.3.1   Stability of compensatory solutes 
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Table 7.1 lists the rate of decomposition of different compensatory solutes per minute 
when 100 mM solutions were incubated at 90°C for two hours in a temperature block. 
Aliquots of these solutions were collected every 30 minutes during the incubation and 
analyzed in the HPLC system. Compensatory solutes appeared as peaks with specific 
retention time and height, and the area under the peak was calculated using the DELTA 
chromatography system. It was observed that as the incubation time increased, there was 
a change in the peak size and area under the peak decreased. 
 
Table 7.1: Rate of decomposition (%) ± SEM of compensatory solutes per minute when 
100 mM solutions were incubated at 90°C 
Solute Rate of decomposition(%) / min * 
Glycine betaine 0.08 ± 0.01  
Dimethylthetin (DMT) 0.05 ± 0.01  
Propio betaine (PB) 0.09 ± 0.01  
CB-1 0.25 ± 0.02  
Deanol betaine (DB) 0.12 ± 0.02  
Homodeanol betaine (HDB) 0.37 ± 0.07  
Homoglycero betaine (HGB) 0.41 ± 0.05  
Diethanol homobetaine (DEHB) 0.40 ± 0.03 % 
* Results from exponential fit of the data from three replicate trials 
 
The area under the peak of a solute sample at different incubation times were compared 
with its area without incubation and the relative area was calculated. The decrease in the 
relative area gave a measure of stability of the solute. Plots of decrease in the relative 
area with the increase in incubation time are as shown in Figure 7.2. 
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Figure 7.2: Decomposition of 100 mM compensatory solution when incubated at 90°C. 
The decrease in relative area under the peak with increase in time of incubation 
represents the stability of the solute. The relative area is relative to the area under the 
peak for each solute without incubation 
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From 7.2 and Table 7.1 we observe that GB, propio betaine and DMT seem to be fairly 
stable compared to DB, HDB, HGB and DEHB. The rate of decomposition is less than 
0.1% per minute for GB, propio betaine and DMT. In case of solutes containing –OH 
groups, their stability decreased with the increase in the size of the molecule. HGB and 
DEHB decomposed approximately at a rate of 0.4% per minute at 90°C. HGB and 
DEHB, which have two –OH groups are less stable than DB and HDB with one –OH 
group. Cyclic betaine, CB-1, is also not very stable as it decomposes at an approximate 
rate of 0.25% per minute at 90°C.  
 
Stability of sulfobetaines was not studied using this method as the UV detector could not 
detect sulfonic acid solutes. Attempts were made to use a refractive index (RI) detector 
instead of an UV detector. However, due to inconsistencies in the results we resorted 
back to the UV detector. 
7.3.2   Density, Viscosity and Hydration Number 
 
Results of density and viscosity measurements are listed in Table 7.2. As expected, 
dynamic viscosities of sorbitol and trehalose are higher compared to other solutes. Of all 
the synthetic compensatory solutes, solutes containing two –OH groups in their structure, 
that is HGB, DEHB and SB-4, have high dynamic viscosities. Dynamic viscosities of 
HDB and CB-1 are approximately 0.002 Pa.s and are in the higher range as well. 
 
Table 7.2 also lists the apparent hydration numbers of different compensatory solutes 
calculated assuming spherical molecules. Trehalose has the highest apparent hydration 
number of 10.7. Synthetic solutes, HGB and DEHB have a hydration number of around 
5.0, which is similar to that of sorbitol. GB, DMT, CSB-1 and urea have very low 
hydration numbers, with CSB-1 and urea having negative hydration numbers. Hydration 
number of sulfobetaines seemed to increase with the increasing distance between S and N 
in their structure. This is evident as hydration number of SB-1 is around 1.1 and that of 
SB-3 is 3.3, which has two extra CH2’s between its S and N compared to SB-1. Similarly, 
the apparent hydration numbers of GB is around 0.7 and that of propio betaine is around 
1.7, which has an extra CH2 between its charges compared to GB. 
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Table 7.2: Density and dynamic viscosities of 23% w/w compensatory solutions. * Apparent hydration number, H, is the number of 
water molecules associated with each molecule of solute in solution. The uncertainties of H are based on the density and viscosity 
uncertainty only and do not take into account the spherical molecule assumption. 
Solute   Density, kg/m3  Dynamic Viscosity, Pa.s  Apparent Hydration Number (H)*
Sorbitol  1083.2 ± 0.5  2.26 x 10-3   5.2 ± 0.0 
Trehalose  1087.3 ± 0.0  2.11 x 10-3  10.7 ± 0.1 
Glycine betaine  1031.7 ± 0.4  1.70 x 10-3    0.7 ± 0.0 
Propio betaine [PB]  1033.6 ± 0.2  1.83 x 10-3   1.6 ± 0.0 
Deanol betaine [DB]  1050.5 ± 0.5  1.83 x 10-3   1.2 ± 0.0 
Homodeanol betaine [HDB]  1049.1 ± 0.4  2.01 x 10-3   2.4 ± 0.1 
Homoglycerol betaine [HGB]  1056.6 ± 0.5  2.17 x 10-3   5.3 ± 0.0 
Diethanol homobetaine [DEHB]  1057.9 ± 0.5  2.30 x 10-3   5.0 ± 0.1 
CB-1  1052.5 ± 0.3  1.96 x 10-3  3.4 ± 0.1 
SB-1  1065.3 ± 0.2  1.69 x 10-3  1.0 ± 0.0 
SB-2  1061.5 ± 0.6  1.76 x 10-3  1.6 ± 0.1 
SB-3  1049.8 ± 0.4  1.98 x 10-3  3.3 ± 0.0 
SB-4  1024.1 ± 0.3  2.19 x 10-3  4.3 ± 0.0 
CSB-1  1064.1 ± 0.7  1.51 x 10-3                              -0.9 ± 0.1 
CSB-2  1050.2 ± 0.6  1.99 x 10-3  3.2 ± 0.1 
Dimethylthetin [DMT]  1054.0 ± 0.6  1.56 x 10-3  0.3 ± 0.1 
Urea  1062.2 ± 0.6  1.26 x 10-3                              -1.1 ± 0.0 
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The increase in apparent hydration number is also observed in betaine analogues with 
hydroxyl groups. Hydration number of HGB (with two –OH groups) is around 5.3, which 
is twice that of HDB with one –OH group. Sulfobetaine, SB-4, with two –OH groups also 
has a high hydration number of 4.3. Another interesting result is that hydration number of 
CB-1 is around 3.4 and that of CSB-1 is -0.9, which is different even though both are 
morpholinium compounds. However, CB-1 is a carboxylic acid analogue and CSB-1 is a 
sulfobetaine. Cyclic sulfobetaine CSB-2 (piperidium compound) also has a high 
hydration number of around 3.2.  
7.3.3   Theoretical Calculations 
 
The dipole moments and the polarizability of various compensatory solutes calculated at 
various levels of theory are listed in Table 7.3 and 7.4 respectively. 
 
Table 7.3: Calculated dipole moments (in debye) 
 
 
                                Method: HF MP2 B3LYP 
 µ/D 
Solute: 
 
Glycine betaine 11.97 11.18 10.85 
Propio betaine 17.91 16.98 16.40 
Dimethylthetin 10.16 9.24 8.78 
HDB  19.32 12.04 13.09 
HGB  19.37 19.17 17.77 
SB-2  25.60 25.03 24.35 
CB-1  17.61 11.49 10.94 
 
Urea  4.00 3.35 3.49 
DMSO 5.00 4.05 3.93 
 
 
All compensatory solutes have a negatively charged end and a positively charged end. All 
synthetic compensatory solutes have a large dipole moment, except for DMT. 
Sulfobetaine SB-2 has the largest dipole moment of all the synthetic solutes. Natural 
solute glycine betaine has a relatively smaller dipole moment. Dipole moments of urea 
and DMSO are smaller than other solutes. 
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Table 7.4: Calculated polarizability 
 
 
               Method: HF B3LYP 
 /Ǻ3
Solute: 
 
Glycine betaine   8.71   9.69 
Propio betaine 10.21   0.00 
Dimethylthetin   8.97 10.09 
HDB  12.13 13.15 
HGB  13.99 16.05 
SB-2  14.60 16.58 
CB-1  13.06 14.10 
 
Urea    3.39   3.84 
DMSO    6.09   6.30 
 
 
 
From Table 7.4, we see that the calculated polarizabilities of synthetic compensatory 
solutes are high compared to other solutes, except for DMT. HGB and SB-2 have the 
highest polarizability, and urea and DMSO the lowest. 
 
The structures of number of compensatory solutes studied are as shown in Figures 7.3 A, 
B and C. The calculations reported are at the same level of theory for all molecular 
species. The charges are Mulliken population analyses corresponding to the MP2 energy. 
 
 
Figure 7.3 A: Structures and Mulliken charges of compensatory solutes (Lever et al., 
2001) 
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Figure 7.3 B: MP2/ 6-31G structures and Mulliken charges for HDB and HGB 
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Figure 7.3 C: MP2/6-31G structures and Mulliken charges for CB-1 and SB-2 
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7.4 DISCUSSION 
 
Only a few synthetic solutes (carboxylic acid analogues) were used for the stability 
experiments as the UV detector could not be used to analyze sulfobetaines (Storer and 
Lever, 2006). A few trials were carried out using a refractive index detector (Jasco) 
instead of a UV detector, which allowed us to analyze all the solutes including 
sulfobetaines. However, results obtained using the RI detector were inconsistent and so it 
was again replaced by an UV detector and a standard derivatization method (Storer et al., 
2006) was followed. The results of stability of sulfobetaines (results not shown) obtained 
using the RI detector gave us a qualitative indication that sulfobetaines are more stable 
than the carboxylic acid analogues.  
 
It was shown in Chapter 6 (section 6.3.2) that a number of synthetic solutes such as HDB, 
HGB and CB-1 that were very good stabilizers of LDH and chymotrypsin against heat 
stress, failed to protect Taq polymerase when it was incubated at 95°C. The reason for 
this failure is evident from the results of stability experiments. These results clearly show 
that CB-1, HDB and HGB decompose at a higher rate than the other solutes when heated 
at 90°C. Consequently, these solutes might have decomposed faster during the incubation 
of Taq polymerase at 95°C for two hours, leading to the formation of starting materials 
which would have inhibited the activity of the enzyme. This was not the case during 
experiments with LDH and chymotrypsin as the enzymes were heated with the 
compensatory solutes for only 10 min and the maximum temperature used was 70°C. 
Thus, the solutes were able to protect LDH and chymotrypsin but failed with Taq 
polymerase. 
 
Density and viscosity measurements were carried as some of the solutes used in this 
thesis are new and not much physical data is available for them. The density and viscosity 
results were further used to calculate the apparent hydration number, H, of the solutes. 
The apparent hydration numbers of different solutes provide us with a picture of 
interaction of water molecules with the solute molecules. The apparent hydration 
numbers indicate the number of water molecules that are associated with a solute 
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molecule in solution. These numbers might give some insight in to the mechanism of 
protein stabilization by compensatory solutes.  
 
Results show that the hydration numbers of sorbitol and trehalose are different from those 
of synthetic betaines. This is may be due to the fact that sorbitol is a polyol and trehalose 
is a disaccharide, and have different structures compared to the synthetic betaines, which 
have some structural similarities. It is observed that solutes that are good protein 
stabilizers (e.g. HDB, HGB, CB-1 and SB-3) have higher hydration numbers compared to 
moderate stabilizers (e.g. GB, DMT and SB-1). This is supported by the negative 
hydration number of urea, which is a denaturant and known for its protein destabilizing 
effects. Also observed from the results is that the apparent hydration number of trehalose 
is almost twice of HGB. However, results of protein stabilization (Chapter 4) showed that 
HGB is a better stabilizer than trehalose during heat denaturation of enzymes. 
 
Wiggins (1990) published a model describing structural differences between hydration 
water and bulk water, according to which two layers of water are found around a protein; 
dense (or weakly bonded) water in the hydration shell of proteins and  less dense water 
(or structured water) in bulk. Based on this theory, Galinski (1993) suggested that 
different solutes will show preferences to one or both the water layers: small highly 
charged molecules preferentially dissolve in hydration water, whereas large molecules of 
low charge density are better dissolved in bulk water. Galinski (1993) determined the 
hydration numbers of natural compatible solutes (glycine betaine and ectoine) using near-
infrared spectroscopy, and based on these hydration numbers they concluded that 
compatible solutes have relatively large hydration shells. Thus, compatible solutes 
because of their large hydration shells prefer to dissolve in the bulk water, which is more 
structured form of water. Our results of apparent hydration numbers of synthetic 
compensatory solutes support these suggestions by Galinski (1993). However, our results 
can only be considered as an estimate of hydration numbers as we have assumed all 
solute molecules to be spherical in our calculations. From the results, it is also observed 
that synthetic solutes that are good protein stabilizers have higher apparent hydration 
numbers compared to the rest. This shows that the solutes prefer the bulk water (less 
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dense water) resulting in the preferential exclusion of compensatory solutes from the 
hydration shell of the proteins. 
 
In a study by Turner (2000), they showed that under low water conditions the stability of 
enzymes increases and makes them possible to perform biotransformations at higher 
temperatures. They suggested that at low water activity enzymes are catalytically active 
at higher temperatures. The apparent hydration numbers of solutes which protect 
enzymes against heat denaturation are high (e.g. HGB, HDB etc), which suggests that the 
solutes attract more water molecules towards them in solution reducing the amount of 
water available for the protein, which in turn might be helping the enzymes to maintain 
their catalytic activity at higher temperatures.  
 
These are just speculative arguments in an effort to understand more about how these 
solutes stabilize the proteins. These arguments are not based on clear and precise results 
as we assumed all solute particles to be spherical while calculating the apparent hydration 
numbers. Also, it has been stated that these calculations have empirical validity only, and 
that no precise meaning should be attached to the apparent hydration numbers (Edward, 
1957).  In an investigation using quantum mechanical calculations and QM/MM 
molecular dynamic simulation (Sironi et al., 2001), the effect of glycine betaine on 
structure and dynamics of the surrounding water was compared with those of trehalose. 
They calculated the of average number of water molecules residing within 3.5 Å of the 
solute atoms (first-shell waters) and those that are hydrogen bonded to the solutes (H-B 
waters), and showed that glycine betaine and trehalose have 7.0 and 18.9 water molecules 
respectively in their H-B waters. In case of trehalose, their values are comparable to our 
calculated apparent hydration number. However, in case of glycine betaine, it is evident 
that the apparent hydration number by our calculations seems to be less compared to their 
calculations. 
 
An attempt was made to determine if there was a correlation between the hydration 
numbers of solutes and the relative activity of enzymes during heat denaturation and 
freeze-drying. Figure 7.4 shows the plot of apparent hydration number of solutes versus 
the relative activity of LDH after freeze drying in their presence. 
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Figure 7.4: Relation between hydration numbers (H) of compensatory solutes and 
relative activity of LDH after freeze-drying in the presence of different 1 M 
compensatory solutions. 
 
Though Figure 7.4 does not show a perfect correlation, it gives an indication that the 
increase in the hydration number of solutes increases its ability to protect LDH against 
freeze-drying. This shows that the solute molecules which have more water molecules in 
their hydration envelope tend to give better water substitution to enzymes during the 
dehydration stage of freeze-drying. To determine if there was a relation between 
protection against heat denaturation of enzymes and apparent hydration numbers of 
solutes, we plotted the change in TD-50 (°C) of LDH and chymotrypsin in the presence of 
different solutes against hydration numbers (Figure 7.5). However, no apparent relation 
could be observed. Changes in TD-50 temperatures versus dynamic viscosity of 1 M 
compensatory solutions was also plotted to determine if any relation existed between the 
viscosity of the solution and the observed stabilization effect (Figure 7.6). Again, no 
relation could be deduced from this plot. 
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Figure 7.5: Relation between apparent hydration number (H) and change in TD-50 
(change in temperature at which 50% of enzyme activity is lost, Table 4.1, Chapter 4) in 
the presence of different compensatory solutes (A) LDH (B) Chymotrypsin. 
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Figure 7.6: Relation between dynamic viscosities of 1 M compensatory solutions and 
changes in TD-50 (change in temperature at which 50% of enzyme activity is lost, Table 
4.1, Chapter 4) (A) LDH (B) Chymotrypsin. 
The structures of compensatory solutes in Figure 7.3 A, B and C were determined at 
MP2/6-31G level of theory. The structures are “gas-phase” structures, but should be a 
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good approximation to structure in solution. It was possible to calculate the dipole 
moment and polarizability of solutes from the electronic wave functions. It is evident 
from Table 7.3 and 7.4 that synthetic solutes HDB, HGB, SB-2 and CB-1, which are 
good protein stabilizers, have large dipole moment and high polarizability compared to 
other compensatory solutes. The large dipole moments could be responsible for 
significant interactions with other molecules and water molecules. They could also 
modify the water structure in solutions. The large dipole moment and polarizability of 
HDB and HGB correlate well with the calculated apparent hydration numbers, which 
suggests that these solutes strongly interact with water molecules. These results could 
also imply that the solutes have higher affinity towards the bulk water and get 
preferentially excluded from the protein surface, which results in good protein 
stabilization. All these results further support the preferential exclusion/ hydration model. 
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Chapter 8 - Discussion and Conclusions 
 
8.1  DISCUSSION 
 
The discussion about specific applications of synthetic compensatory solutes is contained 
within the relevant chapters. In this general discussion an attempt is made to consider the 
effects of compensatory solutes in various applications and to determine if there are any 
general effects observed within any particular group of compensatory solutes. 
 
 The syntheses and different biomedical applications of a range of novel compensatory 
solutes have been investigated in this thesis. The majority of compensatory solutes were 
easy to synthesize and a few of them were inexpensive compared to their natural 
counterparts. Though the purity and the yield of a few solutes are a matter of concern, we 
believe that designing an industrial scale process of syntheses would result in better 
products. As the solutes were synthesized during different stages of the three year project, 
a few solutes have not been used in some experiments described in the thesis. 
 
Thermostable enzymes have allowed for the development of techniques such as PCR. 
However, the majority of the thermostable enzymes are obtained from thermophilic 
organisms, and their isolation and purification makes them expensive. To expand the 
availability of these thermostable enzymes, scientists have explored novel methods such 
as addition of co-solvents and structure stabilizing solutes in order to thermostabilize 
enzymes that are thermolabile. This work presents the thermostabilization of different 
model proteins by synthetic compensatory solutes. As a result, it enabled the 
identification of a number of novel thermostabilizers of enzymes. In the presence of these 
stabilizers, the enzymes were able to maintain their catalytic activity even at temperatures 
where the enzyme, in the absence of solutes, would have been rendered inactive. It was 
also shown that the observed stabilization effects were not just on the catalytic activity of 
the enzyme but also on the structural conformation.  
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Thermostabilization and thermoactivation of enzymes has the potential to pave the way 
for various new applications in a wide range of fields. In fact, the combination of 
thermostabilization and increasing the enzyme’s catalytic activity may be very helpful in 
reducing the quantity of enzyme used in many industrial and laboratory scale 
applications. Furthermore, this increase in activity would increase the speed of a given 
reaction and thus reduce the time required.  
 
Table 8.1 summarizes the effects of various compensatory solutes in some of the 
applications investigated in this thesis. It is evident from the table that trehalose lives up 
to its title as a “universal stabilizer” as it is consistent in its stabilization effect on various 
proteins and stress factors. Sorbitol shows a similar trend though its stabilization effect is 
not as good as trehalose. Table 8.1 also shows that synthetic solutes are good stabilizers 
of proteins. During stabilization against heat, synthetic solutes such as HDB and HGB 
show superior performance than the other compensatory solutes, including trehalose. 
However, during stabilization against low temperatures (e.g. freeze-drying), it is the 
natural solutes such as trehalose which exhibit outstanding stabilization effect. But, 
synthetic solutes do not fail completely here. Solutes such as HGB and HDB, which show 
considerable stabilization during freeze-drying, could be a cheaper option to trehalose 
when considered on a gram basis. They can even be used along with trehalose (mixtures) 
which could bring down the cost of freeze-dried products. 
 
One common feature that is observed from the study of stabilization of proteins is that 
compensatory solutes with OH groups are good stabilizers when compared to other 
solutes. Trehalose, sorbitol, HGB, HDB, DB and sulfobetaines have one or more OH 
groups and are good protein stabilizers. This raises the question whether OH/hydroxyl 
group is a pre-requisite for a solute to be a good protein stabilizer. Though exact 
conclusions cannot be drawn on this, the results of this work suggest that this is true. The 
mechanisms of protein stabilization that have been proposed in the past (detailed in 
Chapter 2) point out that solutes which are good protein stabilizers are good water 
structure formers (kosmotropes) and are excluded from the immediate vicinity of the 
protein surface. Results presented in Chapter 7 of this thesis tell the same story about 
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synthetic solutes. The good protein stabilizers such as HDB and HGB have a bigger 
apparent hydration number, high dipole moment and polarizability. These results suggest 
that stabilizing solutes tend to interact more with water and thus have more affinity 
towards the bulk water than the protein surface, which in turn suggest preferential 
exclusion of the solutes from the surface of the protein. Thus, our results seem to agree 
well and support the preferential exclusion model of protein stabilization (2.2.1, Chapter 
2). 
 
Another interesting observation that we can draw from Table 8.1 is that during freeze-
drying only solutes with OH groups are able to confer protection to the enzymes and the 
solutes without OH groups fail completely. This supports the mechanism and evidence 
provided by Carpenter and co-wrokers (2.2.4.2, Chapter 2), who suggested that solutes 
are able to protect proteins during freeze-drying only because they hydrogen-bond to the 
dried protein, acting as water substitutes. This is well supported by our results which 
show that GB, propio betaine, CB-1 and DMT due to their lack of hydroxyl group fail to 
protect LDH during freeze-drying.   
 
Though the results presented in this work tend to support some of the previously 
proposed protein stabilization mechanisms, we believe that there is no any one particular 
mechanism by which the stabilization of proteins can be explained. Previous workers 
have considered only a few natural stabilizers for their studies of mechanism of protein 
stabilization by co-solvents. These studies if carried out again considering the novel 
synthetic solutes presented in this thesis, would throw more insight into the stabilization 
mechanisms. Also, previously two types of solutes were considered for protein 
stabilization studies; zwitterionic stabilizers that had high dipole moments (e.g. amino 
acids, TMAO, GB), and polyols which formed hydrogen bonds with both water and 
proteins due to the presence of hydroxyl groups. In this work, we have investigated 
solutes that are both zwitterionic and have hydroxyl groups. In this way we have tried to 
combine the two different effects. Similar work was carried out by Lippert and Galinski 
(1992) with their study of enzyme stabilization using ectoine and hydroxyectoine, two 
natural compatible solutes. 
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Table 8.1: Summary of effects of various compensatory solutes in different applications investigated in this thesis. (Stabilization of 
Proteins: ✔ - stabilizer and ✘ - no effect, DNA melting: ‘Increase’ – stabilizes DNA and ‘Decrease’ – reduces DNA melting 
temperature, PCR Enhancer: ✔ - potential enhancer and ✘ - no enhancing effect) (Note: ND – Data not available) 
 
Stabilization against heat Freeze-
thawing 
Freeze-drying Effect on DNA 
melting 
temperature 
PCR 
Enhancer 
 
  Solutes 
LDH       Chymotrypsin CBG Taq 
Polymerase 
Lipase LDH LDH Lipase  
Natural Solutes           
GB ✔ ✔ ✔ ✔ ✘ ✔ ✘ ✘ Decrease ✔ 
Trehalose ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ Decrease ✔ 
Sorbitol ✔ ✔ ✔ ✔ ✔ ✔  ✔ ✔ Decrease ND 
Synthetic Solutes           
Propio betaine ✔ ✔ ✔ ✘ ND ✔ ✘ ND Increase ND 
DB ✔ ✔ ✔ ✔ ND ✔ ✔ ND Increase ND 
HDB ✔ ✔ ✔ ✘ ✔ ✔ ✔ ✔ Increase ND 
HGB ✔ ✔ ✔ ✘ ND ✔ ✔ ND Increase ND 
DEHB ✔ ✘ ✔ ✘ ND ✔ ✔ ND ND ND 
CB-1 ✔ ✔ ✘ ✘ ND ✔ ✘ ND Decrease ND 
DMT ✔ ✔ ✘ ✔ ✘ ✔ ✘ ✔ ND  
Sulfobetaines           
SB-1 ✔ ✘ ✘ ✔ ND ✔ ✘ ND ND ND 
SB-2 ✔ ✔ ✘ ✔ ND ✔ ✔ ND Decrease ✔ 
SB-3 ✔ ✔ ✔ ✔ ND ✔ ✘ ND Increase ND 
SB-4 ✔ ✔ ✘ ✘ ND ✔ ✔ ND Decrease ND 
CSB-1 ND  ND ND ✔ ND ND ND ND Decrease ✔ 
CSB-2 ND  ND ND ✘ ND ND ND ND Decrease ND 
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It is suggested that, in order to stabilize a protein against an external stress, it is better to 
have a range of stabilizers to choose from (as presented in this work) and select the best 
stabilizer for that particular protein and the stress factor. Although protein stabilization 
applications would require a case by case selection of the synthetic solutes (as their effect 
may be enzyme specific or stress specific), the simplicity of stabilization of these 
synthetic solutes has a great potential to improve the cost and time involved in a wide 
range of enzymatic applications, biochemical reactions, diagnostics and industrial fields. 
Also, this kind of stabilization would increase the overall efficiency, and thus allow 
yields unexpected under standard conditions.  
 
Apart from investigating the important application of the synthetic compensatory solutes, 
that is protein stabilization, this thesis also examined applications such as their effect on 
DNA melting temperature and PCR enhancers. Table 8.1 summarizes the effect of 
various compensatory solutes on the DNA melting temperature. The mechanism by 
which compensatory solutes destabilize the DNA double helix is not well understood. A 
number of mechanisms have been proposed based on the results of a few natural 
compensatory solutes. This thesis presents a new range of synthetic compensatory solutes 
which have different effects on DNA melting temperatures. 
 
It is observed that a slight change in the structure of the solute (e.g. distance between the 
charges), changes the effect of the solute on the DNA completely.  Comparing the effect 
of GB and propio betaine on the DNA melting temperature, where GB reduces the 
melting temperature and propio betaine increases it, we see that the only structural 
difference between these two is that propio betaine has an extra CH2 between its charges 
(see Appendix A for the complete list of structures of compensatory solutes). Similarly, 
opposite effects are observed with SB-2 and SB-3, where SB-3 increases and SB-2 
decreases the DNA melting temperature. This is a rather more interesting result as all 
other sulfobetaines considered in this work decrease the melting temperature except for 
SB-3.  
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Further interesting results on DNA melting temperature were obtained with solutes with 
OH groups. Results showed that trehalose and sorbitol stabilize the proteins and 
destabilize the DNA, where as, synthetic solutes DB, HDB, HGB and DEHB stabilize 
both proteins and DNA. However, sulfobetaines SB-1, SB-2 and SB-4, though they have 
OH groups in their structures, destabilize the DNA double helix. Comparing HGB and 
SB-4, it is observed that both are synthetic solutes and both have two OH groups, but 
they have completely opposite effects on the DNA melting temperature, that is HGB 
increases and SB-4 decreases the melting temperature. These interesting properties of 
synthetic compensatory solutes have provided a platform for better understanding of the 
mechanism by which compensatory solutes interact with DNA and other 
macromolecules. Based on observed stabilization of DNA double strand by solutes such 
as HDB and HGB, we believe that a few synthetic compensatory solutes could find 
potential applications in the area of DNA storage, as long-term storage of DNA is 
required for a number of genetic studies (Madisen, 1987). 
 
This work has explored a few potential applications of synthetic compensatory solutes. 
However, various other applications can also be investigated in a number of industries 
such as, 
 
• Diagnostic reagents 
• Cell stabilization  
• Animal products and leather industry. 
• Pharmaceutical industry 
• Cosmetics 
• Food industry 
 
Synthetic compensatory solutes could be expected to function in many of these 
applications, though they have not been specifically tested for them.  Many reagents that 
contain enzymes are usually supplied with stabilizing substances such as glycerol. These 
usual stabilizing substances can be replaced by synthetic compensatory solutes which are 
inexpensive and have better stabilizing properties. A number of commercial PCR 
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reagents contain GB and DMSO as enhancer solutions, which reduce the melting 
temperature of double-stranded DNA and also protect the enzyme against high 
temperatures. Results presented in this thesis show that synthetic solutes are better than 
GB in reducing the DNA melting temperatures. Hence, synthetic solutes may have a 
potential to replace GB in PCR enhancer solutions.  
 
Bacteria are used industrially in processes like organic chemical transformations. 
Cultures of the bacteria can be stored dried or frozen with suitable stabilizing additives. 
Other mammalian cell types have also been preserved using trehalose and other solutes 
(Brumfiel, 2004). These can be some of the other potential applications of our solutes. 
There are also several aspects of pharmaceutical industry such as production of vaccines 
and other protein based pharmaceuticals where our solutes have market potential.  
However, if synthetic solutes are to be used internally in humans, then a number of 
toxicity tests have to be carried out, and at this stage we don’t have any data regarding 
them. 
 
The stabilizing solutes GB and ectoine are being used in cosmetic preparations as active 
ingredients in skin moisturizers and anti-wrinkle creams (http://www.merck.com). We 
have shown from our results that some of our solutes are more effective than GB and 
ectoine in stabilizing proteins and are less expensive. We feel that our synthetic solutes 
have a good commercial potential in the cosmetic industry. Furthermore, less stringent 
trials are needed to prove that the solutes are safe to be used for application on skin 
compared to their applications in the pharmaceutical or food industries.  
 
8.2  CONCLUSIONS 
8.2.1  Syntheses of compensatory solutes 
 
A range of novel compensatory solutes were synthesized in the laboratory. The majority 
of the solutes were easy to synthesize and the yield was usually more than 75%. Some of 
the solutes can be synthesized from inexpensive starting materials and the cost of the 
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solute is cheaper compared to the natural solutes. A few of the solutes, especially HGB 
and sulfobetaines, are more expensive to synthesize due to the high price of their starting 
materials. However, the cost of these expensive solutes could reduce if a large-scale 
process for their synthesis is designed. 
8.2.2  Application of synthetic compensatory solutes as protein stabilizers 
 
This thesis has showed that synthetic compensatory solutes have a potential application 
as protein stabilizers. Based on the results using a few model proteins, it was shown that 
synthetic solutes stabilize proteins against the denaturing effects of high and low 
temperatures. It was also proved that the observed stabilization effect is not just on the 
catalytic activity of the enzyme, but also on its structural conformation. Based on these 
results we also conclude that while selecting a suitable stabilizer for a particular protein, 
it is always better to have a range of stabilizers ready as the stabilization effect of solutes 
may vary from protein to protein. Thus, we have successfully added a number of 
inexpensive solutes to the available range of protein stabilizers. 
8.2.3  Medical application of betaine analogues 
 
The application of DMT, a synthetic betaine analogue, as a therapeutic agent was not 
successful. However, from the study we were able to generate a large-animal CAPD 
model, which to our knowledge is the first attempt. A sheep CAPD model has several 
advantages over a small animal model and will help researchers to study the same animal 
repeatedly in both control and uremic conditions. It was also shown that addition of GB 
in dialysis fluid for chronic renal failure patients can be a viable option as GB was not 
toxic to sheep when administered via dialysis fluid. This is a very helpful result as long-
term oral supplementation with GB in chronic renal failure patients for lowering 
homocysteine concentration has been problematic. 
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8.2.4  Synthetic compensatory solutes for reducing DNA melting 
temperatures and their application as PCR enhancers 
 
A few of the synthetic compensatory solutes were able to reduce the melting 
temperatures of DNA better than most of the well known solutes such as GB, trehalose 
and sorbitol. GB is being used as an active ingredient in a number of PCR enhancers that 
are being marketed by commercial suppliers. Synthetic solutes CSB-1 and SB-2 were 
shown to have the potential to replace GC-Rich Resolution Solution supplied by Roche in 
a Fragile-X PCR assay. Considering Taq Polymerase as another model enzyme for the 
stabilization studies, it was also shown that a few synthetic compensatory solutes are able 
to protect even a thermophilic enzyme (Taq polymerase) against high temperatures. 
8.2.5  Physical data for synthetic compensatory solutes 
 
As most of the solutes synthesized in this thesis are new, information has been provided 
about their stability, density and viscosity. In an attempt to understand more about the 
mechanisms of protein stabilization, the apparent hydration numbers, dipole moment and 
polarizability of synthetic compensatory solutes were calculated. Results presented in this 
thesis seem to agree with the preferential exclusion mechanism of protein stabilization. 
 
8.3  RECOMMENDATIONS FOR FUTURE WORK 
 
Though only a few of synthetic solutes and their application in a few areas were studied, 
results of this work have raised the interest for synthesizing more solutes that might be 
inexpensive and have wider range of applications. Listed below are a number of synthetic 
compensatory solutes and their possible starting materials that could be synthesized for 
any future work in this area. 
 
N
CH3
H3C
CH3
CH2CH2CH2COO
  
Synthetic Solute 1: Trimethylamine + bromobutyric acid 
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N
CH3
CH3
HOCH2CH2 CH2CH2CH2COO
 
Synthetic Solute 2: Deanol + bromobutyric acid 
 
N
HO CH3
CH2CH2COO  
Synthetic Solute 3: 1-methyl-3-pyrrolidinol + acrylic acid 
 
N
CH2CH2OH
CH2CH2COO  
Synthetic Solute 4: 1-piperidine ethanol + acrylic acid 
 
N
CH3
H3C
CH3
CH2CH2SO3
 
Synthetic Solute 5: Trimethylamine + vinylsulfonic acid 
 
Other recommended works includes: 
• The stabilization effect of synthetic compensatory solutes should be studied with 
more model proteins and with different stress factors (e.g. urea denaturation). This 
would give a clear picture whether the observed stabilization effect by solutes is 
protein or stress specific.  
• As more number of novel protein stabilizers is available now, studies to understand 
the mechanism of protein stabilization can be carried out. Near-infrared 
spectroscopic studies with the novel compensatory solutes could add to the 
understanding of their effects on proteins during freeze-drying.  
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• The circular dichroism (CD) spectra and differential scanning calorimetric (DSC) 
studies of DNA in the presence of different compensatory solutes could be carried 
out to study the DNA conformational changes in the presence of different solutes. 
• The effectiveness of novel synthetic solutes as PCR enhancers needs to be 
examined in more GC-rich PCR assays. PCR assays with different denaturing and 
annealing temperatures must be carried out to identify more PCR enhancers.  
• Synthesizing more inexpensive solutes that are similar to presently known PCR 
enhancers would be of great commercial interest. 
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Appendix A - Structures of Compensatory Solutes 
 
NATURAL COMPENSATORY SOLUTES 
 
 
N
CH3
H3C
CH3
CH2COO
OH
HO
H
O
H H
OH
H
HH
H
OH
OH
OH
OH
H
H
CH2OH
HOCH2
O
CH2OH
C OHH
COH H
CH O
CH O
CH2OH
H
H
 
Glycine betaine [GB]                   Trehalose                                                  Sorbitol 
 
 
SYNTHETIC COMPENSATORY SOLUTES 
 
 
S
H3C
H3C
CH2COO N
CH3
CH3
H3C CH2CH2COO N
CH3
HOCH2CH2 CH2COO
CH3  
 
Dimethylthetin [DMT]             Propio betaine [PB]                        Deanol betaine [DB] 
 
 
 
N
CH3
HOCH2CH2
CH3
CH2CH2COO N
CH3
CH2CH2COOHOCH2CHCH2
CH3OH  
 
 Homodeanol betaine [HDB]                                            Homoglycerol betaine [HGB] 
 
 
 
HOCH2CH2
HOCH2CH2
NH3C CH2CH2COO
 
 
                                         Diethanol homobetaine [DEHB]                                   
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HOCH2CH2
HOCH2CH2
NHOCH2CH2 CH2CH2COO
 
N
CH3
HOCH2CH2CH2
CH3
CH2CH2COO
 
       Triethanol homobetaine [TEHB]                Hydroxypropyl homobetaine [HPHB] 
 
 
CYCLIC BETAINES 
 
 
NO
CH3
CH2CH2COO
N
CH3
CH2CH2COO
N
CH3
CH2CH2COO  
 
          CB-1                                           CB-2                                           CB-3 
 
SULFO BETAINES 
 
N
CH3
CH2CH2SO3
CH3
HOCH2CH2 N
CH3
HOCH2CH2
CH3
CH2CH2CH2SO3
 
 
                       SB-1                                                                           SB-2 
 
 
N
CH3
HOCH2CH2 CH2CH2CH2CH2SO3
CH3
HOCH2CH2
HOCH2CH2
NH3C CH2CH2CH2SO3
 
 
                      SB-3                                                                           SB-4 
 
CYCLIC-SULFO BETAINES 
 
 
NO
CH3
CH2CH2CH2SO3
N
CH3
CH2CH2CH2SO3  
 
                    CSB-1                                                                        CSB-2   
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